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Enterotoxigenic Escherichia coli (ETEC) is a major cause of traveller’s and infantile diarrhoea 
in developing countries, and results in considerable mortality in under 5 year olds. Disease is 
mediated through adhesion of ETEC cells to the intestinal brush border and the secretion of the 
heat-stable and/or heat-labile toxin. Whilst the toxins have been well studied it is still not clear 
how their expression is regulated. Existing reports suggest a role for the cyclic AMP receptor 
protein (CRP) in this regulation.  
This work has defined binding of CRP, H-NS and σ70 across the genome of the prototypical 
ETEC strain H10407. We demonstrate a central role for all three factors in regulating 
pathogenicity in ETEC H10407. Specifically, we show that although CRP binding across the 
chromosome of H10407 does not appear to differ significantly from that of non-pathogenic 
Escherichia coli K-12, CRP has been co-opted as a regulator of some plasmid-encoded 
virulence genes. Hence, we show that CRP directly regulates expression of both estA2 and 
estA1, which encode the heat-stable toxins. Furthermore, CRP indirectly represses expression 
of the heat-labile toxin. This work also identifies a role for CRP in controlling transcription of 
a small open reading frame, imbedded within a gene, at the 3’ end of an operon encoding a 
type I secretion system.  
Intriguingly, CRP binding sites on the virulence plasmids p948 and p666 appear to be bound 
by H-NS rather than CRP in vivo. Since CRP and H-NS are known to respond to metabolic and 
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1.1 Bacterial RNA polymerase 
1.1.1 Gene regulation and the central dogma 
The central dogma is a core concept of molecular biology. It describes the flow of genetic 
information from DNA to proteins via an RNA message. Briefly, DNA is organised into 
packets of information called genes that encode proteins. Genes are transcribed to form 
messenger RNA (mRNA) by RNA polymerase. These mRNAs are then translated by 
ribosomes into proteins (Figure 1.1). Transcription and translation are subject to regulation at 
various stages, with the earliest possible point of regulation being transcription initiation.   
1.1.2 Transcription in Escherichia coli- RNA polymerase 
Transcription in Escherichia coli (E. coli) requires a single 400 kDa DNA-dependent multi-
subunit RNA polymerase (RNAP) (Darst, 2001, Browning and Busby, 2004). A high-
resolution structure of RNAP is shown in Figure 1.2A, and a schematic is shown in Figure 
1.2B. The core enzyme consists of five subunits; β, β’, two α subunits, and ω, all of which have 
different functions (Zhang et al., 1999). Early cryo-EM studies revealed that the RNA 
polymerase has an overall ‘crab-claw’ structure, where the DNA double helix is accommodated 
between the ‘claws’ (Darst, 2001). More recent high resolution studies of Thermus aquaticus 
(Taq) RNAP core (3.3 Å) and holoenzyme (4 Å), together with crystal structures of the E. coli 
RNAP holoenzyme, has revealed the fine molecular details of RNAP-DNA interactions during 










Figure 1.1 Gene expression in E. coli 
DNA is shown in blue, RNA is shown in red. Dashed ladders represent bases, solid lines represent the 







































Figure 1.2 Structure of E. coli RNAP holoenzyme  
A) Crystal structure of E. coli RNAP holoenzyme (Murakami, 2013). Diagram contructed using 
PyMOL. Subunits have been colour coded. 
B) The cartoon shows RNAP containing σ70 (shown in orange). Different parts of the enzyme are 
labelled. Subunits are colour coded; the α-subunits are shown in green, β’ is shown in blue/dark 
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Transcription initiates at regions of DNA known as promoters, which are located upstream of 
genes and transcription start sites. Throughout this work transcription start sites are referred to 
as “+1”, whilst promoter sequences upstream are denoted by a “-” prefix. The core RNAP 
enzyme (which has the composition α2ββ’ω) is capable of catalysing RNA synthesis, but cannot 
initiate transcription specifically at promoters (Browning and Busby, 2004). In order to 
recognise promoter regions, the core enzyme must associate with a σ-factor, to form the 
holoenzyme (α2ββ’ωσ) (Ishihama, 1993). The holoenzyme is competent for promoter 
recognition, DNA strand separation (also known as ‘promoter melting’) and transcription 
initiation. To initiate transcription, the RNAP holoenzyme recognises a number of discrete 
sequences within the promoter region. Promoter recognition involves interactions between the 
σ-factor and the promoter DNA (Figure 1.3) (Feklistov et al., 2014). 
RNAP holoenzyme containing the σ70 (Eσ70) recognises two highly conserved sequences 
located upstream of the transcription start site; the -35 hexamer (consensus 5’-TTGACA-3’) 
and the -10 hexamer (consensus 5’-TATAAT-3’) (Saecker et al., 2011, Shultzaberger et al., 
2006). These core promoter elements may be augmented with additional sequences. For 
example, the ‘extended -10’ element (present at 20 % of σ70 promoters) refers to the presence 

















Figure 1.3 Promoter recognition by σ70-containing RNAP holoenzyme 
RNAP recognition of promoter DNA. Domain 4 of the σ-factor recognises the ‘-35 hexamer’ (through 
a helix-turn-helix motif), domain 2 recognises the ‘-10 hexamer’, and domain 3 recognises the 
‘extended -10’ sequence. The “265” determinant of α-CTD recognises the UP element. The α-subunits 
are shown in green, the σ-factor is orange, the ω subunit is purple, the β is gray, and the β’ subunit is 
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1.1.4 The α-subunit 
RNAP contains two α subunits, which play a number of functional roles. Each α subunit 
consists of two domains, which fold independently (Blatter et al., 1994, Gourse et al., 2000). 
Each α subunit is 37 kDa in size, and 329 amino acids long. Residues 8-235 form the N-terminal 
domain, and residues 249-329 form the C-terminal domain. The N-terminus is required for 
dimerisation of the α subunits and the α-NTD dimer serves as a point of assembly for the rest 
of the polymerase (Figure 1.4). The α-NTD can interact with transcriptional regulators (Blatter 
et al, 1994, Ebright and Busby, 1995). The α-CTD also interacts with transcriptional regulators 
and is joined to α-NTD by a flexible 13 amino acid linker (Ebright, 1993, Estrem et al, 1998). 
The α-CTD is able to bind DNA. Residue Arg-265 of α-CTD is part of a helix-hairpin-helix 
motif and recognises the DNA minor groove (Benoff et al., 2002, Ross et al., 2003, Ross and 
Gourse, 2005). This interaction is favoured by AT-rich DNA sequences, known as ‘UP’ 
elements (Ross et al, 1993, Busby and Ebright, 1999). Naturally occurring UP elements have 
been shown to increase promoter activity 20-30 fold. (Ross et al., 1993). Furthermore, synthetic 
UP elements can have even greater stimulatory effects.  In a study of random sequences fused 
upstream of a rrnB P1 promoter-lacZ construct, Estrem et al. (1998) used SELEX (Systematic 
Evolution of Ligands by Exponential enrichment), to identify a 5’–
nnAAA(A/T)(A/T)T(A/T)TTTTnnAAAnnn-3’ consensus sequence for the UP elements. The 
α-CTD also has an important role in transcription activation at promoters which do not contain 
an UP element. For example, deletion of α-CTD results in a 10-fold reduction in RNAP binding 








Figure 1.4 Assembly of RNAP 
Assembly of the RNAP holoenzyme occurs in the order; α2-α2β- α2ββ’ω- α2ββ’ωσ. The σ-factor 
associates before promoter recognition (Ishihama, 1990). The α-subunits are shown in green, the σ-
factor is orange, the ω subunit is purple, the β is gray, and the β’ subunit is shown in blue. Based on 


































1.1.5 β and β’ subunits 
The β and β’ subunits form the claw and the active site of RNAP. The active centre consists of 
a Mg2+ co-factor, held in position by three aspartate residues. These residues are form a highly 
conserved amino acid motif (NADFDGD) in the β’ subunit (Darst, 2001, Dieci et al., 1995, 
Vassylyev et al., 2002, Zhang et al., 1999). There are two further important structural features 
on the active site; the F-bridge helix and the G-trigger loop (Figure 1.2B). These are critical 
mobile parts which play important roles in NTP selection and RNAP translocation (Vassylyev 
et al., 2007). Briefly, RNAP elongates through a ratchet mechanism, where conformational 
changes in the F-bridge helix drive translocation of the elongation complex. The G-trigger loop 
plays an important role by controlling the conformation of the F-bridge helix. Single amino 
acid mutations in either the trigger loop or bridge helix can give rise to altered fidelity and 
processivity of RNAP (Bar-Nahum et al., 2005). Structurally, RNAP can be thought of as 
having four mobile parts which move relative to the active site; these are the clamp, β flap, and 
the β1 and β2 lobes (shown in Figure 1.2B) (Murakami et al., 2002, Murakami and Darst, 
2003).  
1.1.6 The ω subunit 
The ω subunit is a small 91 amino acid protein that binds the β’ subunit, and wraps around the 
β’ CTD (Zhang et al., 1999). The role of the ω subunit remains enigmatic, although some 
reports suggest ω may act as chaperone for the β’ subunit (other subunits appear to be folded 
by the GroEL chaperone) (Minahkin et al., 2001, Mathew & Chatterji, 2006). The best 
characterised action of ω is its ability to render RNAP sensitive to the alarmone ppGpp (Gentry 






The holoenzyme of Taq RNAP (containing σA, the housekeeping σ70 homologue) has been 
solved to a resolution of 4 Å, both in the absence and presence of fork-junction DNA 
(Murakami et al., 2002, Murakami et al., 2002). Other high resolution crystal structures (2.6 Å) 
have been solved for Thermus thermophilus RNAP holoenzyme (Vassylylev et al., 2002). In 
these structures, σ faces upstream, and lies on a surface of core RNAP, with which it makes 
multiple stable contacts.  
The σ70 factor contains four domains (σ4, σ3, σ2, and σ1), as illustrated in Figure 1.5 (Campbell 
et al., 2002). The domains are divided into regions (e.g. domain 4 contains regions 4.1 and 4.2). 
All four domains contact core RNAP but two key contacts are conserved; domain σ4 binds an 
α-helix of the β subunit flap, and σ2
  forms an important interaction with the β’ subunit coiled-
coil (Campbell et al., 2002, Campbell et al., 2008, Murakami and Darst, 2003, Sharp et al., 
1999). The σ4 domain accommodates the β flap helix in a hydrophobic pocket. Consequently, 
this region of the holoenzyme is flexible, which in turn facilitates promoter bending during 
transcription initiation (Murakami et al., 2002). The σ1 domain is specific to σ
70, and region 
σ1.1 plays an important role in preventing non-specific initiation by occupying the main RNAP 
channel. Region σ1.1 is displaced from the channel upon promoter recognition. To facilitate its 
movement, the σ1.1 region is linked to the rest of σ through a 37 amino acid linker (Mekler et 
al., 2002). Region σ1.1 also has roles in transcription regulation, and can regulate DNA entry 
into the active site depending on features of the bound promoter. Domain σ1 also inhibits free 







Figure 1.5 Generalised σ70-family domain organisation 
The figure shows the generalised structure of σ70-family members. The upper schematic shows the 
domain structure, and the lower schematic shows the location of different regions. Green arrows show 
interactions between σ70 with DNA. Yellow arrows show regions involved in DNA melting. Note that 
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1.2 Transcription initiation 
Initiation of transcription consists of four separate events; i) promoter recognition, ii) formation 
of an “open complex”, iii) DNA scrunching (abortive initiation), and iv) promoter escape 
(Figure 1.6) (Browning and Busby, 2004, Murakami and Darst, 2003). 
1.2.1 Promoter recognition 
Domain σ4 of σ
70 recognises the -35 hexamer through a helix-turn-helix motif in region 4.2. 
Thus, region 4.2 residues Lys-593, Gln-589, Arg-588, Arg-586, Glu-585, Arg-584, Thr-583, 
Glu-574, Leu-573, Arg-562 and Arg-554 of E. coli σ70 are involved in recognition of the -35 
element. Gln-589 contacts the base at positions -35, Arg-586 contacts the bases at positions -35 
and -36, Glu-585 contacts the bases at positions -34 and -33, and Arg-584 makes direct contact 
with the bases at positions -31 and -30 (Campbell et al., 2002, Murakami et al., 2002).  Domain 
σ2 contacts the -10 hexamer of promoter DNA through a single helix. Important residues 
involved in recognising the -10 element include; Ser-428, Asn-383, Leu-386 and Leu-110, 
which interact with the base at position -7. The base at position -8 interacts with Ser-428, and 
Thr-432, whilst Phe-419 interacts with the base at position -10. The most important interaction 
occurs between sidechains of Tyr-430, Arg-423, Glu-420, Phe-419 and the base at position -
11 (Feklistov and Darst, 2011). The extended -10 element is bound by residues Glu-458 and 
His-455 in a helix of domain σ3 (Barne et al., 1997). The -35 and UP elements are contacted 









Figure 1.6 Transcription initiation in E. coli 
Open complex formation at promoter regions follows four stages; binding/ promoter recognition, 
isomerisation, abortive initiation and promoter escape. DNA is depicted as solid black lines, the yellow 
line represents the nascent RNA chain. The α-subunits of RNAP are shown in green, the σ-factor is 
orange, the ω subunit is purple, the β is gray, and the β’ subunit is shown in blue. Based on Browning 

























1.2.2 Isomerisation (open complex formation) 
Isomerisation of the -10 element (open complex formation) occurs simultaneously with -10 
recognition. Hence, bases A11 and T7 are ‘flipped out’ of the DNA base stack and 
accommodated by conserved residues in region σ2.3 (Feklistov and Darst, 2011). Consequently, 
these two bases are the best conserved in -10 hexamers (Shultzaberger et al., 2006). Note that 
only position T12 in the -10 element is recognised when DNA is in a double-stranded form 
(Feklistov et al., 2014, Fenton and Gralla, 2001). Hence, all contacts from A11 to T7 are made 
only when DNA is single-stranded (Feklistov and Darst, 2011, Hook-Barnard and Hinton, 
2007).  Unwinding of the -10 element leads to formation of a 12/13 nucleotide ‘transcription 
bubble’. The enzyme ‘claw’ closes around the DNA, which is fed into the active site, and the 
transcription bubble is maintained by the β’ rudder and the β1 lobe (Figure 1.7) (Borukhov and 
Nudler, 2003, Borukhov and Nudler, 2007).   
1.2.3 DNA scrunching (abortive initiation) 
Following isomerisation, a number of abortive initiation cycles commence, producing small 
abortive RNAs 2-15 nucleotides in length (Goldman et al., 2009, Murakami et al., 2002). 
During this initial RNA synthesis, the position of RNAP holoenzyme, relative to the promoter 
DNA, does not change. Rather, DNA ‘scrunching’ occurs, whereby DNA is taken up and 
accommodated inside the polymerase as abortive initiation cycles occur (Kapanidis et al., 2006, 
Revyakin et al., 2006,). The abortive initiation cycles likely represent a build-up of free energy 
in the polymerase, which allows the polymerase to release bound promoter elements and 










Figure 1.7 RNAP promoter recognition (A) and in open complex (B) 
After promoter recognition, DNA is fed into the main channel and DNA-binding clamp. In both 
cartoons, the α-subunits of RNAP are shown in green, the σ-factor is orange, the ω subunit is purple, 
the β is gray, and the β’ subunit is shown in blue. DNA is shown as a black line. Based on Borukhov 
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1.2.4 Promoter escape 
Once a nascent RNA reaches 15 nucleotides in length, elongation becomes productive, and the 
σ-factor is released. Release is driven by changes in RNAP that make it more processive and 
stably bound to the DNA (Murakami et al., 2002, Vassylyev et al., 2002). Some elongation 
complexes may retain (or rebind σ) and this has been implicated in transcriptional pausing 
(Mooney et al., 2005, Reppas et al., 2006, Wade and Struhl, 2004). Once the ternary elongation 
complex is formed transcription continues until termination, where the core polymerase is 
released and is available for σ-rebinding (Murakami and Darst, 2003). 
1.3. Transcriptional regulation in E. coli 
1.3.1 Modulation of RNA polymerase by small molecules- (p)ppGpp and ω 
A number of small molecules are capable of binding to RNAP and regulating transcription. 
The best examples of this are guanosine 5’triphosphate, 3’ diphosphate (pppGpp), and 
guanosine 5’ diphosphate, 3’ diphosphate (ppGpp). (p)ppGpp is produced by cells starved of 
nutrients and (p)ppGpp levels are regulated by RSH (Rel Spo Homologue) family proteins 
(Potrykus and Cashel, 2008). Proteins in this family can synthesise and degrade (p)ppGpp. Two 
RSH family proteins are known to control (p)ppGpp concentration in E. coli; RelA, which is 
only able to synthesize (p)ppGpp, and SpoT, which is important for degrading (p)ppGpp. 
Increased intracellular concentrations of (p)ppGpp trigger the ‘stringent response’; a 
reprogramming of cellular transcription in poor growth conditions that includes a reduction in 
transcription of rRNA and tRNA genes, and increased expression of genes for amino acid 
biosynthesis. Regulation by (p)ppGpp occurs through direct interactions with RNAP (Traxler 
et al., 2008).   
Whether (p)ppGpp activates or represses transcription from a particular promoter depends of 
the half-life of the open complex formed by RNAP (Barker et al., 2001). This is often 
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dependent on the sequence of the discriminator, the sequence downstream of the -10 element 
and upstream of the transcription start site (Figueroa-Bossi et al., 1998, Barker et al., 2001). 
For example, rRNA promoters contain GC-rich discriminators, and form open complexes with 
short half-lives which are sensitive to ppGpp inhibition (Paul et al., 2005). Promoters for genes 
involved in amino acid biosynthesis tend to have low-GC content discriminator sequences, and 
form open complexes with longer half-lives, which ppGpp can activate in concert with the 
DksA protein (Paul et al., 2004).  
Early studies (Igarashi et al., 1989) suggested a role for the ω subunit in responding to ppGpp. 
This requirement for the ω subunit can be complemented by DskA (Vrentas et al., 2005). 
Recently, the crystal structure of ppGpp complexed with RNAP has been solved (Zuo et al., 
2013). In conjunction with cross-linking and mutation analysis (Ross et al., 2013) this revealed 
the binding site of ppGpp. The interaction site lies between the RNAP β’ subunit and the ω 
subunit. The phosphate groups of ppGpp interact with a pocket between β’ and α-NTD, the 
guanosine base interacts with ω (Ross et al., 2013). This interaction of ppGpp with RNAP 
reduces the mobility of the enzyme, which slows open complex formation (Zuo et al., 2013).   
1.3.2 Regulation by σ-factors 
1.3.2.1 σ-factors produced by E. coli 
Different σ-factors recognise different sets of genes. Consequently the transcriptional output 
of the cell can be rapidly altered to suit environmental conditions through the use of alternate 
σ-factors. E. coli produces seven σ-factors (σ70, σ54, σ38, σ32, σ28, σ24, and σ19, summarised in 
Table 1.1). With the exception of σ54 all are members of the σ70 family and thus are structurally 
related (Gruber and Gross, 2003). σ70, the ‘housekeeping’ σ-factor, is essential for viability, 




σ-factor Function Kd for binding 




σ70 / RpoD General constituative σ-
factor 
0.26 1643 
σ54 / RpoN Nitrogen metabolism 0.3 180 
σ38 / RpoS Stationary phase / general 
stress 
4.26 903 
σ32 / RpoH Heat-shock  1.24 312 
σ28 / RpoF Flagellar assembly 0.74 51 
σ24 / RpoE Extracytoplasmic stress 2.43 65 
σ18 / FecI Iron starvation 1.73 7 
 
Table 1.1 σ-factors produced by E. coli 













1988). Genes which assist in survival during starvation are dependent on σ38, the heat-shock 
response is activated by σ32, motility is controlled by σ28, the response to extracytoplasmic 
stress is mediated by σ24, and σ19 controls transcription of the fecABCDE operon (Braun et al., 
2003, Fitzgerald et al., 2014, Gruber and Gross, 2003, Soutourina et al., 1999). These 
alternative σ-factors have between seven (σ19) and 903 (σ38) binding sites across the E. coli 
K-12 genome. The σ54 factor plays an important role in regulating nitrogen metabolism and 
has 180 binding sites (Cho et al., 2014). σ54 activates transcription through a different 
mechanism similar to that of TATA-box binding proteins of eukaryotes. Hence, σ54 has an 
absolute requirement for activator proteins containing an AAA+ domain and requires ATP 
hydrolysis to activate transcription (Buck et al., 2000). At σ54-dependent promoters, DNA must 
be bent to allow contact between the AAA+ activator, and the RNAP holoenzyme containing 
σ54. This often involves an ancillary transcription factor (Kustu et al., 1989).  
Different σ-factors re-direct RNAP to different subsets of promoters according to 
environmental conditions. However, these subsets frequently overlap. For example, σ24 and σ70 
share 52 binding targets, and σ54 and σ70 share 180 binding targets. The largest overlap in 
binding sites is that between σ38 and σ70, which share 805 binding sites (Cho et al., 2014). The 
considerable overlap between σ-factors is thought to provide fine-tuning of gene expression in 
different conditions. Surprisingly, many of these targets for σ-factors lie within genes. For 
example, 25% of σ32 targets and 58 % of σ28 targets lie within genes. Only 17 % of intragenic 
targets for σ28 are associated with transcription of an RNA (Fitzgerald et al., 2014, Wade et al., 
2006). Conversely, widespread intragenic transcription can be driven by σ70 and this is often 





1.3.2.2 Regulating σ-factor activity 
The regulation of alternate σ-factor activity is complex and occurs at all stages of gene 
expression, including post-transcriptional and post-translational regulation. For instance, under 
some conditions, σ70 can be regulated by the anti-σ factor Rsd (Jishage et al., 2001). Given the 
comparatively high affinity of σ70 for core enzyme, compared to other σ-factors, sequestration 
of σ70 by Rsd may increase the potential for σ-factor competition (Table 1.1). The rpoS mRNA 
(encoding σ38) is post-transcriptionally regulated by H-NS (which down-regulates translation), 
HU and Hfq (which increase translation). Furthermore, RpoS can degraded by the RssB-ClpXP 
system (Gruber and Gross, 2003, Hengge-Aronis, 2002).  The rpoH mRNA (encoding σ32) 
contains two regions, A and B, in the vicinity of the translation start site. These regions base 
pair and result in a secondary structure that prevents ribosome binding. The mRNA secondary 
structure is lost at higher temperatures, which permits translation of σ32 (Morita et al., 1999). 
In non-stressful conditions, σ24 is usually inactivated and sequestered by the membrane-
tethered RseA protein. Upon detection of unfolded outer membrane proteins a proteolysis 
cascade is activated, which results in degradation of RseA by the DegS and YaeL proteases, 
releasing σ24 for association with RNAP core enzyme (Alba and Gross, 2004). 
Three sets of genes are involved in motility in E. coli; early, middle and late genes. The only 
early transcription unit encodes the FlhD and the FlhC regulators. The middle genes are 
controlled by the FlhD4C2 complex, which activates transcription at 11 transcription units by 
the σ70 holoenzyme, including the fliA gene which encodes σ28. FlgM, an anti σ-factor, can 
inhibit σ28 activity. Completion of the flagellar basal body and hook results in secretion of 
FlgM out of the cell, releasing σ28, which activates transcription of the late genes (Chilcott and 




1.3.3 Transcriptional activators 
There are many mechanisms for transcription activation; these can involve direct interaction of 
transcription factors (TFs) with RNAP or can be indirect (Browning and Busby, 2004, Lee et 
al., 2012).  A well-defined example of a transcriptional regulator is the cyclic AMP receptor 
protein (CRP). CRP plays a key role in managing carbon metabolism in E. coli, and has become 
a regulatory paradigm. Hence, CRP can activate or repress transcription via many mechanisms 
(Busby and Ebright, 1999, Shimada et al., 2011). CRP commonly activates transcription by 
binding upstream of, or overlapping, promoter -35 elements. Depending on the position of the 
CRP site the activation mechanism is known as class I, II or III (Browning and Busby, 2004). 
Depending on the class of activation CRP interacts with RNAP using different surfaces. These 
surfaces are known as activating regions (Busby and Ebright, 1999).  
CRP binds DNA as a dimer and three defined activating regions are presented by each 
monomer (Lawson et al., 2004). Activating region 1 (AR1) consists of amino acid residues 
156-164 with Thr-158 being the most important residue. These amino acids form an exposed 
11Å by 14Å patch on the surface of CRP, close to a canonical β-turn, adjacent to the helix-
turn-helix DNA binding motif (Zhou et al, 1993, Niu et al, 1994). Activating region 2 (AR2) 
is located towards the N-terminus of CRP and consists of positively charged residues His-19, 
His-21 and Lys-101 (Niu et al., 1996). Hence, AR2 is a positively charged surface of CRP. 
Activating region 3 (AR3) consists of Glu-58, Lys-57, Gly-56, Glu-55, Glu-54, Asp-53 and 
Lys-52. Hence, AR3 is a negatively charged surface on an exposed β-turn. Note that the 
positively charged lysine at position 52 hinders the activity of AR3 and subsitution with 
asparagine converts AR3 into a more potent activating region (Williams et al., 1991, Rhodius 
and Busby, 2000, Rhodius and Busby, 2000). AR1 contacts RNAP at all classes of CRP 
activated promoters. At class II promoters (and some class III promoters) AR3 contacts σ70 and 
AR2 interacts with α-NTD (Rhodius et al., 1997).  
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1.3.3.1 Class I promoters 
At class I promoters CRP binds on the same face of the DNA as RNAP and contacts the α-CTD 
(Figure 1.8A).  For example, at the lac promoter, CRP binds to a site centred 60.5 bases 
upstream of the transcription start site (Malan et al., 1984). Note that the positioning of CRP is 
not fixed. Hence, Gaston et al. (1990) used a modified melR promoter to show that CRP is able 
to activate transcription from positions -60.5, -72.5, -82.5 and -92.5 at class I promoters. Thus, 
correct helical phasing is essential but the CRP site is not fixed. The flexibility in the position 
of the CRP site is thought to be permitted by the unstructured 44 Å linker of the α subunit, 
together with the DNA bend induced by CRP binding (Blatter et al., 1994, Busby and Ebright, 
1994, Schultz et al., 1995). At some promoters “helical phasing” rules may be relaxed 
depending on the promoter elements present. Specifically, the presence of an UP element, or a 
consensus extended -10 element, can compensate for CRP mis-positioning (Zhou et al., 2014). 
AR1 of the downstream subunit is the only determinant of CRP required at class I promoters, 
but there are three components of α-CTD which are important for activation at class I promoters 
(Zhou et al., 1993). Firstly, as discussed earlier, α-CTD residue Arg-265 is essential for DNA 
binding (Gaal et al., 1996). Secondly, the α-CTD ‘287’ determinant (Thr-285, Glu-286, 
Val-287, Glu-288 and Arg-317) forms a 14Å by 23Å surface that interacts with AR1 (Savery 
et al., 2002). Thirdly, at some class I promoters, where the CRP site is centred at -60.5, one α-
CTD is sandwiched between CRP and RNAP σ4 (Figure 1.8A) (Benoff et al., 2002). Here 
residues of the α-CTD 261 determinant (Asp-258, Asp-259 and Glu-261) contact residues in 
σ4 (593-604). In fact, this interaction has been shown to be important at both activator-
dependent and -independent promoters (Chen et al., 2003, Lee et al., 2003, Ross and Gourse, 










Figure 1.8 Transcription activation by CRP at Class I (A) and Class II (B) promoters 
RNAP subunits are labelled. CRP activating regions are shown as yellow dots. DNA is shown as a black 
line. Based on Busby and Ebright (1999). 
A. Class I activation by CRP at a -60.5 position. The ‘261’ determinant on α-CTD can contact 
σ-factor region 4 (residues 573-604). Only the downstream subunit of CRP is contacted by 
α-CTD ‘287’ determinant (the other α-CTD binds non-specifically at upstream DNA). The 
‘265’ determinant is involved in binding DNA, at UP elements, if present. 
B. Class II activation. RNAP contacts both subunits of CRP, which is sited at a -41.5 position.  
(The other α-CTD binds non-specifically at upstream DNA). AR1 of CRP contacts the ‘287’ 
determinant of α-CTD, AR2 contacts α-NTD. An UP element is not essential but does enhance 
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1.3.3.2 Class II promoters 
At class II promoters, CRP binds to a site overlapping the -35 hexamer, centred at 
position -41.5, and interacts with the σ and α subunits of RNAP (Figure 1.8B). AR1, on the 
upstream CRP subunit, contacts the ‘287’ determinant on one α-CTD (Savery et al., 1998). 
This interaction serves to recruit RNAP to the promoter since mutation of AR1 reduces initial 
binding by RNAP 8-fold (West et al., 1993, Niu et al., 1996). AR2 of the downstream subunit 
interacts with residues Glu-165, Asp-164, Glu-163 and Glu-162 on α-NTD (Niu et al., 1996). 
These interactions stimulate isomerisation and deletion of AR2 reduces open complex 
formation 10-fold. If unmasked, AR3 of the downstream subunit interacts with σ70 region 4.2 
(residues 593-603) (Rhodius et al., 2000). At both class I and class II promoters, the ‘265’ 
determinant of α-CTD interacts with the DNA minor groove and this is enhanced by UP 
elements (Gaal et al., 1996).  
1.3.3.3 Class III promoters 
Many bacterial promoters respond to multiple environmental signals and have a more complex 
organisation than the simplistic examples described above. Hence, they may contain sites for 
different TFs or multiple sites for the same TF (Figure 1.9) (Browning and Busby, 2004, Busby 
and Ebright, 1999). At the artificial CC(-93.5) CC (-61.5) promoter, activation is dependent on 
occupation of CRP sites centred at positions -93.5 and -60.5 (Tebbutt et al., 2002). Both sites 
must be bound by CRP, with each CRP dimer being contacted by an α-CTD (Lloyd et al., 
2002). Activation of the acsP2 is achieved through occupation of a CRP sites centred at 
positions -69.5 and -122.5. At both sites, CRP contacts α-CTD via the 287 determinant (Beatty 













Figure 1.9 Transcription activation by CRP at class III promoters 
RNAP subunits are labelled, DNA is shown as black line, activating regions are shown in yellow. Class 
III activation by CRP. Both α-CTD subunits are involved in binding multiple activators at different 
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Two distinct TFs may also work together to activate transcription. For example, at the ansB 
promoter, a CRP site is found 91.5 bp upstream of the transcription start site, and an FNR site 
is located 41.5 bp upstream of the transcription start site. Activation is dependent on occupation 
of both sites (Scott et al., 1995).  
1.3.4 Other mechanisms of transcriptional activation 
The mechanisms of transcriptional activation described above require direct interactions 
between CRP and RNAP. However, transcription can be activated by re-modelling promoter 
DNA topology. A well-studied example of this is regulation by MerR at the mer operon 
promoter (Hobman, 2007). Transcription is activated by binding of MerR to the spacer region 
between the -35 and the -10 elements, which leads to unwinding of the DNA (Figure 1.10A). 
This unwinding results in correct alignment of the promoter -35 and -10 elements for 
recognition by RNAP (Ansari et al., 1992).  
At some promoters, activation is dependent on co-operative binding by two transcription 
factors (Figure 1.10B). For example, at the melAB promoter, CRP binds to a degenerate site 
81.5 bases upstream of the transcription start site. Binding to this site requires MelR, a TF that 
responds to melibiose. Co-operativity is dependent on direct MelR-CRP interactions. Hence, 
MelR recruits CRP to its target (Grainger et al., 2004, Wade et al., 2001). 
In other scenarios, transcription activation can be activated by re-positioning an activator from 
a non-stimulatory binding site (Figure 1.10C). This is exemplified by MalT and CRP at the 
malK promoter. Here, MalT binds with high affinity to three non-activatory sites upstream of 
the promoter. Activation requires i) binding of MalT to two distal binding sites further upstream 
and ii) CRP binding at three sites in between the distal and proximal set of MalT binding sites. 
When all sites are occupied the three promoter proximal MalT molecules are repositioned, 





Figure 1.10 Additional mechanisms of transcription activation 
 The figure shows other mechanisms of transcriptional activation through: 
A) altering the conformation of the core promoter,  
B) co-operative binding to DNA by one of more TFs and  
C) re-positioning of an primary activator by binding a secondary activator.  
In each panel, the primary activator is shown in yellow, the secondary activator is shown in orange. 











1.3.5 CRP structure 
The structure of CRP (Figure 1.11) has been solved to increasing resolution using X-ray 
crystallography (McKay et al., 1982, Parkinson et al., 1996, Passner and Steitz, 1997, Passner 
et al., 2000) and NMR spectroscopy (Popvych et al., 2009). The studies show that CRP consists 
of an N-terminal domain, which binds cAMP through a series of β-sheets (residues 1-136), and 
a C-terminal domain (residues 139-209) that contains the helix-turn-helix DNA binding 
determinant (Busby and Ebright 1999, Passner et al., 2000). Each monomer contains 12 β-
sheets, and 6 α-helices (A-F) (Passner et al, 2000). Helix C (residues 112-133) is involved in 
CRP dimerisation (Weber and Steitz, 1987) whilst helices E (residues 168-176) and F (residues 
180-191) comprise the DNA binding helix-turn-helix motif (Passner and Steitz, 1997, Fic et 
al., 2009). Each CRP monomer can bind two molecules of cAMP; one in a high-affinity anti-
conformation in the N-terminal domain (Weber and Steitz, 1987), and one in a lower-affinity 
syn conformation in the C-terminal domain (Passner and Steitz, 1997, Tutar, 2008). Binding of 
CRP in the syn conformation occurs only at millimolar concentrations of cAMP and is unlikely 
to be physiologically relevant (Fic et al., 2009, Harman, 2001). 
NMR spectroscopy (Popovych et al., 2009) revealed the mechanism of cAMP-induced 
modulation of CRP activity.  Binding of cAMP to CRP in the anti-conformation stabilises an 
extension of the dimerization helix by three turns, which subsequently rotates the DNA-
recognition helices by 60o, bringing them closer together. This positions the F-helix optimally 
for sequence-specific interactions with the DNA major groove. The hinge formed by Leu-137 
and Asp-138 links the N-terminal domain and C-terminal domain, and facilitates this 
conformation change. The extension of the ‘C’ helix occurs through Val-126 to Phe-136, which 





Figure 1.11 Crystal structure of CRP complexed with adenosine 3’5’ cyclic 
monophosphate and DNA  
The N-terminal domain of each monomer is shown is shown in red, the C-terminal domain is shown 
in green. The dimerisation helices (helix “C”) is shown in orange, the DNA-binding helices (helix 
“F”) are shown in yellow. cAMP bound to the high-affinity anti-cAMP binding sites is shown in blue. 















Three interactions are made between cAMP and CRP. Firstly, the adenine base of cyclic AMP 
contacts Thr-127 and Ser-128, the latter of which is rotated by 120o relative to the cAMP 
binding pocket. Secondly, the sugar-phosphate group of cAMP interacts with amino acids Gly-
71 to Ala-84. Thirdly, binding of cAMP removes Trp-85 from the cAMP binding site. 
(Popovych et al., 2009). Interestingly, CRP can be bound by cGMP. However, this does not 
trigger the conformational change described above (Fic et al., 2009). When not bound by 
cAMP, CRP is not able to bind DNA specifically. 
The cAMP-CRP complex binds to DNA at a 22bp sequence, which has the consensus 5’-
AAATGTGATCTAGATCACATTT-3’. Sequence recognition occurs through ‘direct 
readout’, where amino acids directly recognise the nucleotide bases of binding site, and indirect 
readout, which involves recognition of the DNA sugar-phosphate backbone. Critical amino 
acid-base interactions are made within two 5 bp half-sites, which are underscored above. Key 
amino acid residues of CRP involved in interactions with nucleotide bases are Arg-185 (which 
contacts the guanosine base at position 7, relative to the 5’ end of the site, and the thymine base 
at position 8 on the opposite strand), Glu-181 (which contacts the cytosine base at position 7 
on the opposite strand) and Arg-180 (which contacts the guanosine base at position 5) (Busby 
and Ebright 1999, Ebright et al., 1989, Lawson et al., 2004). Binding of CRP results in an 80o 
bend occurring in DNA (Schultz et al., 1991, Lawson et al., 2004). 
1.3.6 Catabolite repression  
Carbon catabolite repression (CCR) is a phenomenon observed in most heterotrophic bacteria, 
and is a metabolic strategy for regulating genes that facilitate the use of alternate carbon 
sources. Often, this regulation involves changes in intracellular cyclic AMP concentrations 




phosphorylated to glucose 6-phosphate by a phosphorelay, known as a phosphotransferase 
system (PTS) as it enters the cell (Saier, 1998) (Figure 1.12).  Phospho-enol pyruvate (PEP) 
supplies the phosphate group at the beginning of the phosphorelay, and is converted to 
pyruvate. The phosphate group supplied is eventually transferred to EIIAGlc (enzyme IIA) 
through EI (enzyme I) and HPr (histidine protein). EIIA transfers the phosphate group from a 
membrane-bound complex consisting of EIIBC, which is responsible for phosphorylating 
glucose upon import (Görke and Stűlke, 2008). If glucose is not imported, EIIAGlc, a subunit 
of EIIGlc, remains phosphorylated.  
The presence of phosphorylated EIIAGlc, together with an unknown factor (‘Factor X’), results 
in the activation of membrane-bound adenyl cyclase (encoded by cya), which produces cyclic 
adenosine 3’,5’ monophosphate (cAMP) (Hogema et al., 1998). When grown in media 
containing different glucose concentrations, Notley-McRobb et al., (1997) have shown that 
cAMP concentrations are not directly linked to glucose concentrations, but instead exhibit two 
distinct upshifts when glucose concentrations decrease. The first increase occurs when glucose 
levels fall below 0.3 mM, and the second occurs when glucose concentrations fall below 1 μM, 
although the precise threshold varies between E. coli strains. Growth in minimal media resulted 
in intracellular cyclic AMP concentrations increasing 10-fold from 20 μM up to 180 μM (Green 
et al., 2014, Notley-McRobb et al., 1997). Hence, the cAMP-CRP complex activates 
expression of many genes involved in the use of alternate carbon sources and these genes are 
subject to CCR (Busby and Ebright, 1999, Görke and Stűlke, 2008).  
EIIAGlc also plays a noteworthy role in CCR. Unphosphorylated EIIAGlc inhibits transporters 
which may import secondary carbon sources, when a preferred carbon source (usually glucose) 
is available (Inada et al, 1996). For example, at the lac operon, binding of allolactose (a product 





Figure 1.12 Carbon catabolite repression (CCR) in E. coli 
Glucose enters the cell via the glucose specific EIIGlc complex in the inner membrane and is phosphorylated through the phosphotransferase system. The 
phosphorylation state of EIIAGlc is a key factor in determining the phosphorelay, which is controlled by the ratio of phosphoenolpyruvate (PEP) to pyruvate. 
High concentrations of phosphorylated EIIAGlc lead to activation of adenyl cyclase (AC), in the presence of an unknown factor (factor ‘X’). HPr (Histidine 

































In the presence of glucose, EIIAGlc becomes unphosphorylated, and in this state is able to inhibit 
transporters for these inducers, for example, LacY, the lactose permease (Nelson et al., 1983). 
This inhibition occurs only in the presence of lactose, which must be bound to the transporter 
(Hogema et al., 1999). This phenomenon is known as “Inducer Exclusion”, and prevents the 
import of many other secondary catabolites in the presence of glucose (Görke and Stűlke, 
2008). cAMP-CRP plays an important role in this process by regulating the expression of the 
glucose PTS EIIBC complex encoded by the ptsG gene (Kimata et al., 1997). The correlation 
between intracellular cAMP concentrations and glucose concentrations has been subject to 
controversy. The current prevailing opinion is that intracellular cAMP concentrations are 
markers of low energy levels in the cell. CRP (complexed with cAMP) activates catabolic 
genes and represses anabolic genes, hence increased cAMP concentrations lead to increased 
energy production through increased catabolism (Narang, 2009).   
1.3.7 The CRP regulon 
As discussed above, CRP (complexed with cAMP) facilitates the utilisation of alternative 
carbon sources by controlling gene expression (Busby and Ebright, 1999, Gosset et al., 2004, 
Narang et al., 2009). Thus, many studies have tried to identify the complete set of genes 
regulated by CRP in E. coli. Shimada et al. (2011) have provided the most comprehensive 
study of CRP-dependent promoters to date. This work shows that CRP regulates at least four 
irreversible, rate-limiting reactions in the glycolysis pathway by controlling expression of i) 
Glk (which phosphorylates glucose upon import into the cell) ii) YggF (a type II fructose 1,6-
bisphosphatase) iii) Pps (phosphoenolpyruvate synthase) and iv) PckA (phophoenolpyruvate 
carboxykinase). The activation of PckA expression implicates CRP in regulating switching 
between glycolysis and gluconeogenesis. In addition, CRP also activates expression of several 
“last step” enzymes in the pentose phosphate pathway that shuttle D-glyceraldehyde-3-
phosphate back into central metabolism. Shimada et al. also confirmed two other important 
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roles for CRP; the regulation of metabolic transporters and the regulation of “slave” TFs. Thus, 
CRP regulates the expression of 16 phosphotransferase systems, 11 major superfamily 
transporters, all 9 ABC transporters involved in carbohydrate import and 70 transcription 
factors involved in many aspects of metabolism (Shimada et al., 2011).  
The regulatory role of CRP is not limited to central metabolism. For instance, CRP affects the 
expression of the stationary phase σ-factor, σS (Hengge-Aronis, 2002). Motility is also 
controlled by CRP, in conjunction with H-NS; both proteins are required to activate 
transcription from the flhDC promoter (Soutourina et al, 1999). The chaperones GroEL/GroES 
are indirectly regulated by CRP as are DnaJ, DnaK and several proteases (including ClpPBX 
and Lon) (Gosset et al, 2004). Thus, the CRP regulon is extensive, and contains many indirect 
pathways. 
1.4. Repression 
i) Steric inhibition: 
The simplest mechanism of repression is steric inhibition, whereby a repressor binds over 
promoter elements and prevents RNAP binding (Figure 1.13A). A good example of such 
regulation is the Lac repressor, LacI, at the lac operon. LacI binds to the lacO1 operator site (at 
position +11) to repress transcription of the downstream genes lacZ, lacY and lacA (Sellitti et 
al., 1987). Binding of LacI to two further operators, lacO2 (centred at position +412) and lacO3 
(centred at position -82) further stimulates repression (Wilson et al., 2007).  
ii) DNA looping: 
At the gal P1 promoter, GalR binds two operators at positions -60.5 (OE) and +53.5 (OI) relative 
to the transcription start site (Figure 1.13B). Interactions between the bound GalR molecules 




Figure 1.13 Mechanisms of transcriptional repression 
Mechanisms of transcriptional repression by (A) steric hinderance, (B) DNA looping, and (C) ‘anti-
activation’ by CytR at the deoP2 promoter. Red dimers represent repressors, light green circles 
represent additional factors, orange dimers represent activators, and DNA is shown as a black line. 

























factor (HU), which binds at a position +6.5, is required to stabilise the loop. This facilitates 
DNA looping and prevents RNAP from accessing galP1 (Choy and Adhya, 1992, Semsey et 
al., 2002). DNA looping also occurs at the lac promoter; LacI dimers bound to operator regions 
lacO1 and lacO2, or lacO1 and lacO3 form DNA loops. This looping mechanism represses the 
lac operon 600-fold as opposed to 20-fold repression due to steric hinderance by occupancy of 
lacO1 (Oehler et al., 1990). 
iii) Anti-activation: 
Another mechanism of repression is anti-activation. A well-documented example is the 
interaction of the repressor CytR and CRP at promoters controlling genes involved pyrimidine 
metabolism. At the deoP2 promoter, CytR binds between two CRP dimers and denies the 
RNAP α-CTD access to the AR1 (Figure 1.13C) (Shin et al., 2001).  
1.5 Transcriptional regulation by Nucleoid-Associated Proteins (NAPs) 
Most genes are also subject to regulation by one or more small basic proteins called nucleoid-
associated proteins (NAPs). At least 12 have been identified in Gram negative bacteria. These 
include MvaT, EbfC, CbpA, CbpB, H-NS, StpA, Dps, IHF, Fis, MukB, Lrp and HU (Dorman 
and Dillon, 2010). The relative abundance of NAPs inside the cell alters in response to changes 
in growth rate and the environment. Hence, NAPs often regulate transcription in response to 
growth rate. 
1.5.1 Fis 
Fis (factor for inversion stimulation) is a protein involved in preparing cells for exponential 
growth. This is reflected in the abundance of Fis; it is present in exponentially growing cells at 
60,000 copies per cell, but is not detectable in stationary phase cells (Ali Azam et al., 1999). 
Globally, Fis has an important chromosome structuring role and stimulates DNA “branching”, 
which refers to increased formation of apical loops (Schneider et al., 2001).  However, Fis has 
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a specific regulatory role at some promoters. For example, Fis binds upstream of the promoter 
for the rrnB operon, and stimulates transcription initiation from the P1 promoter (Zhang and 
Bremer, 1996). Thus Fis is an important regulator of ribosome biogenesis. 
1.5.2 H-NS 
H-NS is found in most bacteria and binds AT-rich regions of the genome (Bertin et al., 1999, 
Navarre et al., 2006, Navarre et al., 2007).  H-NS (137 amino acids) contains two domains; the 
N-terminal domain is involved in dimerisation and multimerisation, the C-terminal domain 
binds DNA (Dorman, 2004). In E. coli H-NS, Ala-116, Thr-114, Arg-113, Glu-101 and Thr-
109 are important DNA-binding determinants (Sette et al., 2009). An H-NS-like protein, Lsr2, 
has been identified in Mycobacterium tuberculosis and other closely related Gram positive 
bacteria. Similarly Lsr2 targets AT-rich DNA, including some virulence genes, and recognises 
target DNA in the same way (Gordon et al., 2010). Strikingly, E. coli H-NS and 
Mycobacterium smegmatis Lsr2 are only 20 % identical, but can functionally substitute for one 
another (Gordon et al. 2008).  
Repression by H-NS is mediated by binding to a ‘nucleation site’, followed by multimerisation 
across adjacent DNA (Lang et al., 2007, Rimsky et al., 2001). Binding by H-NS can occur in 
two different ways; ‘stiffening’ and ‘bridging’, and the switch between these forms is mediated 
by divalent cations (Liu et al., 2010). Thus, there are three models for transcriptional repression 
by H-NS i) occluding RNAP from promoters through filamentation, ii) forming DNA loops 
that trap RNAP iii) impeding RNAP elongation and hence promoting transcriptional 
termination (Dame et al., 2002, Dole et al., 2004, Lim et al., 2012, Lucchini et al., 2006, Peters 





1.6 Defining regulons in E. coli K-12 
A recent aim of many studies has been the identification of the complete set of binding sites 
for TFs, like CRP, and NAPs like H-NS. Strategies to identify sites for these factors are 
discussed below.  
1.6.1 Bioinformatic prediction of transcript TFs binding sites 
The first global studies of TF binding made use of newly available genome sequences and 
relied on in silico approaches (Robison et al, 1998, Tan et al, 2001). In particular, the 
application of Position Weight Matrices (PWM) played an important role. PWM are generated 
by aligning already characterised TFs binding sites. This allows a consensus sequence, 
describing the probability of a given nucleotide occurring at a given position in the binding 
site, to be generated. Using this approach, Robison et al. (1998) predicted sites for 55 
transcription factors across the E. coli genome, including a total of 220 high-affinity CRP sites 
(81 % in non-coding regions), and 9097 low-affinity sites (34 % in non-coding regions). Tan 
et al (2001), used a similar approach, but combined datasets from E. coli and Hemophilus 
influenzae to improve the predictive power of the PWM. This study predicted 117 binding sites 
for CRP in E. coli, of which over 90 % were located upstream of genes. As shown by Robison 
et al., Tan et al. also found weaker CRP sites within genes. Thus, bioinformatic approaches are 
useful for estimating the number and distribution of TF binding sites. However, there are 
limitations; all sites require experimental verification. For example, some sites may not be 
bound in vivo or may require cooperative binding with another TFs (Hollands et al., 2007). 
Moreover, bioinformatic predictions can only be made if the TF binding site is already defined. 
1.6.2 In vivo transcriptional profiling and ROMA 
The development of DNA microarrays allowed the effects of TFs on global gene expression to 
be determined for the first time. Briefly, RNA is extracted from wildtype cells and cells lacking  
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the TF of interest (Figure 1.14A). Logically, some of the resulting changes in gene expression 
will be a consequence of removing the TF and, hence, TF regulated genes can be identified 
(Gosset et al., 2004, Mockler and Ecker, 2005). However, this approach is problematic because 
it is impossible to separate direct regulatory events from changes in gene expression caused by 
i) altered growth rates and ii) downstream gene regulatory effects mediated by slave TFs. Many 
of these problems can be avoided by reconstituting the TF regulatory network in vitro. For 
example, Zheng et al. (2004) used ROMA (Run-Off transcription and Microarray Analysis) to 
define a CRP regulon. ROMA uses purified genomic DNA as a template for in vitro 
transcription, the products of which are subjected to reverse transcription and analysed using 
DNA microarrays (MacLellan et al., 2009) (Figure 1.14B). Typically, two experiments are 
performed, one using RNAP in the absence of a TF, and another where the TF is present. This 
study identified 152 targets for CRP-dependent regulation. However, 17 operons known to be 
regulated by CRP were not identified by ROMA. This is expected because many promoters 
rely on interplay between several TFs. For instance, the melAB promoter requires binding of 
MelR to sites flanking CRP to activate transcription (Wade et al, 2001).  
1.6.3 ChIP-chip and ChIP-seq 
Chromatin immunoprecipitation (ChIP) coupled with microarray analysis (ChIP-chip) has 
provided a powerful tool for direct mapping of TF binding sites in vivo. ChIP involves rapid 
formaldehyde crosslinking of protein-DNA complexes in cells, followed by cell lysis and 
shearing of chromatin. Immunoprecipitation of protein-DNA complexes using antibodies 
isolates DNA bound by a specific TF. The precipitated DNA is labelled and hybridised to a 
microarray. This allows profiling of bound sites (Figure 1.15A). Often, this requires that DNA 
from a ‘mock’ immunoprecipitation is used as a control (Buck and Lieb, 2004). ChIP can also 
be coupled with next generation DNA-sequencing (NGS), in a technique known as ChIP-seq. 







Figure 1.14 Global transcriptome analysis using in vivo profiling (A) and ROMA (B). 
A. In vivo profiling: cells are grown under test and control conditions. RNA is extracted, converted 
to cDNA using reverse transcriptase. Test and control samples are labelled with Cy5 and Cy3 
(respectively), and are hybridised to a microarray. 
B. Run-off transcription analysis (ROMA): Genomic DNA (gDNA) is extracted from cells and is 
fragmented by either restriction enzymes or sonication. Purified RNA polymerase is added to 
purified gDNA in vitro in the presence or absence of the TF. RNA from in vitro transcription 
is purified, converted to cDNA. Samples are labelled with fluorescent dyes and hybridised to a 
microarray. 
 
































































Figure 1.15 Identifying transcription factor binding sites in vivo using ChIP-chip (A) 
and ChIP-seq (B), and in vitro using genomic SELEX (C) 
A. ChIP-chip analysis. Following fixing, lysis and sonication, protein-DNA complexes are 
immunoprecipitated, eluted, and fluorescently labelled for hybridisation to a microarray. DNA 
is shown as black lines, coloured circles are DNA-binding proteins, red circles are DNA-
binding proteins of interest. Based on Buck and Lieb (2004). 
B. Illumina library preparation using ChIP-DNA, prepared as shown in (A). Black lines show 
DNA, red circles depict a DNA-binding protein. 
C. Genomic SELEX, as developed by Shimada et al. (2005). gDNA is isolated from cells and is 
cloned into a cloning vector. Fragments are amplified through PCR, and are mixed with a 
purified, His-tagged TF. The mixture is passed through a Ni-NDTA column which binds the 
transcription factor. Following washing, DNA is eluted and is subject to further SELEX cycles, 
before sequencing or hybridisation to a DNA chip. Plasmid vectors are shown as red circles, 






























for a particular organism. (Mardis, 2007, Park, 2009). Specifically, ChIP-seq can map DNA 
binding to a resolution of 20-30 bp depending on the size of sonicated DNA, whereas resolution 
from microarrays depends largely on microarray probe density (Mockler and Ecker, 2005).  
The enhanced resolution afforded by NGS means that ChIP-seq is particularly useful for 
mapping protein binding sites in genomes with repetitive elements, which microarrays are 
unable to distinguish between (Park, 2009). The ChIP-seq workflow is initially similar to that 
of ChIP-chip. Cross-linked and sonicated DNA is immunoprecipiated. However, instead of 
labelling with fluorescent dyes, DNA fragments are used to prepare a library for NGS. For 
Illumina NGS platforms, this involves ligation of ‘barcoded’ DNA adapters to both ends of 
each DNA fragment (a workflow is shown in Figure 1.15B). One significant advantage of 
ChIP-seq is that multiple samples can be analysed together (multiplexing) if adapters with 
different ‘barcodes’ are chosen for each sample. (Mardis, 2007, Park, 2009).  
In an early use of these approaches Grainger et al. (2005) exploited ChIP-chip to map CRP and 
RNAP binding across the E. coli K-12 MG1655 genome in the presence of IPTG, salicylic acid 
and rifampicin. This study identified 68 binding sites for CRP and 39 novel targets. 
Furthermore, this study provided evidence to support suggestions made by Robison et al 
(1998), which predicted thousands of weak sites for CRP binding across the K-12 genome. 
This hints at an ancillary “NAP-like” role for CRP, perhaps involving the DNA bend of 80o 
induced upon CRP binding to DNA (Schultz et al, 1991, Lawson et al, 2004). 
1.6.4 Genomic SELEX 
Genomic SELEX methodology generates comprehensive lists of TF binding sites (Shimada et 
al., 2005, Ishihama, 2010). A simplified Genomic SELEX workflow is shown in Figure 1.15C. 
Genomic SELEX uses sonicated genomic DNA fragments, which are cloned into a plasmid 
vector, and amplified by PCR for each SELEX experiment. Once generated, this library is 
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repeatedly passed through a nickel-nitrilotriacetic acid (Ni-NDTA) column, which is pre-
bound by a 6x His tagged TF. DNA fragments are then eluted from the column, and are either 
subject to another round of SELEX selection, or amplified by PCR, and cloned into a plasmid 
vector for SELEX-clos (cloning-sequencing) or SELEX-chip (microarray analysis) (Shimada 
et al., 2005). 
The study by Shimada et al. (2011), using both SELEX-clos and SELEX-chip, provided the 
most comprehensive analysis of genome wide CRP binding in E. coli K-12 and identified a 
total of 254 CRP targets.  
1.7 Enterotoxigenic E. coli (ETEC) 
The complex gene regulatory systems described above allow E. coli to compete with other 
microbes, and the host organism, for nutrients available in the mammalian gut. Whilst many 
E. coli strains live harmoniously with their host some E. coli strains are the cause of 
gastrointestinal disease. In countries with poor sanitation infrastructure Enterotoxigenic E. coli 
(ETEC) is a common causes of such disease. ETEC is an extracellular pathogen that mediates 
disease by secreting toxins and was isolated in 1971 from patients in Bangladesh thought to 
have Cholera (Sack et al., 1971). ETEC is responsible for 200 million diarrhoeal episodes and 
380,000 deaths, mostly in infants under 5 years of age, every year (Isidean et al., 2011, Rivera 
et al., 2013, Walker et al., 2007).  
1.7.1 An overview of ETEC virulence factors 
ETEC that survive the low pH of the stomach express fimbrial adhesins and adhere to the brush 
border of the small intestine (Figure 1.16) (Porter et al., 2011 Fleckenstein et al., 2010). Once 
attached, ETEC secrete one or both of two toxins. The 84 kDa heat-labile toxin (LT) and the 2 






Figure 1.16 A model of ETEC infection 
ETEC cells (depicted here in red) adhere to the brush border of the small intestine using a number of 
different adhesins- these include CFs (these vary widely), EtpA, and invasins such as TibA and Tia (not 
shown). Host proteins are shown in blue, ETEC proteins are shown in green. Either ST or LT (or both) 
are secreted and bind to their respective receptors (Guanylate cyclase C, and ganglioside GM1). PKA 
(Protein Kinase A) inhibits anti-microbial peptide production (here denoted as AMP). Based on Croxen 





























cholerae (Gibert et al., 1990). The ST toxin is a mimic of the human hormones uroguanylin 
and guanylin (Taxt et al., 2010). Both LT and ST trigger the loss of sodium and chloride ions 
into the gut lumen, which causes watery diarrhoea, abdominal pain and vomiting. If untreated, 
these symptoms include coma and death (Nataro and Kaper, 1998). 
1.7.2 Heat-labile toxins (LT) 
LT is comprised of six subunits (five ‘B’ subunits and one ‘A’ subunit). The B subunits form 
a ‘doughnut’ structure around the A subunit. The A subunit consists of two regions, A1, which 
has ADP-ribosylating activity, and A2, which interacts with both the A1 and the B subunits 
(Sixma et al., 1991). The A and B subunits are transported into the periplasm by the Sec 
pathway, and folded and assembled by DsbA, before being exported by the General Secretion 
Pathway (GSP) (Tauschek et al., 2002, Yu et al., 1992). Where present, a GTPase (encoded by 
the chromosomal leoA locus) may assist in secretion by interacting with GSP (Brown et al, 
2007).  
Once secreted, LT binds to the ganglioside GM1 receptor on host epithelial cells and is 
endocytosed. The A1 subunit of the toxin ADP-ribosylates host Gsα, (a trimeric G protein). This 
activates adenyl cyclase resulting in elevated cAMP levels, activation of host protein kinase A, 
and phosphorylation of the Cystic Fibrosis Transmembrane Regulator (CFTR) protein (Cheng 
et al., 1991, Hamilton et al., 1978, Moss and Richardson, 1978). The consequence of this 
cascade is loss of chloride ions into the intestinal lumen and inhibition of sodium and chloride 
ion absorption (Spangler, 1992). The LT toxin may also contribute to adherence and 
colonisation (Johnson et al., 2009).   
1.7.3 Heat-stable toxin 
The heat-stable toxins (ST) are a group of non-immunogenic cysteine-rich peptides that remain 
functional after heating to 100 oC (Evans et al., 1973). They have significant homology to 
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human hormones uroguanylin, and guanylin (Taxt et al., 2010). There are two variants of ST 
secreted by ETEC to induce diarrhoea; STa1 and STa2. These are closely related and function 
through identical mechanisms. The 18 amino acid STa1 peptide is distributed amongst ETEC 
isolates from animals and humans whilst the 19 residue STa2 variant is specific to humans. 
STa1 and STa2 share 14 amino acids and are both methanol soluble and protease resistant 
(Moseley et al., 1983, Steinsland et al., 2002, Taxt et al., 2010).  Expression of ST alone, 
without LT expression, is sufficient to cause diarrhoea (Levine et al, 1977).  
Both STa1 and STa2 are expressed as ~70 amino acid pre-pro-peptides that are cleaved on 
export via the Sec system (Okamoto et al, 1995). Once in the periplasm, the disulphide 
oxidoreductase enzyme (DsbA) mediates disulphide bond formation between three pairs of 
cysteine residues (Okamoto et al., 1995, Yamanaka et al., 1994). The toxin is then secreted 
across the outer membrane through TolC (Yamanaka et al., 1998). ST toxins bind mammalian 
membrane-bound guanyl cyclase C (GC-C), resulting in cGMP accumulation, and 
phosphorylation of CFTR by the cAMP-dependent protein kinase. Thus, both LT and ST drive 
release of chloride ions into the gut lumen by the CFTR, resulting in water loss and diarrhoea 
(Chao et al., 1994, Newsome et al., 1978). There is some evidence that STa forms 35Å 
hexameric rings to interact with GC-C (Sato and Shimonishi, 2003). 
1.7.4 Colonisation Factors (CFs) 
In order to attach to the intestinal brush border ETEC cells express colonisation factors (CFs). 
These interact with epithelial cell glyco-conjugates (Gaastra and Svennerholm, 1996). CFs are 
often plasmid-encoded, and the expression of CFs is associated with diarrhoeal disease (Evans 
et al., 1975). There are at least 25 serotypically different CFs and many others are under 
investigation (Table 1.2) (Gaastra and Svennerholm, 1996, Qadri et al., 2005). The CFs range 





























Table 1.2 Colonisation Factors of ETEC 









colonisation factor (CFA/I) was characterised in 1979 (Evans et al., 1979). CFA/I forms a 7 nm 
fimbriae on the cell surface and is the archetypal member of class V pili, of which there are 8 
expressed by different ETEC strains (Anantha et al., 2004). Class V pili are assembled by the 
alternate chaperone pathway, which is similar but distinct from the chaperone-usher pathway 
involved in assembly of pap (P) and fim (Type I) pili. Assembly by the alternate chaperone 
pathway is simple and requires only the Sec system and the four genes of the fimbrial operon 
(Anantha et al., 2004, Soto and Hultgren, 1999). In ETEC H10407 the CFA/I fimbrial 
apparatus is encoded by the cfaBCE operon. CfaA, B, C and E are the chaperone, major pilin 
subunit, outer membrane usher, and tip protein respectively (Jordi et al., 1992). The 
transcription factor CfaD, controls expression of the operon (Savelkoul et al., 1990). 
1.7.5 Ancillary colonisation factors 
In addition to the ‘classical’ virulence factors described above, a number of minor virulence 
factors have recently been reported. In particular, the discovery that ETEC can invade some 
epithelial cell lines has led to the characterisation of additional afimbrial adhesins (Elsinghorst 
and Weitz, 1994, Fleckenstein et al., 1996).  
1.7.5.1 The tib and tia loci 
TibA is a 104 kDa outer membrane glycoprotein, expressed in 16 % of ETEC strains. The 
protein is encoded by the tibABCD operon (Elsinghorst and Weitz, 1994, Turner et al., 2006). 
TibA is an autotransporter, which, when localised to the outer membrane, allows recombinant 
K-12 strains to adhere to and invade epithelial cells (Elsinghorst and Weitz, 1994, Lindenthal 
and Elsinghorst, 1999, Lindenthal and Elsinghorst, 2001). The tia locus was characterised at a 
similar time, and encodes Tia; a 25 kDa outer membrane invasin that is inserted into the 
bacterial membrane by 8 transmembrane domains (Fleckenstein et al., 1996, Mammarappallil 
and Elsinghorst, 2000). The tia locus was found in 5 % of ETEC strains and also encodes an 
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invasin (Fleckenstein et al., 1996, Turner et al., 2006). Deleting tia leads to a 75 % reduction 
in invasion compared to H10407 strains expressing both Tia and TibA. Deleting tib reduces 
invasion by 85 % and deleting both invasins reduces invasion by 90 % (Elsinghorst and Weitz, 
1994, Mammarappallil and Elsinghorst, 2000,). Despite this, the role and contribution of the 
tib and tia loci to invasion is unclear. 
1.7.5.2 The Etp system 
The Etp system (encoded by etpBAC) is another accessory virulence determinant in ETEC. 
EtpA is a large glycoprotein of 170 kDa. EtpB forms a β-barrel involved in transport and 
afimbrial adhesion. EtpC is a transglycosylase. Recombinant E. coli K-12 strains expressing 
etpBAC adhere to epithelial cells (Fleckenstein et al., 2006). EtpA mediates this adhesion via 
flagella, acting as an adaptor (Roy et al., 2009). EtpA has been shown to play an important role 
in efficient heat-labile toxin delivery (Roy et al., 2012).  
1.7.5.3 CexE and the Aat system 
The CexE protein is well conserved between ETEC strains and may possess “dispersin-like” 
activity. Dispersin is a hydrophilic factor that coats the surface of some E. coli strains to 
enhance dispersal of cells by preventing self-aggregation mediated by hydrophobic fimbrial 
adhesins. In Enteroaggregative E. coli (EAEC) dispersin is secreted by the Aat type I secretion 
system that is also found in ETEC (Crossman et al., 2010, Nishi et al., 2003, Shiekh et al., 
2002). The cexE gene is genomically associated with the aat operon in H10407, hence, it seems 
likely that CexE is exported by the Aat system in ETEC (Crossman et al., 2010). A model for 
the organisation of Aat system proposed by Nishi et al. is shown in Figure 1.17. In this model 
AatA forms an outer membrane channel that docks with the ATP-binding AatC subunit and 








Figure 1.17 Predicted function of the ETEC Aat system based on Aat system of EAEC 
Yellow bolts and black arrows highlight NTP hydrolysis. Red arrows show the proposed secretion 





















Dispersin, (or CexE in this case) is transported across the inner membrane by the Sec 
machinery, and is exported across the outer membrane through AatA. 
1.8 ETEC genomics and phylogeny 
There are five phylogenetic groups of E. coli (A, B1, B2 D and E) (Chaudhuri and Henderson, 
2012). Turner et al. (2006) identified ETEC strains belonging to all of these lineages and no 
correlation between phylogeny and preferred host. The best characterised ETEC is the 
prototype strain H10407, a member of the group A phylogeny. The ETEC H10407 genome 
contains a 5,153,435 bp chromosome, two large plasmids (p948 and p666) and two smaller 
plasmids (p58 and p52). Most virulence factors (including LT, ST, CFA/I and the Aat system 
(Figure 1.18)) are encoded by p948 and p666. The chromosome of H10407 contains an 
additional 755,359 bp of DNA compared to E. coli K-12, localised to 25 regions and 599 genes. 
Surprisingly, only 8 % of these genes, including the primary virulence factors, are found in 
other ETEC strains (Crossman et al., 2010).  
1.9 Transcriptional control of virulence genes in ETEC 
Current evidence suggests that regulation of virulence factor expression in ETEC is mediated 
by a combination of ETEC specific regulators (such as Rns and CfaD) and TFs found in all 
E. coli strains (such as CRP and H-NS). Rns is an AraC family TF, 32 kDa in size, which is 
widespread in ETEC isolates (Caron et al., 1989, Caron et al., 1990, Munson et al., 2002). At 
the Pcoo promoter (which controls expression of CS1 fimbriae), Rns binds at positions -109.5 
and -37.5 relative to the transcription start site and activates transcription. However, despite 
also regulating the transcription of other virulence factors the Rns regulon in poorly defined 
(Munson and Scott, 1999). CfaD activates transcription at the cfa operon (Jordi et al., 1992) in 
addition to overcoming repression mediated by the nucleoid associated protein H-NS (Jordi et 





Figure 1.18 Assembly and secretion ETEC virulence factors  
The four panels show the various assembly and secretion mechanisms used by different ETEC virulence 
factors. All four pathways require the Sec YEG complex located in the inner membrane for translocation 
of unfolded substrates. A) Assembly of CFA/I pili requires four genes encoded by the cfaABCE operon, 
and occurs through the process donor strand exchange. B) Secretion of CexE (a putative dispersin) 
requires export through the inner membrane by Sec, followed by export through the Aat system. Both 
the ST (C) and LT (D) toxins are assembled in the periplasm by DsbA. ST is secreted through TolC, 
and LT is secreted through the general secretory pathway type II secretion system. Based on Turner et 































et al., 1991) and the ST toxin (Alderete and Robertson, 1977, Busque et al., 1995) possibly 
implicating CRP in their regulation (Saier, 1998). Moreover, CRP is proposed to directly 
repress transcription of the eltAB gene, encoding the heat-labile toxin, by binding to three sites 
upstream of the promoter; a high affinity site centred at -31.5, and two lower affinity sites 
centred at -132 and -261 upstream of the promoter (Bodero and Munson, 2009).  
1.10 Overview and aims of this study 
The reports discussed above hint at a role for CRP in the regulation of ETEC virulence factors, 
particularly since CRP plays an important in implementing CCR, and hence glucose repression. 
Sugar metabolism is known to be an important determinant of intestinal colonisation by E. coli 
MG1655, and thus it is perhaps not surprising that CRP is co-opted as a virulence regulator in 
many enterobacteria (Chang et al., 2004, Le Bouguénec and Schouler, 2011). It seems plausible 
that CRP is likely to play a role in the regulation of ETEC given the core genome shared by 
ETEC and laboratory K-12 strains (Crossman et al., 2010). To investigate this, we choose to 
investigate the regulation of virulence factor expression in the prototype strain H10407, which 
is known to cause particularly severe disease (Porter et al., 2011, Turner et al., 2006). 
In this work, we have elucidated the CRP, H-NS and σ70 regulons of the prototype ETEC strain 
H10407, using bioinformatics and ChIP-seq. In subsequent genetic and biochemical analysis 
of individual targets we show that i) regulation of ST toxin production in ETEC H10407 is 
dependent on CRP ii) the NAP H-NS represses expression of ST iii) repression of LT 
expression by CRP occurs via an indirect mechanism and iv) that CRP activates transcription 





















2.1 Buffers and generic reagents 
All solutions were made up in deionised and distilled water (ddH2O) unless stated. Solutions 
were autoclaved at 121 oC for 15 minutes at 5 psi before use. All reagents (e.g. enzymes etc.) 
were purchased from Sigma or Life Technologies unless stated otherwise. 
 
Phenol/chloroform extraction: 
 Phenol/chloroform/isoamyl alcohol pH 8 (25:24:1).  
Ethanol precipitation: 
 100 % (v/v) Ethanol. 
 70 % (v/v) Ethanol. 
 3 M Sodium acetate pH.5.2. 
 20 mg/ml Glycogen.  
Preparation of competent cells:  
 100 mM Calcium chloride.  
 50 % (v/v) Glycerol. 
Polyacrylamide gel electrophoresis (PAGE) and denaturing sequencing gel reagents: 
 5x TBE: 0.445 M Tris borate pH 8.3, 10 mM Na2EDTA. Supplied by Fisher Scientific, 
and diluted to a 1x stock using ddH2O before use. 
 Ammonium persulphate. Supplied by Sigma. 
 TEMED (N,N,N′,N′-Tetramethylethylenediamine). Supplied by Sigma. 
 30 % (w/v) Acrylamide: 0.8 % (w/v) bisacrylamide mix. Supplied by Geneflow.  




Agarose gel electrophoresis: 
 6x Loading dye: 10 mM Tris pH 7.5, 1 mM EDTA, 20 % (v/v) glycerol, 0.025 % (v/v) 
bromophenol blue, 0.025 % (v/v) xylene cyanol FF. 
 5x TBE: 0.445 M Tris borate pH 8.3, 10 mM Na2EDTA. Supplied by Fisher Scientific. 
The 5x solution is diluted to a 1x stock using ddH2O before use.  
 Powdered agarose: supplied by Bioline. 
β-galactosidase assays: 
 13 mM (8 mg/ml) 2-Nitrophenyl β-D-galactopyranoside (ONPG): made up to 1 L 
in ‘Z-buffer’. 
 ‘Z-buffer’: 8.53 g Na2HPO4, 4.87 g NaH2PO4.2H2O 0.75 g KCl, 0.25 g MgSO4 per L 
of ddH2O, then autoclaved.  
 β-mercaptoethanol: immediately before use, 271 μl β-mercaptoethanol was added per 
100 ml of ‘Z-buffer’. 
 1 % (w/v) Sodium deoxycholate. 
 100 % (v/v) Toluene.  
 1 M Sodium carbonate.  
CRP purification:  
 1 M Potassium phosphate (pH 7.5): 162.75 ml 1 M K2HPO4, 37.26 ml KH2PO4. 
 1 M Sodium phosphate (pH 6.8): 46.3 ml 1 M Na2HPO4, 53.7 ml KH2PO4. 
 Lysis buffer: 50 mM potassium phosphate (pH 7.5), 2 mM EDTA, 0.2 M NaCl, 5 % 
(w/v) glycerol. DTT (2 mM) was added after autoclaving.  
 Dialysis buffer: 50 mM potassium phosphate (pH 7.5), 2 mM EDTA, 5 % (w/v) 
glycerol. DTT (2 mM) was added after autoclaving.  
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 Column wash buffer: 0.5 M potassium phosphate (pH 7.5), 2 mM EDTA, 5 % (w/v) 
glycerol, DTT (2 mM) was added after autoclaving.  
 Column wash buffer with 1 M NaCl: 0.5 M potassium phosphate (pH 7.5), 2 mM 
EDTA, 1 M NaCl, 5 % (w/v) glycerol, 2 mM DTT (2 mM) added after autoclaving.  
 CRP stock buffer: 10 mM sodium phosphate (pH 6.8), 0.1 mM EDTA, 0.2 M NaCl, 
50 % (w/v) glycerol. 
 Superbroth (per litre): 20 g tryptone, 5 g yeast extract, 0.5 g NaCl, 0.19 g KCl. 
 2x SDS-PAGE loading dye. Purchased from Life Technologies. 
 Pre-cast NuPage 4-12 % (w/v) Bis-Tris polyacrylamide protein gels. Purchased 
from Life Technologies. 
 1x MES buffer: 50 mM MES (2-[N-morpholino]ethanesulphonic acid), 50 mM Tris 
base, 0.1 % (w/v) SDS, 1 mM EDTA, pH 7.3. Diluted from 20x MES (purchased from 
Life Technologies) using ddH2O. 
 
In vitro transcription: 
 10x Transcription buffer (TNSC buffer): 400 mM Tris acetate pH 7.9, 10 mM 
MgCl2, 1 M KCl, 10 mM DTT. 
 STOP solution: 97.5 % (v/v) deionised formamide, 10 mM EDTA, 0.3 % (v/v) 
Bromophenol Blue/ Xylene Cyanol FF.  
 P32 labelled α-UTP (3000 Ci/mmol). Supplied by Perkin-Elmer. 
Radiolabelling of DNA fragments: 
 G-50 sephadex beads. Resuspended in a 12 % (v/v) slurry with TE.  
 T4 polynucleotide kinase. Supplied by NEB, used with supplied 10x buffer. 
 P32 labelled γ-dATP (7000 Ci/mmol). Supplied by MP Biomedicals. 
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 TE (Tris-EDTA) buffer: 10 mM Tris-HCl, 1 mM EDTA (pH 8.0). 
Electrophoretic mobility shift assays: 
 10x Transcription buffer (TNSC buffer): 400 mM Tris acetate pH 7.9, 10 mM 
MgCl2, 1 M KCl, 10 mM DTT. 
M13 sequencing reactions: 
 2 M Sodium hydroxide 
 Annealing buffer: 1 M Tris-HCl pH 7.5, 100 mM MgCl2, 160 mM DTT. 
 ‘A’ mix short: 840 μM of dCTP, dGTP, and dTTP each, 14 μM ddATP, 93.5μM dATP, 
40 mM Tris-HCl pH7.5, 50 mM  NaCl. 
 T7 polymerase dilution buffer: 25 mM Tris-HCl pH 7.5, 5 mM DTT, 100 μg/ml BSA, 
5% (v/v) glycerol. 
 Label mix ‘A’: 1.375 mM of dCTP, dGTP, and dTTP each, 333.5 mM NaCl. 
 STOP solution: 0.025 % (v/v) bromophenol blue, 0.025 % (v/v) xylene cyanol FF, 10 
mM EDTA pH 7.5, 97.5% (v/v) formamide.  
 P32 labelled α-dATP (3000 Ci/mmol). Supplied by Perkin-Elmer. 
Primer extension: 
All solutions DEPC treated and autoclaved (except 100 % and 70 % (v/v) ethanol). 
 1x Hybridisation buffer (20 mM HEPES, 0.4 M NaCl, 80 % (v/v) formamide). 
 100 % (v/v) Ethanol. 
 70% (v/v) Ethanol (made up with DEPC-treated ddH2O). 
 3 M Sodium acetate pH 5.2 
 3 M Sodium acetate pH 7 
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G+A ladder generation: 
 DNAse I blue: 5 M urea, 20 mM NaOH, 1 mM EDTA, 0.025 % (v/v) bromophenol 
blue, 0.025 % (v/v) xylene cyanol FF. 
 10 M Piperidine. Diluted with ddH2O before use.  
 100% (v/v) Formic acid. 
DNAse I footprints: 
 Recombinant DNAse I. Supplied by Roche. 
 DNAse I blue: 5 M urea, 20 mM NaOH, 1 mM EDTA, 0.025 % (v/v) bromophenol 
blue, 0.025 % (v/v) xylene cyanol FF. 
 10x Transcription buffer (TNSC buffer): 400 mM Tris acetate pH 7.9, 10 mM 
MgCl2, 1 M KCl, 10 mM DTT. 
 DNAse I STOP solution: 0.3 M sodium acetate, 10 mM EDTA.  
TCA precipitation: 
 100 % (w/v) Trichloroacetic acid. 
 100 % (v/v) Methanol. 
 2x SDS-PAGE loading dye. Purchased from Life Technologies. 
 1 x PBS: 137 mM NaCl, 10 mM Na2HPO4, 2.7 mM KCl, 1.8 mM KHPO4. pH 7.3. 
Tablets purchased from Oxoid. 
 Pre-cast NuPage 4-12 % (w/v) Bis-Tris polyacrylamide protein gels. Purchased 
from Life Technologies. 
 1x MES buffer: 50 mM MES (2-[N-morpholino]ethanesulphonic acid), 50 mM Tis 
base, 0.1 % (w/v) SDS, 1 mM EDTA, pH 7.3. Diluted from 20x MES (purchased from 
Life Technologies) using ddH2O. 
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Silver staining of protein gels: 
 SilverQuest kit. Purchased from Life Technologies.  
ChIP-seq reagents: 
 1x TBS (20 mM Tris-HCl, pH 7.4, 0.9 % (w/v) NaCl). 
 FA lysis buffer “150mM NaCl” (50 mM Hepes-KOH, pH 7, 150 mM NaCl, 1 mM 
EDTA, 1 % (w/v) Triton X-100, 0.1 % (w/v) Sodium Deoxycholate, 0.1 % (w/v) SDS). 
 FA lysis buffer “500mM NaCl” (50 mM Hepes-KOH, pH 7, 500 mM NaCl, 1 mM 
EDTA, 1 % (w/v) Triton X-100, 0.1 % (w/v) Sodium Deoxycholate, 0.1 % (w/v) SDS). 
 ChIP wash buffer (10 mM Tris-HCl, pH 8, 250 mM LiCl, 1 mM EDTA, 0.5 % (w/v) 
Nonidet-P40, 0.5 % Sodium Deoxycholate).  
 ChIP elution buffer (50 mM Tris-HCl, pH 7.5, 10 mM EDTA, 1 % (w/v) SDS).  
 1x TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA).  
 NEXTflex ChIP-seq Barcodes-24 (supplied by BioOscientific). 
 Agencourt AMPure magnetic beads (supplied by Beckman Coulter) XP DNA clean-
up kit. 
 Quick blunting and quick ligation kits (supplied by NEB). 
 Klenow fragment (3’→5’ exo-) (supplied NEB). 
 Monoclonal anti-FLAG, anti-CRP, anti-β, and anti-σ70 antibodies (supplied by 
Neoclone).  
 Monoclonal anti-H-NS antibody (kindly donated by Jay Hinton). 
 Qubit fluorometer/ assay kit (supplied by Life Technologies). 
 10 mM Tris-HCl pH 7.5/8. 
 Protein A sepharose beads (supplied by GE Healthcare, GE17-0780-01). Washed 
with ddH2O and stored in a 50 % (v/v) slurry with 1x TBS.  
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 Spin-X columns. 
 Acrylamide gel extraction buffer (0.3 M NaCl, 10 mM Tris-HCl, pH 8, 1 mM EDTA). 
2.2 Solid growth media 
LB agar:  
LB agar was purchased from Sigma. Thirty-five g of powdered agar was dissolved in 1 litre 
of ddH2O, before autoclaving. 
MacConkey lactose agar: 
MacConkey agar containing lactose (10 g/l) was purchased from Oxoid. Fifty-two g of 
powdered agar was dissolved in 1 litre of ddH2O, before autoclaving.  
2.3 Liquid growth media 
LB broth: 
LB broth was purchased from Sigma. Twenty g of powdered LB broth was dissolved in 1 
litre of ddH2O before autoclaving.   
10x M9 salts: 
Sixty g Na2HPO4, 30 g KH2PO4, 5 g NaCl, 10 g NH4Cl, 10 mg biotin and 10 mg thiamine 
were dissolved in 1 litre of ddH2O, before the pH was adjusted to pH 7.4, followed by 
autoclaving. 
M9 minimal media: 
M9 minimal medium was made up on the day of use. To make 100 ml of this media, the 
following solutions were autoclaved individually and mixed in the following ratio; 10 ml 10x 
M9 salts, 200 μl 1 M MgSO4, 100 μl 0.1 M CaCl2, 1.5 ml 20 % (w/v) fructose, 0.5 ml 20 % 
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(w/v) casamino acids, made up to 100 ml with autoclaved ddH2O. If required, 100 μg/ml 
thymine was added to the media. 
2.4 Antibiotics 
Antibiotic stocks were made up and used as follows: 
 Ampicillin: 100 mg/ml (dissolved in water) stored at -20 oC. The final concentration 
used in agar and broth unless stated otherwise was 100 µg/ml. 
 Kanamycin: 50 mg/ml (dissolved in water) stored at -20 oC. The final concentration 
used in agar and broth unless stated otherwise was 100 µg/ml. 
 Tetracycline: 35 mg/ml (dissolved in methanol) stored at -20 oC. The final 
concentration used in agar and broth unless stated otherwise was 35 µg/ml. 
 Trimethoprim: used at 20 μg/ml.  
Antibiotics were added to media at the stated concentrations, once media had cooled to below 
50 oC after autoclaving.  
2.5 Preparation of competent cells 
Overnight culture (1 ml) was used to inoculate 50 ml of fresh LB medium. This was incubated 
at 37 oC until the OD650 of the culture was between 0.3-0.6 (measured using a Jenway 6300 
spectrophotometer). The culture was then decanted into centrifuge tubes, chilled on ice for 10 
minutes, and cells harvested by centrifuging at 1,600 xg for 5 minutes at 4 oC. Cells were then 
re-suspended in 25 ml 100 mM ice-cold sterile CaCl2, incubated on ice for 20 minutes, re-
harvested and suspended in 3.3 ml ice-cold 100 mM calcium chloride. The suspension was left 
overnight on ice to maximise competency before 1 ml was aliquoted into microfuge tubes with 




2.6 Transformation of bacterial cells 
One to five µl of plasmid DNA (or a ligation reaction) was incubated on ice with 100 μl of 
competent cells for 1 hour. Cells were then heat shocked at 42 oC for 2 minutes, before being 
returned to ice briefly. Five hundred µl of LB medium was added to the cells which were 
incubated at 37 oC for at least 45 minutes to recover. After this period, cells were pelleted by 
centrifugation at 2,400 xg for 2 minutes. Cells were re-suspended in 100 µl of LB medium and 
plated out on an appropriate medium. 
2.7 Phenol-chloroform extraction/ ethanol precipitation of DNA 
An equal volume of the phenol-chloroform mix was added to the DNA sample to be extracted. 
This was mixed vigorously for 15 seconds before centrifugation at 2,400 xg for 3 minutes. The 
upper aqueous phase was transferred to a new microfuge tube, and 2.5-3 volumes of ice-cold 
100 % ethanol, along with 0.1 volumes of 3 M sodium acetate pH 5.2 was added. If the size of 
the DNA was <100 bp 1 µl 20 mg/ml glycogen was also added. DNA was precipitated at -80 oC 
for 30 minutes and collected by centrifugation at 17,000 xg and the pellet was washed in ice-
cold 70 % (v/v) ethanol, dried under vacuum, and resuspended in the required volume of dH2O.   
2.8 Agencourt AMPure XP magnetic bead clean up 
For ChIP-seq experiments, DNA purification was performed using Agencourt AMPure XP 
magnetic beads, supplied by Beckman Coulter. All clean up steps were performed in 
accordance with the manufacturer’s instructions. AMPure magnetic beads were also be used 
for size selection of DNA libraries containing DNA of variable sizes. 
2.9 PCR reactions 
PCR reactions were done in 50 µl volumes of reaction buffer containing ATP/GTP/CTP/TTP 
(0.5 mM each), 2 μM of each primer, and 50-200 ng template.  Phusion DNA polymerase from 
NEB (New England Biosciences) and Velocity from Bioline were used ad hoc throughout the 
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work. The annealing temperature used in PCR varied according to the oligonucleotide and was 
typically 3 oC lower than the lowest primer Tm used. We allowed 30 seconds of elongation for 
every 1000 bp of DNA amplified.  
A typical PCR cycle consisted of the following: 
94 oC      1 minute   (initial melting of DNA) 
94 oC     30 seconds (DNA melting) 
50 oC     30 seconds (primer annealing)                                Repeated for 35 cycles 
72 oC     35 seconds (elongation) 
72 oC     10 minutes (final elongation) 
2.10 Megaprimer PCR reactions 
Megaprimer PCR was used to generate point mutations in large DNA fragments that lacked 
appropriately positioned restriction sites (Figure 2.1). The first PCR reaction generates a 
“megaprimer containing the point mutation required. The megaprimer is then used in a second 
PCR reaction, along with a second flanking primer to generate the final product containing the 
point mutation.  
2.11 Plasmid and RNA extraction using Qiagen maxiprep, miniprep, or RNeasy 
extraction kits 
Nucleic acid extractions were done using Qiagen kits. Briefly, the DNA is bound to a silica 
column, washed with a high salt solution, and then eluted in water. DNA for in vitro 
transcription was extracted on a large scale using the Qiagen maxiprep kit. Small scale 
extractions for generating plasmid stocks and cloning vectors utilised the Qiagen miniprep kit. 




Figure 2.1 Mega-primer PCR 
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Megaprimer






2.12 Ligation of PCR products into plasmid vectors 
PCR products were purified using Qiagen PCR purification columns according to the 
manufacturer’s instructions. The kit removes oligonucleotide primers under 40 bp. Following 
clean-up PCR products were digested with the appropriate restriction enzymes, re-purified, and 
then used in ligation reactions. Plasmid vectors used in ligation reactions were first digested 
with appropriate restriction enzymes and then treated with alkaline phosphatase to cleave 5’ 
hydroxyl groups. Vectors smaller than 10 kb were purified using gel extraction as described 
above. Vectors larger than 10 kb were purified using phenol-chloroform extraction, followed 
by ethanol precipitation. Ligation reactions were done in 20 μl containing 3/1 ratio of plasmid 
vector to purified and restricted PCR product (about 50 ng and 100-200 ng respectively), 2 μl 
of supplied 10x buffer, and 2 μl of T4 DNA ligase. 
2.13 Sanger sequencing of plasmid constructs 
Sanger sequencing was done by the Functional Genomics and Proteomics Facility at the 
University of Birmingham. Sequencing reactions were submitted in a 10 μl total volume, with 
1 μl 10 μM primer, and at least 200 ng of DNA. 
2.15 Agarose gel electrophoresis 
One % (w/v) agarose gels were prepared by dissolving 1 g of agarose to 100 ml of 1x TBE. 
The suspension was microwaved for 1 minute, on a high setting, to dissolve the agarose. 
Ethidium bromide (1 % v/v) was added before the gel was poured. Gels were run at 150 V for 
20-30 minutes in 1x TBE running buffer, or as required.  
2.16 Polyacrylamide gel electrophoresis (PAGE) 
Acrylamide gels (7.5 % w/v) were prepared by mixing the appropriate reagents (5x TBE, 30 % 
(w/v) acrylamide stock (Geneflow), and distilled water) together to the required concentration, 
before polymerisation with 0.01 volumes of 10 % w/v APS (ammonium persulphate) and a 
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0.001 volumes of TEMED (N,N,N′,N′-Tetramethylethylenediamine). After running at 20 mA 
for 20 mins, gels were stained for 10 minutes in water containing 1 % (v/v) ethidium bromide 
(Fisher Scientific). Loading dye was used to track migration of samples in the gel. A UV 
transilluminator was used to visualise the DNA after electrophoresis.  
2.17 Denaturing PAGE 
Six % (w/v) denaturing PAGE was done using Sequagel reagents (Geneflow) or by adding urea 
to 6 % (w/v) acrylamide solutions to a final concentration of (36 % w/v). 
2.18 Oligonucleotides used in this study 
Oligonucleotides (Life Technologies or ALTA Biosciences) are shown in Table 2.1.  
2.19 Bacterial strains used in this study 
All strains are shown in Table 2.2.  
2.20 Plasmid vectors used in this study 





Oligo name (F: 
Forward, R: Reverse) 
 Table 2.1 Oligonucleotides used in this study 
 
Sequence (5’ -> 3’) 
  
Oligonucleotides used for generation of CRP target fragments located by 
bioinformatics screen on p948 & p666 
H10407 CRP target 1F GGCTGCGAATTCTTTTGTGATTAATTTCACAAAATAAGGTGTTATTCAGTGTGTGCTG
CAATATTCAGGATGCATGA 
H10407 CRP target 1R GCCCGAAGCTTCATGTTATTCTCCATATCAGATAAATAGCACCTGTATTTCATGCATC
CTGAATATTGCAGCACAC 










H10407 CRP target 3F GGCTGCGAATTCTAGTATGATACACATCACAAAAAAATAAAAAAGTTTGCGCAATCGT
TCTGATTTTGAT 
H10407 CRP target 3R GCCCGAAGCTTCATATTACCTCCGAAACACGTCGTCCACGAATATTTAAATCAAAATC
AGAACGATTGC 
H10407 CRP target 4F GGCTGCGAATTCTTTTGTGATTGATTTCATAAAACAAGACGTCGTTTAATATGCGCCT
GAATATTCACGAGGGAAGTCTTTCTTTTTATATGGTG 
H10407 CRP target 4R GCCCGAAGCTTCATGTTTTTACCTTTTATTCATAACAGGGTGAGCAATGACAAAAAAT
ATTTTATTTCCGGGAACACCATATAAAAAGAAAGAC 
H10407 CRP target 5F GGCTGCGAATTCTTCGTACTGTCACCTTTTTAAATCATAAAAACTCTGATATTTGAAC
GAAGTCAAATTT 
H10407 CRP target 5R GCCCGAAGCTTGAACGATTTTTTCCAAAAAATGATGATGAATAAAAGAAATTTGACTT
CGTTCAAATAT 
H10407 CRP target 6F GGCTGCGAATTCTGAATCATATGCGATTCACCAATGAATCCTTTTTATAATGTAAAAT
AAATTAAAATA 
H10407 CRP target 6R GCCCGAAGCTTCATTAACTTATATTTTAAATAATGTATTTTAATTTATTTTACATTA 
H10407 CRP target 7F GGCTGCGAATTCTAACATGATGCAACTCACAAAAAAAATAAAAAAATTGCAAAATCCG
TTTAACTAATCT 
H10407 CRP target 7R GCCCGAAGCTTCATGTTACCTCCCGTCATGTTGTTTCACGGATATTTGAGATTAGTTA
AACGGATTTTG 




H10407 CRP target 8R GCCCGAAGCTTCATTCTTTGCCAGCAAATCCTGCACACGTGGGTTCTTTACAAATTCA
TCTG 
H10407 CRP target 9F GGCTGCGAATTCTTTTGTGGAGTGGGTTAAATTATTTACGGATAAAGTCACCAGAGGT
GGAAAAATGAAA 
H10407 CRP target 9R GCCCGAAGCTTTTTCATTTTTCCACCTCTGGTGACTTTATCCGTAAATAATTTAACCC
ACTCCACAAAA 

















































 Oligonucleotides for generating PeltAB derivatives 
PeltAB 1.1 F GGCTGCGAATTCGCATGGATGTTTTATAAAAAACATGATTGACATCATGTTGCATATA
GG 
PeltAB 1.2 F GGCTGCGAATTCGCATGGATGTTTTATAAAAAACATGATTGACATCATGTTGCATATA
GG 
PeltAB 1.3 F GGCTGCGAATTCGCATGGATGTTTTATAAAAAACAACATTGACATGTTGTTGCATATA
GG 
PeltAB R GCCCGAAGCTTCATCGAGGATATATATCATACAAGAAGACAATCCGGAAAAAGAT 
 Oligonucleotides used for inserting lacUV5 promoter into pJRH1-4 
lacUV5 promoter F GGCTGCTGATCATTTACACTTTATGCTTCCGGCTCGTATAATGTGTGGAACATCCCCT
TTATCTAGGAGGCCATGGCTGCAGACACTTGAATG 
 Oligonucleotides used for sequencing and amplification of DNA fragments from 
pRW50 and pSR 
pSR UP CCATATATCAGGGTTATTGTCTC 
pSR DOWN CATCACCGAAACGCGCGAGG 
pRW50 UP GTTCTCGCAAGGACGAGAATTTC 
pRW50 DOWN AATCTTCACGCTTGAGATAC 
 Oligonucleotides for used for primer extension 





 Oligonucleotides for PaatS expression analysis (in addition to those listed above) 
Target 2 ΔSD 
sequence reverse (used 







 Oligonucleotides used for cloning aat operon subunits into BACTH plasmids 
pKT25 aatC UP GCATGCCTGCAGGGATGATTAAATTAAGTATTGA 
pKT25 aatC DOWN TACTTAGGTACCCGTTAAAAGGATATAACCTTCA 
pUT18 aatS UP GCATGCCTGCAGGATGATTTTTTTTTTGTTATT 
pUT18 aatS DOWN: TACTTAGGTACCCGTGTTGTTTTAAAAGAACTAG 
pUT18 aatS short UP: GCATGCCTGCAGGATGTCATCTGCTAGCAGTATTTT 
pUT18C aatS DOWN: TCATTAGGTACCCGTCATGTTGTTTTAAAAGAACTAG 
pKT25 aatP F GCATGCCTGCAGGGATGTCATTTGTTTTTATGATACTG 
pKT25 aatP R TACTTAGGTACCCGTGAAAATCTTTCTTTTATTAA 
pKT25 aatA F GCATGCCTGCAGGGATGAAGATTATATTTATATTATTA 
pKT25 aatA R TACTTAGGTACCCGCTAACCAATAAAAAACAAATGCAT 
pKT25 aatB F GCATGCCTGCAGGGATGAAATTGAATTATATAAAATGC 
pKT25 aatB R TACTTAGGTACCCGTTAATCATGTAGTGTTATCTCAAATGC 
pKT25 aatD F GCATGCCTGCAGGGATGATTGTTAAAATGGAGAATATAATT 
pKT25 aatD R TACTTAGGTACCCGTTATACATCAATGACAAAAAATGG 
pUT18 aatP F GCATGCCTGCAGGATGTCATTTGTTTTTATGATACTG 
pUT18 aatP R TACTTAGGTACCCGTGAAAATCTTTCTTTTATTAAGAT 
pUT18 aatA F GCATGCCTGCAGGATGAAGATTATATTTATATTATTAGCT 
pUT18 aatA R TACTTAGGTACCCGACCAATAAAAAACAAATGCAT 
pUT18 aatB F GCATGCCTGCAGGATGAAATTGAATTATATAAAATGC 
pUT18 aatB R TACTTAGGTACCCGATCATGTAGTGTTATCTCTGC 
pUT18 aatC F GCATGCCTGCAGGATGATTAAATTAAGTATTGAT 
pUT18 aatC R TACTTAGGTACCCGAAAGGATATAACCTTCA 
pUT18 aatD F GCATGCCTGCAGGATGATTGTTAAAATGGAGAATATAATT 
pUT18 aatD R TACTTAGGTACCCGTACATCAATGACAAAAAATGG 
 Oligonucleotides used for generating pJRH1-4 
aat operon F TGCGAAGCTGCCATGGCTGCAGACACTTGAATGTCATTTGTTTTTATGATACTG 
aat operon R TACTTAGGATCCTTATACATCAATGACAAAAAATGG 




CexE R TACTTACCATGGTTATTTATACCAATAAGGGGTGTCACCACCGGCAGA 
73 
 
 Oligonucleotides used for sequencing pJRH1-4 constructs 
CexE seq F 2 GTGTTATTCTGGCTATGGGGTCTCTCTC 
aatP seq F 2 GATACTGAAAGAGGCGTTGC 
aatA seq F 2 CAGTCAAACTTGTGATGCGG 
aatB seq F 2 GTACTACAATGAAATTAACGCACT 
aatC seq F 2 AATAACAGCGGTATGGAGG 
aatD seq F 2 ACAAGGTGGAACAGTTGTTATGG 
Pre-CexE R seq 2 AGAGAGACCCCATAGCC 
CexE R seq 2 TACAATGTCGGGACTCAACC 
Post-CexE R seq 2 TGACAGTTGCCCCTCCCT 
aatP R seq 2 GAATAGTCATTGTCTCGACG 
aatA R seq 2 ATAACAGAGTCCCCTCTCAG 
aatB R seq 2 AGAAATAACAACGCGATCAG 
aatC R seq 2 ACCCCTAATAACAATGTGC 


























Table 2.1 Oligonucleotides used in this study 




Table 2.2 Strains used in this study 
 
Strain Genotype Source 
M182 Δ(lacIPOZY) X74 galK galU 
strA  
Casadaban and Cohen (1980) 
M182 Δcrp M182 Δcrp39 Busby et al. (1983) 
JCB387 ΔnirB Δlac Typas and Hengge (2006) 
ETEC H10407 Wildtype ETEC strain, 
CFA/I LT+ STh+ STp+ 
O78:H11 
Crossman et al. (2010) 
ETEC H10407 ΔthyA ETEC strain H10407 with 
thyA gene deleted. 
Stringer et al. (2012) 
ETEC crpFLAG3 ETEC strain H10407 with 
the FLAG3 inserted into the 
C-terminal end of the crp 
gene. 
This study  
BTH101 F-, cya-99, araD139, galE15, 
galK16, rpsL1 (Strr), hsdR2, 
mcrA1, mcrB1. 
Karimova et al. 1998 
ER2925 ara-14, leuB6 fhuA31 lacY1 
tsx78 glnV44 galK2 galT22 
mcrA dcm-6 hisG4 rfbD1 
R(zgb210::Tn10)TetS endA1 
rpsL136 dam13::Tn9 xylA-5 
mtl-1 thi-1 mcrB1 hsdR2 
(New England Biolabs) 
M182 Δhns Generated by P1 transduction 
of M182 with hns::kan from 









Table 2.3 Plasmids used in this study 
Plasmid Features Source 
pRW50 Large 16.9 kb plasmid featuring EcoR1-HindIII 
restriction sites sandwiching a cloning site, 
upstream of a lacZ fusion. Encodes TetR. RK2 
origin. 
Lodge et al. (1992) 
pRW225 15 kb pRW50-based derivative with a deleted 
ribosome binding site. Used for translational 
fusion, encodes TetR. RK2 origin. 
Islam et al. (2012) 
pSR 2.6 kb plasmid featuring EcoR1-HindIII 
restriction sites sandwiching a cloning site, 
upstream of a λoop terminator site. A pBR322 
derived plasmid encoding AmpR. ColE1 origin. 
Kolb et al. (1995) 
pDCRP crp gene preceding its native promoter (located on 
EcoRI-SalI flanked fragment). pBR322 derived. 
Encodes AmpR. ColE1 origin. 
Bell et al. (1990) 
pLG314 pLG339-based vector containing melR gene, 
controlled by a galP2 promoter, subcloned on a 
EcoR1-BamH1 fragment from pCM118-314 
within the TetR gene. Encodes KanR. pSC101 
origin. 
Wade et al. (2001) 
pCexE Pet26b vector with aat operon cloned into MCS 
using NdeI-XhoI restriction site. The aatD is in a 
non-native position downstream of aatC. Encodes 
KanR. f1 origin. 
(dna2.0) Kindly 
donated by Dr 
Yanina 
Sevastsyanovich 




pAMD135 pGEM-T- containing MG1655 thyA gene flanked 
by FLAG3 epitopes. f1 origin. 
Stringer et al. (2012) 
pUT18 Encodes T18 domain of Bordetella pertussis 
adenyl cyclase, downstream of the PstII-KpnI 
cloning site. Both features are downstream of the 
lac promoter. Encodes AmpR. ColE1 origin. 
Karimova et al., 
(1998), Karimova et 
al., (2001) 
pUT18C Encodes T18 domain of Bordetella pertussis 
adenyl cyclase, upstream of the PstII-KpnI 
cloning site. Both features are downstream of the 
lac promoter. Encodes AmpR. ColE1 origin. 
Karimova et al., 




pKT25 Encodes T25 domain of Bordetella pertussis 
adenyl cyclase, upstream of the PstII-KpnI 
cloning site. Both features are downstream of the 
lac promoter. Encodes KanR.  p15a origin. 
Karimova et al., 
(1998), Karimova et 
al. (2001) 
pJ204-aatS Contains putative aatS gene under control of 
lacUV5 promoter. Ordered from dna 2.0. Encodes 
AmpR. Ori_pUC origin. 
(dna 2.0.) 
pJRH1 pLG314 derivative containing aat operon from 
ETEC strain H10407 (sub-cloned from pCexE). 
aatD is in a non-native position downstream of 
aatC. Under the control of a lacUV5 promoter. 
Encodes KanR. pSC101 origin 
This study 
pJRH2 Derivative of pJRH1, but contains cexE cloned 
upstream of aatP downstream of the lacUV5 
promoter. 
This study 
pJRH3 Derivative of pJRH1, but contains an interrupted 
start codon in the putative aatS open reading 
frame. 
This study 
pJRH4 Derivative of pJRH2 but contains an interrupted 















2.21 β-galactosidase assays 
β-galactosidase assays were done as in Miller et al (1972). Overnight cultures were set up from 
fresh colonies, the following day, 100 µl from each overnight incubation was used to sub-
culture into fresh media. Cultures were grown to mid-log phase (OD650= 0.3-0.6, measured 
using a Jenway 6300 spectrophotometer). Cells were lysed with 1 drop of (100 % v/v) toluene 
and 1 drop 1 % (w/v) sodium deoxycholate, before vigorous mixing. Lysates were aerated at 
37 oC for 20 minutes to remove the toluene. Prior to doing the experiment, 2-Nitrophenyl β-D-
galactopyranoside (ONPG) was made up to a concentration of 13 mM (8 mg/ml) in ‘Z-buffer’ 
and 271 μl of β-mercaptoethanol was added per 100 ml of ONPG. 
Lysates (100 µl) were incubated with 2.5 ml 13 mM ONPG to start the reaction. The solution 
was allowed to turn yellow before the reaction was stopped with 1 ml of 1 M sodium carbonate. 
The OD420 of the reaction was then measured. 
β-galactosidase activity was then calculated using the following formula: 
Activity (Miller units) = 1000 x 2.5 x A x OD420 = 20,000 x OD420 
                                                             4.5 x T x V x OD650           T        OD650 
 
T= Time (mins) 
A= Final assay volume (3.6 ml) 
V= Volume of lysed culture used (0.1 ml). 
2.5= Conversion factor to convert OD650 into dry protein mass (mg) – assumes that OD650 of 1 
is equivalent to 0.4 mg/ml bacterial dry mass.  
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1000/4.5= Conversion factor to convert A420 into moles of O-nitrophenol- assumes that 
1mole/ml O-nitrophenol has an absorption of 0.0045 at OD420. 
Data shown is from three independent replicates, the mean activity is shown and one standard 
deviation is shown either side of the mean. 
2.22 Bacterial two-hybrid system (BACTH) 
The bacterial two-hybrid system is used to detect interactions between proteins (Figure 2.2). 
Developed by Karimova et al. (1998), the system makes use of the Bordetella pertussis 
adenylyl cyclase, which consists of two domains; T25 and T18. Unless in close proximity the 
two domains generate cAMP. In the BACTH T25 and T18 are encoded by plasmids pKT25 
and pUT18 respectively. Genes encoding proteins that may interact are cloned into these 
plasmids to create T25 and T18 protein fusions. The plasmids encoding the T18 and T25 fusion 
proteins are used to transform BTH101, a strain lacking adenyl cyclase.  If the fusion proteins 
interact, the two domains of adenyl cyclase are brought together, and cAMP is synthesized. 
CRP then binds cAMP and switches on expression of the lacZYA operon. This is detected using 
β-galactosidase assays. In this study, all gene fusions were generated by cloning into pKT25 
or pUT18 using the PstII, and KpnI restriction sites. In subsequent assays a positive control, 
which measures the interactions between two leucine zippers, is included. In addition a 








Figure 2.2 The bacterial two-hybrid system (BACTH) 
Two proteins of interest are each genetically fused to domain of the Bordatella pertussis adenylyl 
cyclase (T25 and T18). If the two proteins interact, domains T25 and T18 are brought into close 
proximity and are able to interact, generating cAMP. This activates CRP which leads to lacZYA 



























2.23 CRP purification 
CRP was purified using the Ghosaini method.  
A 5 ml overnight culture was inoculated with M182Δcrp cells harbouring the pDCRP plasmid. 
In preparation for the next day, 1.2 ml of ddH2O was used to rehydrate 60 mg cAMP-agarose, 
which was mixed for 5 minutes and overnight at room temperature. 
The following day, a Bio-rad poly prep column was prepared. This column has an internal 
reservoir, but is attached to an external reservoir, which is used for pre-loading washes.  
The column, and rehydrated cAMP-agarose from the previous day, was moved to a 4 oC cold 
room, and was half-filled with ddH2O to equilibrate. cAMP-agarose was then gradually added 
to the column, and was allowed to settle for two hours (final column volume was 0.8 ml).  Two 
washes were then carried out at high flow rate; first, 10 ml column wash buffer  + 1 M NaCl, 
and then 5 ml dialysis buffer.  Zero point two ml of dialysis buffer was kept in the column, on 
top of the cAMP-agarose; which was left overnight. One ml of the overnight culture was used 
to inoculate 600 ml of superbroth, supplemented with 100 μg/ml ampicillin, which was 
incubated with shaking overnight at 37 oC. 
The following day, the OD650 of this culture was measured using a ten-fold dilution (in 
superbroth medium) in a Jenway 6300 spectrophotometer. A volume of this (calculated by 
using the formula V (μl) = 2000/OD650), was saved at -20 
oC for the final SDS-PAGE analysis. 
A 1.5 ml aliquot of the culture was also saved for plasmid extraction.  
The remainder of the 600 ml culture was harvested by first aliquoting the culture into two 
centrifuge pots, followed by centrifugation of at 1600 xg for 15 minutes at 4 oC. One of the 
resulting pellets was stored at -20 oC, the other was used for the purification. The culture pellet 
from one pot was resuspended in 6 ml lysis buffer (containing 50 μg/ml PMSF 
(phenylmethylsulphonyl fluoride in isopropanol) and sonicated. Complete lysis results in a ten-
fold drop in OD650, so the success of the sonication was assessed using a 1/500 dilution before, 
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and a 1/100 dilution after of the culture.  The lysate was then transferred to an Oak Ridge tube 
for centrifuging at 10,000 xg for 30 mins at 4 oC. Two μl of the resulting supernatant was 
retained for SDS analysis (known as sample ‘2’), and the remainder was used for the remainder 
of the purifcation.  
The culture supernatant was moved to the cold-room, where the cAMP-agarose column was 
equilibrated using 5 ml dialysis buffer on a high flow rate. Once the buffer volume in the 
external resevoir had depleted to 0.2 ml, the supernatant was loaded into internal reservoir (at 
a flow rate of 5 ml/hr). This wash was kept for SDS-PAGE analysis (known as sample ‘3’). 
The first 1 ml of lysate wash from the column, and the remainder of the eluate was also kept 
for SDS-PAGE analysis (known as sample ‘4’). When the column buffer volume had receded 
to 0.2 ml 5 ml dialysis buffer was added to the internal reservoir, with a flow rate of 5 ml/hr, 
an the wash was kept as SDS-PAGE sample ‘5’. When 0.2 ml buffer remained in the column, 
1 ml column wash buffer containing 5 mM 5’+3’ AMP was added. Once the buffer volume 
had receded to 0.2 ml, another 3 ml was added column wash buffer (containing 5 mM 5’+3’ 
AMP) was added. The wash was kept as sample ‘6’ for SDS-PAGE analysis. When the column 
buffer volume reduced to 0.2 ml, 1 ml column wash buffer was added. Once the column volume 
receded to 0.2 ml, another 3 ml of column wash buffer was added. The wash was saved as 
SDS-PAGE sample’7’.  
Once the column buffer volume had receded to 0.2 ml, CRP bound to the column was eluted 
using 5 ml column wash buffer with 5 mM cAMP. Every 18 minutes, eluate fractions were 
collected in 0.5 ml aliquots using a slower 2 ml/h flow rate. In total, 8 fractions were collected 
and used in the SDS-PAGE analysis.  
All 8 fractions and the other samples collected were analysed on 4-12 % (w/v) SDS-PAGE gels 
(supplied by Invitrogen). The final volumes of each sample were loaded after boiling for 5 
minutes; 5 µl of sample 1 was loaded, 10 µl aliquots of samples 2-7 were mixed with 290 µl 
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SDS-PAGE sample buffer, 10 µl was then loaded. Five µl SDS-7 standards and 5 µl 0.2 µg/µl 
wild type CRP standard in sample buffer were run alongside the samples. Fractions were then 
combined according to the SDS-PAGE gels and were placed in dialysis tubing. The tubing was 
placed in 500 ml CRP stock buffer at 4 oC and left overnight. The buffer was replenished the 
next day and left for a 3 hours. CRP preparations stored in microfuge tubes at -20 oC.  
CRP concentration was determined by Biorad assays. BSA standard curves were prepared 
using concentrations ranging from 0 to 10 mg/ml. CRP dilutions were made in 800 µl aliquot 
(up to 200-fold) using water, and 200 µl Biorad reagent was added to each. After incubated at 
room temperature for 5 minutes, OD595 measurements were taken. CRP concentration (g/L) 
was calculated using the BSA standard curve, and the Molar concentration was calculated (the 
molecular weight of CRP is 23.6 kDa).  
CRP concentrations were compared by eye alongside BSA standards on 4-12 % (w/v) SDS-
PAGE gel (supplied by Invitrogen). Samples were loaded after being boiled for 2 minutes. 
Samples loaded were: 0.5 µg, 1.0 µg, and 2.0 µg of CRP preparation in sample buffer (note 
that these amounts were guided by the Biorad analysis). Ten µl of previously purified CRP 
sample was also loaded. In addition, 5 µl of SDS-7 standards were loaded. 
 2.24 In vitro multi-round transcription assays 
Supercoiled pSR plasmid DNA (containing the desired promoter DNA fragment) was purified 
using a Qiagen Maxiprep kit, and used as a template for subsequent in vitro transcription 
reactions as described by Kolb et al. (1995). Reactions were done in buffer containing 20 mM 
Tris pH 7.9, 5 mM MgCl2, 500 µM DTT, 50 mM KCl, 100 µg ml
-1 BSA, 200 µM 
ATP/GTP/CTP, and 10 M UTP and 5 μCi α-P32- UTP, using 16 μg ml-1 template. If required 
DNA was incubated with purified CRP and 0.2 mM cAMP for 5 minutes (37 oC), before 
400 nM RNAP holoenzyme containing σ70 (Cambio) was added. The reaction was run for 10 
minutes at 37 oC, and stopped with 20 µl of ‘STOP’ solution. Four µl of each reaction was 
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analysed by denaturing PAGE (at 60 W for 1 hr) and exposure of the dried gel to a Biorad 
phosphorscreen. After exposure the gel image was captured using a Biorad FX® 
phosphoimager and Quantity One software.  
2.25 Radiolabelling of DNA fragments 
DNA fragments used in EMSA analysis were flanked by EcoRI and HindIII restriction sites to 
allow cloning into the plasmid pSR. This permitted AatII-HindIII fragments to be excised, and 
~100-200 ng of DNA was radiolabelled at both ends using T4 polynucleotide kinase according 
to the manufacturer’s instructions. In other cases, 1 μl (~0.1 ng) of primer was used. One μl of 
P32 labelled γ-dATP (10 μCi/μl) was used to label DNA in a 20 μl reaction. Unincorporated 
nucleotides were removed using two 200 µl G-50 Sephadex columns. 
2.26 Electrophoretic mobility shift assays 
End-labelled DNA fragments were incubated at 37 oC with purified CRP protein (see results 
figure legends for more detail), and 0.2 mM cAMP in 1x Transcription buffer. Herring sperm 
DNA (HS-DNA) was added as a non-specific competitor at a final concentration of 
12.5 µg ml-1. After 20 minutes the sample was loaded on a 7.5 % (w/v) polyacrylamide gel. 
The gel was run at 250 V for 1-2 hours before being dried and exposed to a phosphorscreen.  
2.27 M13 sequencing reaction 
The T7 sequencing kit supplied by USB was used to generate sequencing reactions to calibrate 
primer extension reaction products.  
Ten μg of single-stranded template M13mp18 phage DNA (supplied in kit) was diluted to a 
volume of 32 μl and incubated with 8 µl 2 M NaOH at room temperature for 10 minutes. 
Seven µl 3 M sodium acetate (pH 4.8), 4 µl dH2O and 120 µl 100 % (v/v) ethanol was added, 
before incubation at -80 oC for 15 minutes. After centrifugation at 17,000 xg for 15 minutes at 
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4 oC, the supernatant was discarded and the pellet washed with ice-cold 70 % (v/v) ethanol 
before centrifugation for 10 minutes at 17,000 xg at 4 oC. The pellet was dried by vacuum 
desiccation, and was re-dissolved in 10 µl of dH2O. Ten ρmol of the undiluted stock of the 
universal primer and 2 µl of the annealing buffer was added before vigorous mixing and 
centrifugation, before incubation at 65 oC for 5 minutes. The tube was transferred to a 37 oC 
heat block for 10 minutes, then to room temperature for 5 minutes, before brief centrifugation.  
Two point five µl of each of ‘A’ Mix-short, ‘C’ Mix-short, ‘G’ Mix-short, and ‘T’ Mix-short 
was transferred into four tubes. One µl of T7 polymerase stock (8 units/μl) was diluted using 4 
µl of dilution buffer in preparation for the labelling step. Fourteen to fifteen µl of the annealed 
template/primer mix was mixed with 3 µl labelling mix, 1 µl of α-P32 dATP (10 µCi/μl), and 2 
µl of the diluted T7 polymerase mix, before incubation at room temperature for 5 minutes. 
During this period, the four tubes, ‘A’,’G’,’C’, and ‘T’ were warmed at 37 oC for over 1 minute. 
Termination reactions were carried out by transferring 4.5 µl of the reaction into each of the 
four tubes, with gentle mixing by pipetting. This was incubated at 37 oC for 5 minutes. The 
reactions were stopped using 5 µl of ‘STOP’ solution, before mixing and brief centrifugation. 
The tubes can be stored at -20 oC after this stage. 
Before being loading on a 6 % (w/v) denaturing PAGE, 3 µl of each aliquot was heated at 75-
80 oC for 2 minutes, before 1.5-2 µl of each sample was loaded.  
2.28 Primer extension reactions 
RNA was purified from cells harbouring a pRW50 plasmid containing the cloned promoter 
fragment of interest. The experiment was carried out over two days: 
Day 1: Primer D49724 (anneals downstream of the HindIII site on pRW50) was radiolabelled 
using T4 polynucleotide kinase and γ- P32 labelled ATP, as described above. Forty µg of 
purified RNA was mixed with 1 μl of radiolabelled primer and precipitated using 1/10 volume 
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of 3 M sodium acetate, and 2.5 volumes of cold 100 % (v/v) ethanol. The sample was recovered 
by centrifugation at 17,000 xg at 4 oC for 10 minutes. The pellet was washed with 1 ml 70 % 
(v/v) ethanol, before centrifugation at 17,000 xg at 4 oC for 5 minutes, and drying in a speedvac 
at 45 oC for 5-10 minutes. The pellet was re-suspended in 30 μl hybridisation buffer (20 mM 
HEPES, 0.4 M NaCl, 80 % formamide), before vigorous mixing and incubation for 5 minutes 
at 50 oC. To anneal the primer, the RNA/primer solution was incubated at 75 oC for 15 minutes, 
then at 50 oC for 3 hours. Seventy-five µl cold 100 % (v/v) ethanol was added, the solution was 
mixed and then left overnight at -80oC. 
Day 2: The annealed primer/RNA was centrifuged at 17,000 xg for 10 minutes at 4 oC, before 
being washed with 1 ml of 70 % (v/v) ethanol, with a further spin at 17,000 xg for 5 minutes at 
4 oC. The supernatant was removed and the pellet was then dried by speedvac for 20 minutes. 
The pellet was re-suspended in 31 µL DEPC-treated dH2O. 
Primer extension reactions were carried out in 50 mM Tris-HCl pH 8.3 (at 25 oC), 50 mM KCl, 
10 mM MgCl2, 0.5 mM spermidine (in the form of a 5x reverse transcriptase buffer, purchased 
from Promega), and 1 mM DTT, and 0.2 mM dNTPS (final concentrations) were added. The 
total reaction volume was made up to 50 µl, through the addition of 0.6 µl of RNasin (purchased 
from Promega, a RNase inhibitor), and 2.5 µl AMV reverse transcriptase (purchased from 
Promega).  The sample was incubated at 37 oC for 1 hour, before incubation at 72 oC (to 
inactivate the reverse transcriptase), and was spun briefly. To degrade RNA, 1 µl of a 10 mg/ml 
RNase A solution and was incubated for 30 minutes at 37 oC, before DNA was precipitated 
using 6.7 µl 3 M ammonium acetate (pH 4.8) and 125 µl 100 % (v/v) ethanol, with 30 minutes 
incubated at -80 oC. The sample was centrifuged at 17,000 xg for 10 minutes 4 oC, before 
washing with 1 ml cold 70 % (v/v) ethanol, and further centrifugation at 17,000 xg for 10 
minutes at 4 oC. The supernatant was removed and the pellet was dried by speedvac for 20 
minutes. The pellet was resuspended in 4 µl STOP solution, and 1-2 μl of this was run on a 
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pre-run 6 % (w/v) denaturing gel alongside M13 sequencing reactions, which was run at 60 W 
for 2 hours.  
2.29 Generation of ‘G+A’ ladder 
To generate ‘G+A’ ladders, the DNA sequence of interest was first cloned into pSR. From this, 
an AatII-HindIII fragment was created, and radio-labelled at the HindIII end. Three to four µl 
(~ 100-200 ng) of this fragment was diluted in 8 µl of dH2O and mixed with 50 µl of formic 
acid. The mixture was incubated at room temperature for 2.5 minutes then stopped with 200 µl 
0.3 M sodium acetate solution, 1 µl (20 mg/ml) glycogen, and 700 µl ice-cold 100 % (v/v) 
ethanol. DNA was precipitated at -70 oC for 15 minutes, before centrifuging at 17,000 xg for 
15 minutes at 4 oC. The DNA pellet was washed three times in 70 % (v/v) ethanol, each time, 
centrifuging at 17,000 xg at 4 oC for 10 minutes. The pellet was then dried under vacuum, 
before resuspension in 1 M piperidine (diluted with dH2O from 10 M stock). The reaction was 
incubated at 90 oC for 30 minutes and stopped by the addition of 1 µl glycogen, 10 µl of 3 M 
sodium acetate, and 300 µl ice-cold 100 % (v/v) ethanol, before precipitation at -70 oC for 
15 minutes. This DNA was collected by centrifugation at 17,000 xg for 15 minutes at 4 oC and 
was washed twice in 70 % (v/v) ethanol as described previously. The DNA pellet was dried 
under vacuum before being resuspended in 20 µl of DNAse I blue. 
2.30 DNAse I footprints 
Fragments for DNAse I footprinting were AatII-HindIII fragments from a pSR plasmid 
containing the promoter insert of interest. Plasmids were first digested using HindIII and 
treated with alkaline phosphatase. Products were then purified, and digested using AatII before 
being purification by gel extraction. Fragments were then labelled at the HindIII-restricted end, 
using γ-P32 ATP and T4 polynucleotide kinase.  Footprints were done at 37 oC in buffer 
containing 120 mM KCl, 100 µM EDTA, 20 mM Tris pH 7, and 10 mM MgCl2. Ten to forty 
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ng of DNA was used per footprint with 12.5 µg ml-1 Herring Sperm DNA as a competitive 
inhibitor. Purified CRP was diluted in buffer containing 0.2 mM cAMP before being incubated 
with DNA for 10 minutes at 37 oC (at a total reaction volume of 20 µl). Two µl diluted DNAse 
I (at a concentration where each DNA fragment is cleaved once) was added for 1 minute. This 
dilution was determined through a previous calibration experiment. Reactions were stopped 
using 200 µl of a ‘STOP’ solution containing, 0.3 M sodium acetate pH 7 and 10 mM EDTA. 
Reactions were then subjected to phenol-chloroform extraction and ethanol precipitation, and 
were resuspended in 4 µl of DNAse I blue. Prior to loading, all samples and the G +A ladder 
were heated to 90 oC for 2 minutes. These were loaded onto a pre-run 6 % (w/v) denaturing gel 
run at 60 W.    
2.31 TCA precipitations 
TCA (Trichloroacetic acid) precipitation was used to extract secreted proteins in culture 
supernatants. One ml of overnight culture was used to inoculate 50 ml of LB containing the 
appropriate antibiotics. Cells were grown to mid-log phase (OD600 = 0.5). Cells from 20 ml of 
each culture were centrifugation at 1600 xg for 20 minutes at 4 oC. Supernatants were 
harvested, and pellets were saved (both supernatants and cell pellets can be stored at -20 oC). 
The volumes of supernatants were adjusted to compensate for differences in OD600 values, 
before being passed through 0.22 μM filters, into clean polypropylene tubes. Two ml of ice-
cold 100 % (w/v) TCA was added to each tube, before thorough mixing and incubation for 45 
minutes on ice. Precipitated proteins were collected by centrifugation at 10,000 xg for at least 
90 minutes at 4 oC. Following centrifugation, the supernatant was discarded and protein pellets 
were resuspended in 1 ml 100 % (v/v) cold methanol and transferred to clean microfuge tubes. 
After centrifugation for 45 minutes at 17,000 xg at 4 oC, supernatants were discarded, and 
pellets were dried at 37 oC for at least 30 minutes. Protein pellets were resuspended in 20 μl 2x 
SDS-PAGE loading dye. Cell pellets were re-suspended in 1 ml PBS. Volumes were adjusted 
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according to OD600 values. One μl of the cell suspension was mixed with 10 μl 2x SDS-PAGE 
loading dye.  
TCA precipitation samples were run on 4-12 % (w/v) Bis-Tris polyacrylamide pre-cast protein 
gels purchased from Life Technologies. Protein gels were mounted in tanks containing 1x MES 
SDS running buffer. Prior to loading, 10 μl samples of both TCA precipitated protein samples 
and cell pellet samples (resuspended in 2x SDS-PAGE  loading dye) were boiled for 10 minutes 
at 100 oC. All 10 μl of sample was loaded onto the gel. Gels were calibrated with 10 μl of 
PageRuler Plus prestained protein ladder (supplied by Thermo Scientific), which was boiled 
for 10 minutes at 100 oC before loading into a separate well. Gels were run at 100 V for 1 hour, 
before gels were fixed and silver stained.  
2.32 Silver staining of protein gels 
Protein gels were fixed and stained using a SilverQuest kit (purchased from Life Technologies).  
2.33 FRUIT  
For genome wide ChIP-seq experiment to measure CRP binding, it was necessary to tag CRP 
C-terminally, using a 3x FLAG tag (N-DYKDDDDK3-C) (Einhauer and Jungbauer, 2001). 
This tag was fused to the crp gene on the chromosome of ETEC H10407 using a new 
recombineering technique, described in Figure 2.3, known as FRUIT (Flexible 
Recombineering Using Integration of thyA) (Stringer et al, 2012). The FRUIT technique for 
adding a FLAG3 tag involves amplifying the Escherichia coli MG1655 thyA gene flanked by 
FLAG3 from plasmid pAMD135 (Stringer et al, 2012). This requires a primer containing the 




Figure 2.3 Flexible recombineering using integration of thyA (FRUIT) 
The thyA gene, flanked by FLAG3 was amplified from pAMD135 using primers ‘upstream targeting crpFLAG3’ and ‘downstream targeting crpFLAG3’, which 
have 5’ regions (shown in green) which anneal to the 3’ end of the crp gene in ETEC H10407. The resulting PCR product is electroporated into ETEC H10407 
ΔthyA, together with pKD46 which encodes the λ Red recombination proteins. The PCR product is recombined into the 3’ end of the crp gene on the ETEC 
H10407 genome, and is selected for using media without thymine. The thyA gene, and one set of FLAG3 is removed by selection using media containing 20 
μg/ml trimethoprim and 100 μg/ml thymine. Based on Stringer et al. (2012).  
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(‘upstream targeting crpFLAG3’ and ‘downstream targeting crpFLAG3’). This product (100-
200 ng PCR product) is electroporated into ETEC cells lacking the thyA gene, and carrying 
pKD46, a plasmid which encodes the λ Red recombination system, (Datsenko and Wanner, 
2000). Cells are grown in M9 minimal media containing 100 μg/ml thymine, and the Red 
system is then induced with 0.2 % (w/v) arabinose resulting in recombination of FLAG3-thyA-
FLAG3 into the C-terminal region. Recombinant colonies are selected for by growth on M9 
minimal media lacking thymine but containing ampicillin. Low-level homologous 
recombination occurs spontaneously between the two sets of FLAG tags, if cells are grown in 
minimal media containing 20 μg/ml trimethoprim and 100 μg/ml thymine. This removes the 
thyA gene, and one set of 3x FLAG tags. Strains were verified by sequencing colony PCR 
products using ‘upstream crpFLAG3 check’ and ‘downstream crpFLAG3   primers’.  Following 
tagging of the crp gene using FLAG3, the resulting strains was streaked onto solid MacConkey 
maltose media alongside wildtype cells, and the Δcrp mutants. Colonies of the crpFLAG3 strain 
appeared purple on the plates. 
2.34 ChIP-seq in ETEC H10407 
The method used for ChIP-seq and subsequent data analysis was as described by Singh et al. 
(2014). All experiments were performed in duplicate. ETEC cells were grown to exponential 
phase (sub-cultured from overnights) in 40 ml cultures (M9 minimal media supplemented with 
1 % (w/v) fructose) and fixed using formaldehyde at a final concentration of 1 % (v/v). After 
incubation for 20 minutes, fixing was quenched using 10 ml of 2.5 M glycine. Cells were 
collected by centrifugation for 5 minutes at 1600 xg at 4 oC, and were re-suspended in 0.5-1x 
the original culture volume in 1x TBS. Cells were collected by centrifugation as before, before 
being resuspended in 1 ml 1x TBS, and this washing step was then repeated. After washing, 
cells were resuspended in 1 ml FA lysis buffer (150 mM NaCl unless stated) containing 4 
mg/ml lysozyme, and incubated at 37 oC for 30 minutes. The lysate was then chilled on ice for 
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at least 5 minutes before sonication, using a Bioruptor sonicator, set to two 15-minute cycles 
(30 seconds on, 30 seconds off), at 4 oC. Cell lysates were cleared by centrifugation at 17,000 
xg for 5 minutes, and supernatants saved. Lysates were diluted in FA lysis buffer in such a way 
that there was 1 ml of lysate for every 20 mls of original culture. Twenty μl of each diluted 
lysate was saved and used as an ‘input’ control for real-time PCR experiments.  
For immunoprecipitations, cocktails were set containing 500 µl of diluted lysate, 300 µl FA 
lysis buffer, and 25 µl Protein A beads (GE Healthcare, GE17-0780-01), which were made up 
in a 50% (v/v) slurry with TBS. Note that all steps involving direct pipetting of Protein A beads 
used blunted tips to avoid shearing the beads.  Two µl of anti-H-NS or anti-FLAG, or 1 µl of 
anti-σ70 was then added to the cocktail. The cocktail was mixed on a rotating wheel for 90 
minutes at room temperature.  
To create the library for Illumina NGS sequencing, the protein A beads were collected by 
centrifugation at 1500 xg for 1 minute, and the supernatant removed and discarded. Seven 
hundred µl of FA lysis buffer was used to resuspend the beads, which were then transferred to 
a Spin-X column. This column was rotated for 3 minutes at room temperature before the beads 
were collected by centrifugation at 1500 xg for 1 minute, and the flowthrough was discarded. 
All wash steps were done using 750 µl of the solution mentioned, with rotation for 3 minutes 
before the beads were collected by centrifugation at 1500 xg for 1 minute (with flow-through 
discarded). Following transfer of beads to the spin-X-column, beads were washed twice with 
FA lysis buffer and twice with 10 mM Tris-HCl, pH 7.5. DNA fragment blunting reactions 
were done by resuspending beads in buffer consisting of 10 µl 10x quick blunting buffer, 10 
µl dNTP mix (supplied in kit), 80 µl dH2O and 2 µl blunt enzyme mix. Column lids were sealed 
with parafilm and the columns were rotated (in such a way that tubes were not inverted) at 
room temperature for 30 minutes. The beads were then washed twice with FA lysis buffer, and 
twice with 10 mM Tris-HCl, pH 8. ‘A tail’ addition was done by resuspending beads in the 
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buffer consisting of 10 µl NEB buffer 2, 2 µl 100 mM dATP, 88 µl dH2O and 2 µl Klenow 
fragment. Lids were sealed with parafilm and the columns were rotated (in such a way that 
tubes were not inverted) at 37 oC for 30 minutes. The beads were washed twice with FA lysis 
buffer, and twice with 10 mM Tris-HCl, pH 7.5. NEXTflex barcoded adaptors (BioOscientific) 
were ligated to DNA fragments by resuspending beads in buffer consisting of 100 µl 1x ligase 
buffer (50 µl 2x ligase buffer + 50 µl dH2O), 1 µl NEXTflex adaptors (undiluted 0.6 μM stock) 
and 4 µl quick ligase. Tube lids were sealed with parafilm and the columns were rotated (in 
such a way that tubes were not inverted) at room temperature for 15 minutes. The beads were 
then washed twice with FA lysis buffer, once with high-salt FA lysis buffer (500 mM NaCl), 
once with ChIP wash buffer, once with 1x TE buffer, and another wash was carried out using 
300 µl 1x TE, but without rotation. Spin-X-columns were then transferred to new dolphin-
nosed tubes. The beads were resuspended in 100 µl elution buffer, and the columns were 
incubated 65 oC for 10 minutes. This was quickly transferred to a micro-centrifuge before the 
DNA was eluted by centrifugation at 1500 xg for 1 minute. Eluates and ‘input’ samples were 
de-crosslinked by boiling for 10 minutes. Phenol/chloroform extraction (using glycogen as a 
carrier molecule) or AMPure magnetic beads were used to clean up samples, which were eluted 
in 11/12 µl of dH2O. Before library amplification, a real-time PCR was run using oligos 
‘NEXTflex primer 1 & 2’ and 0.1-0.4 ng of library, with manual critical threshold set to 0.1. 
PCR was then used to amplify libraries to the equal concentrations, using a different number 
of cycles for each sample.  
Following PCR, libraries were purified using AMPure magnetic beads and loaded onto an 8 % 
(w/v) acrylamide gel, which was run at 1 hour for 100 V. After running, the gel was stained in 
1 % (v/v) ethidium bromide for 5 minutes. Using a UV transilluminator to visualise the DNA, 
a 200-600 bp “smear” was cut out from the gel with care taken to avoid the “adaptor-adaptor” 
band at 150 bp. The gel slice was shredded as follows; the bottom of a 0.7 ml tube was pierced 
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using a hot needle, the tube was then placed inside a 1.5 ml tube. The gel slice was placed 
inside the 0.7 ml tube, and both tubes spun at 17,000 xg for 5 minutes. The 0.7 ml tube was 
removed and discarded, and 0.4 ml acrylamide extraction buffer was added to the shredded gel. 
Tube lids were sealed with parafilm, and the tubes rotated overnight at 4 oC. The next day, the 
entire mixture (liquid and gel) was transferred to a Spin-X-column, which was spun for 5 
minutes at 17,000 xg. DNA was ethanol precipitated. Individual libraries were quantified using 
a Qubit 2.0 fluorometer (Life Technologies). Values obtained were used to create an equimolar 
mix of libraries in a single tube (~ 4 nM final concentration), which was sent for sequencing 
on an Illumina HiSeq platform at the University of Buffalo Next Generation Sequencing 
Facility). 
2.35 Bioinformatics 
Raw sequence reads were aligned to the ETEC H10407 genome using the CLC Genomics 
workbench, and peak calling was carried out using custom python scripts, as described by 
Singh et al., (2014). Initially, the analysis was performed separately on each replicate. The 
maximum read density across the genome is first calculated (M), and another parameter, known 
as variable (V), was assigned a value of 1. In the process of peak calling, V was incrementally 
increased by a value of 1 until it equalled the value of M, and at every increase, the genomic 
coordinates scoring above V were registered. Following this, a total value for the number of 
times each coordinate registered was calculated. A threshold value (T), previously assigned 
(based on visual observation of the data) was applied, and coordinates with cumulative scores 
of V greater than T were called as ‘strand peaks’. Separate values of T were applied to different 
data sets to accommodate for differences in total read numbers. This process is performed for 
both strands. Note that peaks generated by ChIP-seq on the positive and minus strands are off-
set due to the nature of alignment, which is affected by experimental parameters. As a result, 
94 
 
pairs of peaks on the positive and minus strand which closely coincide are recorded. The 
optimum distance between these pairs is defined separately for each replicate.  
Next, the peaks on the positive and negative strand are moved towards each other, in 1 bp steps, 
from a range of 1-200 bp. At each stage, the correlation of the two peaks is calculated using a 
Pearson correlation. The distance yielding the best correlation (highest R value) was used to 
calculate the ‘optimal strand shift’. This was used to further define pairs of positive and minus 
strand peaks; peaks on both strands which co-localised within two ‘optimal strand shift’ 
distances of each other were recorded. Distances between pairs of positive and minus strand 
peaks were averaged to calculate peak centres. Finally, datasets from individual replicates were 
combined. Peaks were called from both replicates only if peaks occurred in both replicates, and 
peak centres were within 40 bp of each other. Again, distances between peak centres from two 
replicates are averaged to create final peaks.  This analysis works well at low stringency peak 
calling, and for calling peaks which occur in close succession to one another, as pairs of peaks 
must conform to the expected shape and peak width, and must be reproducible. The thresholds 
used in the earlier analysis are adjusted for total read numbers and are applied to the mock 
replicates, to look for artefactual enrichment. The DNA sequence 50 bp upstream to 50 bp 
downstream of peaks were submitted to MEME (Bailey et al., 2009) to identify CRP binding 
sites, and to generate sequence motifs. Sequences around peaks were submitted to BLAST 
searches to search for homologues in Escherichia coli K-12 MG1655. Distances from 
transcription start sites were calculated (using mapped transcription start sites from Kim et al., 
(2012), and Cho et al., (2014)). To identify the most frequent distances between CRP peaks 
and transcription start sites, distances from +200 bp upstream and -100 bp downstream of 
transcription start sites were selected, and organised into groups separated by 5 bp. The data 
are available on the EBI database (EBI submission: E-MTAB-2917). 
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Circular plots were generated to show genome-wide σ70, H-NS and CRP binding using 
DNAPlotter software (Carver et al., 2009). Linear ChIP-seq plots were generated using 
SignalMap software (Nimblegen). 
To investigate the overlap between σ70, H-NS and CRP peaks, peak locations were aligned 
manually in an excel spreadsheet. Note that for H-NS, this is not straightforward, since binding 
is filamentous and peak calling preferentially identifies the nucleation site as opposed to the 
whole binding tract. Hence, some comparisons involving H-NS have been made over greater 
distances since H-NS filaments have been found to extend, on average, over 1 kb in E.coli 
(Kahramanoglou et al., 2011). 
In silico prediction of CRP sites in both intergenic and intragenic regions was done using 
PREDetector software (Hiard et al., 2007), which generates a PWM from a list of given sites. 
In this analysis, we used a list of 68 sites previously identified by Grainger et al., 2005. 
Predicted sites are scored based on their similarity to the consensus; higher scoring sites better 
resemble the consensus. Genbank files were imported into the program for plasmids p948 and 



























3.1 ChIP-seq analysis of CRP, H-NS and σ70 binding across the ETEC H10407 genome 
In this chapter, chromatin immunoprecipation coupled with next generation sequencing (ChIP-
seq) was used to map CRP, H-NS and RNAP σ70 subunit binding across the genome of  ETEC 
H10407. For immunoprecipitations we used a i) crpFLAG3 H10407 derivative and mouse 
mono-clonal anti-FLAG, ii) rabbit polyclonal anti-H-NS or iii) mouse mono-clonal anti-σ70 
antibody. 
The H10407 derivative carrying the crpFLAG3 allele was generated using a recombineering 
method known as FRUIT (Flexible Recombineering Using Integration of thyA) (Stringer et al., 
2012). Strains encoding either an N- or C- terminally tagged CRP were generated. However, 
the strain harbouring the N-terminal FLAG3 fusion was defective for growth and was not 
studied further. Conversely, the strain encoding the C-terminally tagged CRP had a CRP+ 
phenotype (appeared purple of MacConkey maltose agar (Figure 3.1)) and was used for 
subsequent ChIP-seq experiments.  
ETEC H10407 or the crpFLAG3 derivative were grown to mid-log phase at 37 
oC in M9 
minimal media supplemented with 1 % (w/v) fructose before being fixed with formaldehyde 
and harvested. Immunoprecipitations were done with anti-FLAG, anti-H-NS or anti-σ70 in 
duplicate alongside mock immunoprecipitations (i.e. with no antibody) as a control. After 
immunoprecipitation, the resulting DNA sample was used for Illumina HiSeq library 
generation. After sequencing reads were aligned to the H10407 genome and binding peaks 
were called automatically using custom python scripts (Singh et al., 2014). The CRP binding 
motifs within peaks were found using MEME (Bailey et al., 2009).  
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3.1.1 CRP binding sites across the ETEC H10407 chromosome 
We identified 111, 364 and 1089 peaks for binding of CRP, H-NS and σ70 respectively. The 
binding profiles of CRP (orange), H-NS (green), and σ70 (blue) are plotted against the features 
of the ETEC chromosome (Figure 3.2A) or plasmids (Figure 3.2B).  
The 111 CRP binding peaks, and associated DNA motifs, are shown in Table 3.1. Of the 111 
CRP sites, 19 were within 100 bp of a peak for σ70 binding and 5 overlapped with loci at which 
H-NS was bound. Similarly, 30 of the 364 H-NS bound loci were also bound by σ70. A Venn 
diagram illustrating the overlap in CRP, H-NS and σ70 binding is shown in Figure 3.3. Some 







Figure 3.1 Image of E. coli crpFLAG3 growing alongside wildtype cells and Δcrp cells on 







    
Figure 3.2 CRP, H-NS and σ70 binding across the chromosome (A) and virulence 
plasmids (B) of ETEC H10407 as determined by ChIP-seq analysis 
In both sets of plots (A and B), genes are indicated in by grey blocks in the outermost two tracks. The 
GC content is depicted by the third track, where regions highlighted light blue contain a GC content 
which is higher than average, and purple highlighted regions indicate regions containing a lower than 
average GC content. The green tracks shows binding by H-NS, the orange tracks shows binding by 
CRP, and dark blue tracks show binding by σ70 as determined by ChIP-seq analysis. Plots were made 
using DNAPlotter software (Carver et al., 2009). Note that for σ70 plots on p948 and p666, reads have 



















Table 3.1 CRP targets identified by ChIP-seq analysis 
Peak Centre a Binding Site(s) b Gene(s) d K-12 Homologues e 
45284 TGTGATTGGTATCACA ETEC_0040 caiT 
92014 AGTGATGGATGTCACG (ETEC_0078) (cra) 
176905 AGCGTTCCACGTCACA (ETEC_0150) (hemL) 
408885 TGTGATCTCTCTCGCA ETEC_0385/ETEC_0386 yahN/yahO 
468009 AGGGATCTGCGTCACA ETEC_0443 aroM 
492973 ATCGATTGCGTTCACG ETEC_0464 tsx 
540805 TGTGATCTTTATCACA ETEC_0511 maa 
574230 GATGACGACGATCACA (ETEC_0538) (ybaT) 
683187 AGTGATCGAGTTAACA ETEC_0628 cstA 
697540 AGTGATTTGCGTCACA ETEC_0639 rnk 
739223 CGTTACCCTTGTCGCA ETEC_0680 rihA 
941002 TGTGATGAGTATCACG ETEC_0869 ybiJ 
958866 TGTGTACGAAATCACA ETEC_0886/ETEC_0887 ybiS/ybiT 




1263558 TTTGACGGCTATCACG ETEC_1166 ptsG 
1274886 TGTGATCTGGATCACA ETEC_1176/ETEC_1177 ycfQ/bhsA 
1301786 GATGATCCGCATCACA (ETEC_1206)/ETEC_1207 ETEC-specific/ETEC-specific 
1348166 ATTGAACAGGATCACA (ETEC_1259)/ETEC_1260 (rluE)/icd 
1376374 GGTGAGCTGGCTCACA ETEC_1292/ETEC_1293 ycgB/dadA 
1388620 AGTGAGCCAGTTAACA (ETEC_1303) (dhal) 
1541732 CGTGAACCGGGTCACA ETEC_1443/ETEC_1444 ycjZ/mppA 
1567885 GTTAAGTAAAATCACA ETEC_1462/ETEC_1463 paaZ/paaA 
1701402 TGTGATGGATGTCACT ETEC_1568 ydeN 
1767726 TGTGATTAACAGCACA ETEC_1628 mlc 
1777143 TGTGATCTAGCGCCAA ETEC_1637 pntA 
1811426 CGTGATCAAGATCACG (ETEC_1668A) (ETEC specific) 




2126754 TGTGGCGTGCATCACA n.a. n.a. 
2201816 GGTGACGCGCGTCACA ETEC_2057 yedP 




2492757 ATTGATCGCCCTCACA ETEC_2309 yeiQ 
2555083 CGTGACCAAAGTCTCA (ETEC_2360) (yfaQ) 
2729713 TTTGAAGCTTGTCACA ETEC_2510/ETEC_2511 mntH/nupC 
2735124 AGTTATTCATGTCACG ETEC_2514 yfeC 
2795423 TGTGAGCCATGACACA (ETEC_2572)/ETEC_2573 (aegA)/narQ 
2810983 CGTGATCAAGATCACA ETEC_2586 hyfA 
2887131 TTTGATCTCGCTCACA (ETEC_2666)/ETEC_2665 (xseA)/guaB 
3012645 TGTGATCCCCACAACA (ETEC_2793) (ung) 
3048307 TTTGACGAGCATCACC (ETEC_2822) (emrB) 
3132920 GGTGACCGGTTTCACA ETEC_2905/ETEC_2906 ascG/ascF 
3161660 TGTGACCGTGGTCGCA (ETEC_2933) (nlpD) 
3184337 CGTGATGCGTGTAACA (ETEC_2956)/ETEC_2955 (cysI)/cysH 




3234980 TGCGATCGTTATCACA (ETEC_2994)/ETEC_2995 (fucU)/fucR 
3265047 TGTGACCTGGGTCACG ETEC_3017 rppH 
3324543 TGTGGGCTACGTAACA (ETEC_3075) (ydhD) 
3361162 n.d. ETEC_3105 serA 
3368992 TTTGATGCACCGCACA (ETEC_3113) (ygfI) 
3382158 TGTGATCTACAACACG ETEC_3126 cmtB 
3390811 TGTGATTTGCTTCACA ETEC_3133 galP 
3408173 TGTGATGTGGATAACA ETEC_3154 nupG 
3442697 TGTGATGATTGTCGCA ETEC_3186 ETEC-specific 
3558573 AGTGATTTGGCTCACA ETEC_3291 ygiS 
3580767 AGTGACTTGCATCACA (ETEC_3318) (yqiH) 
3635301 ATTGATCTAACTCACG ETEC_3362 uxaC 




3721308 GGTGATTGATGTCACC (ETEC_3446) (greA) 
3785700 CGTGGGTCGCATCACA (ETEC_3510) (mreC) 
3878729 GGTGATTTTGATCACG ETEC_3614/ETEC_3615 ppiA/tsgA 
3908574 GGTGATCGCGCTCACA (ETEC_3645) (hofM) 
3918861 TGTGAGTGGAATCGCA ETEC_3652/ETEC_3653 yhgE/pck 
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3986400 CGTGATTTTATCCACA ETEC_3707 rpoH 
4105040 AGTAAGGCAAGTCCCT n.a. n.a. 







4158433 n.d. ETEC_3846 lldP 
4196869 TGCAATCGATATCACA ETEC_3886 dinD 
4251326 CTTACTCCTGCTCACA ETEC_3938 ETEC specific 
4266125 GGTGATGGCATCCGCG (ETEC_3956) (nepI) 
4290730 GGTGAGCAAAACCACG (ETEC_3979) (yidR) 
4322430 ATTGACCTGAGTCACA (ETEC_4010) (yieL) 
4340544 CTTGACCACGGTCAGA (ETEC_4025)/ETEC_4024 (atpA)/atpG 
4344649 TGTGATCTGAAGCACG ETEC_4030 atpI 
4373517 TGTAATGCTGGTAACA (ETEC_4051) (ilvG) 
4402013 CGTGCTGCATATCACG (ETEC_4077) (rffM) 




4508745 TGTGATATTTGTCACA (ETEC_4165)/ETEC_4164 (fdhD)/fdoG 
4517442 CGTGATCGCTGTCCCA (ETEC_4173) (rhaA) 
4564670 TGCGATCCGCCTCATA ETEC_4216/ETEC_4217 ptsA/frwC 
4668870 TGTAACAGAGATCACA ETEC_4289/ETEC_4290 malE/malK 
4725047 TGTGCGGATGATCACA n.a. n.a. 
4731402 TGTGATCTTGCGCATA (ETEC_4365) (aphA) 
4761367 CGTGATGGCTGTCACG ETEC_4389 fdhF 
4846352 n.d. ETEC_4464 ETEC-specific 
4848117 CGTGAGTTCTGTCACA n.a. n.a. 
4863253 TTTGATCAACATCGCA (ETEC_4478) (ETEC-specific) 
4873926 GGTGATCTATTTCACA ETEC_4486/ETEC_4487 aspA/fxsA 
4930149 TGTGATGAACTTCAAA ETEC_4545/ETEC_4546 yjfY/rpsF 
4940903 TGTGATCACTATCGCA ETEC_4557/ETEC_4558 ETEC-specific/ytfA 
4993073 TGTGACTGGTATCTCG (ETEC_4604) (valS) 
5002854 TGTAACCTTTGTCACA ETEC_4610/tRNA-Leu yjgB/tRNA-Leu 
5030724 TGCGATGAATGTCACA ETEC_4633/ETEC_4634 gntP/uxuA 
5129400 CGTACCGTCGGTCACA (ETEC_4736) (yjjI) 
5129944 TGTGATGTATATCGAA ETEC_4736/ETEC_4737 yjjI/deoC 
a Peak centres are annotated according to the chromosome of H10407. Underlined co-ordinates share 
no homology to E. coli K-12. 
b Binding sites found within an identified peak, using MEME software. Bases conforming to the 
consensus CRP binding site are shown in bold. Binding sites unidentified by MEME as listed as ‘not 
determined’ (n.d.). 
c Values represent the fold of enrichment above the background (‘Fold above threshold’). 
d Genes located within 300 bp downstream of an identified CRP site. Brackets indicate where the CRP 
site is intragenic. CRP sites not associated with a gene (further than 300 bp upstream) are listed a ‘not 
associated’ (n.a.). 
e K-12 homologues to the ETEC gene indicated. ETEC genes without a listed homologue are listed as 
‘not associated’ (n.a.). Genes underlined match CRP targets previously by Grainger et al., 2005, and 
genes in bold are listed as CRP-dependent in the Ecocyc database. Where genes are listed in brackets, 










Figure 3.3 Overlap of CRP, H-NS and σ70 binding sites identified in E. coli H10407 
The total number of peaks for each protein is shown in red numbers. Overlap between peaks is shown 





























Figure 3.4A Overlap of σ70 and CRP binding sites at selected chromosomal loci 
Genes are shown in grey, the gene shown in blue is defined below each panel. σ70 binding is shown in 
dark blue, and CRP binding is shown in orange below. Reads per peak are as follows; cstA: σ70: 527, 
CRP: 715. ascG: σ70: 767, CRP: 2321. rpoS: σ70: 7438, CRP: 2498. 
 
 
Figure 3.4B Overlap of σ70 and H-NS binding sites at selected chromosomal loci 
Genes are shown in grey, the gene shown in blue is defined below each panel. σ70 binding is shown in 
dark blue, and H-NS binding is shown in green below. Reads per peak are as follows; lpp: σ70: 2644, 
H-NS: 366. hybO: σ70: 3868, H-NS: 275. tnaL: σ70: 3799, H-NS: 428. 
 
 
Figure 3.4C Overlap of CRP and H-NS binding sites at selected chromosomal loci 
Genes are shown in grey, the gene shown in blue is defined below each panel. CRP binding is shown 
in orange, and H-NS binding is shown in green below. Reads per peak are as follows; putA: CRP: 859, 



















Figure 3.4D Overlap of CRP, H-NS, and σ70 binding sites at selected chromosomal loci 
Genes are shown in grey, the gene shown in blue is defined below each panel. CRP is shown in orange, 
H-NS binding is shown in green, and σ70 binding is shown in dark blue, below. Reads per peak are as 
follows; guaB: CRP: 3918, H-NS: 106, σ70: 21413. rplJ: CRP: 741, H-NS: 253, σ70: 29108. 





























3.1.2 Properties of DNA loci bound by CRP 
We next analysed the DNA sequence and genomic context of peaks for CRP binding. The CRP 
ChIP-seq signal correlated weakly (correlation coefficient= 0.139) with the number of bases in 
the CRP site that matched the known consensus (Figure 3.5A). Ninety-three percent of the 111 
CRP binding peaks fell within or adjacent to genes that are common to both E. coli K-12 
MG1655 and H10407 (Figure 3.5B). The CRP motifs associated with binding peaks were most 
frequently found 92.5 and 40.5 bp upstream of known transcription start sites, in agreement 
with CRP regulatory paradigms (Busby and Ebright, 1999). The majority of CRP sites were in 
intergenic regions (66 %) with the remaining 34 % being located within genes. Twenty two of 
the 111 CRP binding sites identified are nearby genes listed as CRP regulated in E. coli K-12 
on the Ecocyc and Regulon databases (Keseler et al., 2005, Huerta et al., 1998). Additionally, 
12 of the E. coli K-12 CRP sites previously identified using ChIP-chip were identified in 
H10407, and in total, 46 out of the 111 targets identified in H10407 have been identified in 
K-12 by previous studies (Figure 3.5B) (Grainger et al., 2005, Shimada et al., 2011).  However, 
8 CRP sites were located upstream of, or within, ETEC-specific genes. The function of genes 
targeted by CRP in ETEC H10407 and E. coli K-12 is similar (Figure 3.5D). Amongst the 111 
chromosomal peaks for CRP binding were many well studied CRP regulated promoters (Aiba 
et al., 1985, Busby et al., 1983, Kimata et al., 1997, Shimada et al., 2011). A selection of these 
targets is shown in Figure 3.6. For example, CRP is known to bind to five sites upstream of the 





























































Figure 3.5 Analysis of CRP targets found by ChIP-seq on the ETEC strain H10407 
chromosome 
A) Correlation of FAT (Fold Above Threshold) score with half-site match to the consensus 
(correlation coefficient= 0.139). 
B) Overlap of CRP targets found in H10407 with those of K-12, found by Grainger et al., (2005) 
by ChIP-chip, and by all studies. The total number of CRP targets was obtained from Shimada 
et al., (2010), and uses data from RegulonBD, Ecocyc, Grainger et al., (2005), and Shimada et 
al., (2010). Numbers in parenthesis indicate targets in or upstream of ETEC-specific genes. All 
other targets are upstream or within K-12 genes or homologs. 
C) Consensus motif for CRP binding associated with 96 % of identified CRP targets, shown as a 
sequence logo, generated using MEME software (Bailey et al., 2009). 
D) Gene categories in which CRP targets fall as found by ChIP-chip or ChIP-seq on the 
chromosome of E. coli K-12 (Grainger et al., 2005) and ETEC H10407 respectively. Genes 
have are broadly sorted based on general function. Genes shown contain a CRP binding site 
within the coding sequence or in a nearby intergenic region. Genes characterised as “other” 
























Figure 3.6 In vivo binding of CRP at selected chromosomal loci as determined by ChIP-
seq analysis 
Genes are depicted by gray blocks, the gene previously shown to be regulated by CRP are depicted by 
a blue block. CRP binding is shown by orange peaks. CRP binding motifs identified by MEME are 
shown above the tracks, CRP half-sites are shown in orange, and are mismatches to the consensus are 


































3.1.3 Properties of chromosomal DNA loci bound by H-NS 
Of the 364 H-NS peaks identified, 28 % of these were within genes. H-NS binding was focused 
to AT-rich regions of the genome as has been previously observed (Navarre et al., 2007). We 
observed binding at previously identified H-NS targets. Some examples of H-NS binding are 
shown in Figure 3.7 (Dole et al., 2004, Lucht et al., 1994, Olsén et al., 1993, Pul et al., 2010, 
Shin et al., 2005).  
3.1.4 Properties of chromosomal DNA loci bound by σ70 
1089 σ70 peaks were identified, 85 % of which localised to intergenic regions. Figure 3.8 shows 
some examples of σ70 binding. We observed σ70 peaks upstream of genes important for rapid 







Figure 3.7 In vivo binding of H-NS at selected chromosomal loci as determined by ChIP-
seq analysis 
Genes are shown in grey, the gene shown in blue is defined below each panel. H-NS binding is shown 























Figure 3.8 In vivo binding of σ70 at selected chromosomal loci as determined by ChIP-
seq analysis 
Genes are shown in grey, the gene shown in blue is defined below each panel. σ70 binding is shown in 




























3.2 CRP binding across plasmids p948 and p666 of H10407 
Unexpectedly, CRP binding was restricted to the chromosome of ETEC H10407, and no CRP 
binding was detected on any of the four plasmids (Figure 3.2B). This was surprising since the 
heat-labile toxin promoter is thought to be bound by three CRP dimers (Bodero and Munson, 
2009). Conversely, H-NS binding was observed across all four plasmids.  To further investigate 
CRP binding across the plasmids p948 and p666, which carry the ‘classic’ virulence factors, 
we used a regulon prediction program (PREDetector) that generates a PWM from a list of 
known transcription factor targets and then searches for matches to the PWM (Hiard et al., 
2007). Each match is given a “score” and the user sets an arbitrary cut-off below which 
predicted sites are discarded. Sites with high scores are a better match to the PWM. Table 3.2 
is a list of all sites identified from the bioinformatics screening. Binding sites were grouped 
into bins with other similarly scored sites. 
3.2.1 In vitro characterisation of predicted sites on H10407 virulence plasmids 
Following the bioinformatic screen the affinity of CRP for a selection of sites was investigated 
using Electrophoretic Mobility Shift Assays (EMSAs). The 7 sites with the highest scores, and 
the highest scoring site from each of the three lowest scoring bins, were selected. All selected 
sites are shown in red in Table 3.2. For simplicity, the sites were arbitrarily named 1-10. Figure 
3.9A is a cartoon showing the position of each predicted CRP binding site relative to genes 
located on plasmids p948 and p666. For the EMSA assays ~120 bp DNA fragments, 






Table 3.2 CRP targets predicted by PREDetector software 








13 to 14 ttttgtgaaattaatcacaaaa 13.78  (1) ETEC_p666_0090 Yes 
  taaagtgataaaaatcacataa 13.77  (2) ETEC_p948_0870c, 
aatC 
Yes 
12 to 13 ttttgtgatgtgtatcatacta 12.57  (3) ETEC_p948_0360c, 
estA2 
Yes 
11 to 12 ttttatgaaatcaatcacaaaa 11.82  (4) ETEC_p666_0110 No 
  atatttgaacgaagtcaaattt 11.1  (5) ETEC_p666_0360, traJ Yes 
10 to 11 taatgtaaaataaattaaaata 10.5  (6) ETEC_p948_0510 No 
  ttttgtgagttgcatcatgtta 10.41  (7) ETEC_p666_0750, 
estA1 
Yes 
9 to 10 atatgtgatattaatagcacaa 9.86  (8) ETEC_p948_0410, 
cfaC 
No 
  ttatttgaagcaaatcaacttt 9.85  ETEC_p948_0490, traJ n.d. 
  taatgtgattttgataatgaaa 9.62  ETEC_p948_0230c, 
repA2 
n.d. 
  aactttaataaacaccacatta 9.56  ETEC_p948_0830 n.d. 
  atttttgatatgtctgacatta 9.53  ETEC_p948_0700 n.d. 
  attttttatatatattgcatta 9.5  ETEC_p948_0700 n.d. 
  aattatgatgttgtacatataa 9.36  ETEC_p58_0005 n.d. 
  aagtgcgaatctattaacaata 9.08  ETEC_p948_0800 n.d. 
  aaataagatacacataaaaaaa 9  ETEC_p52_0001 n.d. 
  atttgtgaatcacttcacgacc 9  ETEC_p52_0006, rop n.d. 
8 to 9 ttttgtggagtgggttaaatta 8.89  (9) ETEC_p948_0510 No 
  aaacgttactacgttcacgttt 8.73  ETEC_p666_0880, relE n.d. 
  aaaattgtaatagataaaaaaa 8.63  ETEC_p948_0910, 
cexE 
n.d. 
  ataggtaaatctgttcaaaaaa 8.62  ETEC_p948_0790 n.d. 
  tgcagtaattaacgtcacattt 8.59  ETEC_p948_0020, 
eatA 
n.d. 
  aaatgcgatgaagctaataaat 8.46  ETEC_p666_0560, stbB n.d. 
  aaacgggaagctaatcgcataa 8.43  ETEC_p948_0530 n.d. 
  aatcttgaaaaatataaccaaa 8.28  ETEC_p948_0870 n.d. 
  tactgtgaattaattaacgttg 8.28  ETEC_p948_0120, 
etpB 
n.d. 
  aattgtggaagaaattacaatg 8.25  40522 -> 40543 n.d. 
  ttttactatcaatatcatatta 8.24  ETEC_p666_0750, sta1 n.d. 
  ataattgatatacataaactta 8.16  ETEC_p948_0990 n.d. 
  ttttctgaatgagatcgccttt 8.14  ETEC_p58_0001 n.d. 
  caatgttatttatatcattaaa 8.12  ETEC_p948_0990 n.d. 
  taatatcaaataaagcacaact 8.08  ETEC_p948_0120, 
etpB 
n.d. 
  aaatgtattccgtctcacatgt 8.04  ETEC_p948_0700 n.d. 
  ttttgtgattttctactatatt 8.04  ETEC_p948_0890c n.d. 
7 to 8 attttttaacaactttatattt 7.98  (10) ETEC_p948_0890c No 
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  aaattttatctaaagaaaataa 7.9  42550 -> 42571 n.d. 
  aaagacaacataaataacattt 7.9  ETEC_p948_0020c, 
eatA 
n.d. 
  aatcgtgacgcaagttacgaaa 7.85  ETEC_p948_0500c, 
traM 
n.d. 
  ttacactataaacatcacagtt 7.83  42327 -> 42348 n.d. 
  taatatttagaacatcataata 7.82  44227 -> 44248 n.d. 
  caaattgaaccagatcaaaatc 7.77  ETEC_p948_0490c, 
traJ 
n.d. 
  atttctgatacattaaacgtat 7.65  43228 -> 43249 n.d. 
  aaatgaattttcaatcaaatta 7.65  ETEC_p666_0870c n.d. 
  ttttattattccatacacataa 7.64  ETEC_p666_0650c, 
eltB 
n.d. 
  aagtgcgaatctattaacaata 7.62  ETEC_p948_0800c n.d. 
  attcatgcagcaaatcacatca 7.61  ETEC_p948_0500c, 
traM 
n.d. 
  aaatgttatatcttcctcttta 7.58  ETEC_p666_0350c, 
traY 
n.d. 
  ttatgttaactcaatttcaata 7.52  37232 -> 37253 n.d. 
  aaactcaaattgagtcacaaca 7.51  ETEC_p948_0680, stbA n.d. 
  aattatggtgataataatattt 7.48  41344 -> 41365 n.d. 
  aataataataaaaagcaaaaaa 7.47  ETEC_p948_1070c n.d. 
  aaatgtaattgataataaaaaa 7.45  38188 -> 38209 n.d. 
  aattgtggaagaaattacaatg 7.44  40522 -> 40543 n.d. 
  atcttcgaccatattcgcatat 7.4  47921 -> 47942 n.d. 
  cattgtcatatttatcagaaaa 7.39  ETEC_p948_0990c n.d. 
  caatgttatttatatcattaaa 7.39  ETEC_p948_0990c n.d. 
  atttcttatagaaattactttt 7.38  ETEC_p948_0800c n.d. 
  aatggcgatgctaataaaataa 7.37  ETEC_p666_0660c, 
eltA 
n.d. 
  ttttgttattattatctaagct 7.31  ETEC_p948_0870c n.d. 
  gaacatgagcagcatcataaaa 7.31  ETEC_p666_0360c, 
traJ 
n.d. 
  tactgcggcgcagttcacgatt 7.3  ETEC_p948_0050c n.d. 
  aattttggtctcggtcagatat 7.3  ETEC_p666_0650c, 
eltB 
n.d. 
  aatcgtgaactgcgccgcagta 7.3  ETEC_p948_0240 n.d. 
  tttttttaattgcgttgcatat 7.27  ETEC_p948_0900c n.d. 
  ataagtgatagtcttaatacta 7.26  ETEC_p948_0470 n.d. 
  taatgtgttaggcattaacatt 7.25  61025 -> 61046 n.d. 
  tgatgtggtatgttttatcttt 7.21  ETEC_p666_0110c n.d. 
  caatatgatttagttaacggta 7.2  ETEC_p666_0550, stbA n.d. 
  aaacgcaatgtatttcattatt 7.2  60523 -> 60544 n.d. 
  tcaggtgatgcacttcaaaaag 7.19  29938 -> 29959 n.d. 
  atctttgataattttctcaatg 7.19  25210 -> 25231 n.d. 
  ttactcaatcctcttcacaaca 7.18  ETEC_p666_0560, stbB n.d. 
  atttgtgtcatgggttaccata 7.16  75209 -> 75230 n.d. 
  atatttgatatctgtgatatct 7.14  43102 -> 43123 n.d. 
  agattaaaaaaacaccacaaaa 7.14  90310 -> 90331 n.d. 
  aatgatgaatatcatcaattat 7.13  39580 -> 39601 n.d. 
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  tttttccatctgcatcaaaatt 7.12  67889 -> 67910 n.d. 
  ttttatgatggatatagtacta 7.12  42475 -> 42496 n.d. 
  aattgttattggtgaaataatt 7.12  5162 -> 5183 n.d. 
  ttgttttatcaaaatcatgttt 7.11  4348 -> 4369 n.d. 
  tcttgtgagggagattgtattt 7.11  77103 -> 77124 n.d. 
  atattagaacgatattgcataa 7.11  74898 -> 74919 n.d. 
  tactgtgaattaattaacgttg 7.09  ETEC_p948_0120c, 
etpB 
n.d. 
  aactttaataaacaccacatta 7.09  ETEC_p948_0830c n.d. 
  tgttttttacaacatcacactt 7.08  ETEC_p666_0750c, 
sta1 
n.d. 
  tgttttttacaacatcacactt 7.08  ETEC_p666_0750c, 
sta1 
n.d. 
  ataggtaaatctgttcaaaaaa 7.08  ETEC_p948_0790c n.d. 
  taacgtggcattaaccacgtaa 7.07  ETEC_p948_0490c, 
traJ 
n.d. 
  tgatttgactgctcttaaattt 7.06  ETEC_p666_0870c n.d. 
  aaacgggaacgggttcacaaac 7.03  10961 -> 10982 n.d. 
  aaatgcaaactttatgatatat 7.02  37876 -> 37897 n.d. 
  aaatgtattccgtctcacatgt 7  61211 -> 61232 n.d. 
 
Sites investigated using EMSA analysis are indicated in red. 
a Each bin contains sites with a similar affinity for CRP as predicted by PREDetector. 
b Denotes the sequence of the CRP site predicted by PREDetector. Nucleotides in bold conform to the 
consensus CRP binding site.  
c Denotes the score assigned to the target by PREDetector depending on similarity to the consensus. 
Sites identified below a cut-off score of 7 were omitted from the analysis.  












   
Figure 3.9 Genomic context and sequence of high-affinity CRP targets predicted by 
bioinformatics analysis on plasmids p948 and p666 
The genomic context of each predicted CRP target is shown (A), where the CRP sites are shown as 
orange boxes, the site number is shown within each box. Blue arrows indicate nearby genes, black lines 
represent intergenic DNA. Red text and arrows give the distance from the centre of the CRP site to the 
nearest gene boundary. The corresponding sequence of each predicted CRP sites are shown (B). CRP 
half-sites are shown in orange, with mis-matches to the consensus underscored. The start codons of 


































































The raw EMSA data are shown in Figure 3.10 and a quantification of the data for one 
representative site of each bin (i.e sites from Figure 3.10A) is shown in Figure 3.11. Targets 4, 
6, 8, 9 and 10 did not bind CRP whilst targets 1, 2, 3, 5 and 7 did. Hence, binding of CRP 
broadly correlated with predicted site score. Interestingly, these five high-affinity sites (1, 2, 3, 
5 and 7) were all bound by H-NS in vivo (Figure 3.12). Thus, we speculate that H-NS might 
prevent CRP binding to these sites in vivo. Importantly, targets 3 and 7 were upstream of the 





Figure 3.10 In vitro analysis of CRP binding to selected targets predicted in silico by EMSA 
Radiolabelled AatII-HindIII fragments were incubated with purified CRP for 20 minutes at 37 oC before being run on a 7.5 % (w/v) polyacrylamide gel. Gels 
were run at 200 V for 2 hours, before being dried and exposed to a phosphorscreen. Each window shows the results from an EMSA experiment using a 
different CRP target. CRP concentrations from left to right in each window are as follows; 0, 175, 350 and 700 nM. All reactions contained 0.2 mM cAMP. 
Free DNA and CRP-DNA complexes are indicated by arrows. Scores assigned by the bioinformatics screen are given in red.   
Score: 13.78 12.57 11.1 9.86 8.8910.41 7.98
13.77 11.82 10.5















Figure 3.11 Graphical representation of in vitro analysis of CRP binding to selected 
targets predicted in silico 



































Binding of CRP targets representative  
































Figure 3.12 In vivo binding of CRP and H-NS at high-affinity CRP target identified by 
bioinformatics on virulence plasmids p948 and p666 as determined by ChIP-seq 
Each panel shows CRP and H-NS binding across a different locus. Genes are depicted in grey 
blocks. CRP targets identified by bioinformatics are shown above genes, half sites are shown 
in orange. Deviations from the consensus are indicated by underlined bases. Binding scores are 
given in red. CRP binding across each region as determined by ChIP-seq analysis is shown in 
orange. H-NS binding is shown in green. The blue indicates the relative position of the CRP 
site. Blue blocks indicate the heat-stable toxin genes estA1 and estA2. The maximum number 





























3.3 Discussion: a role for CRP in ETEC virulence 
The aim of the work presented in this chapter was to investigate the role of CRP, H-NS and σ70 
in regulating expression of ETEC virulence factors. Using ChIP-seq 111 high-confidence CRP 
binding sites were identified on the chromosome. Additionally, 364 peaks for H-NS, and 1089 
peaks for σ70 were found. The majority of CRP binding sites were in intergenic regions but 
very few (7 %) of these sites were located upstream of ETEC-specific genes. In summary, 
binding targets of CRP in ETEC H10407 appears to be very similar to that of K-12 (Table 3.1 
and Figure 3.5). Hence, CRP binding was abundant in the vicinity of genes encoding 
transporters, phosphotransferase systems, metabolic enzymes, and transcription factors.  
We observed small differences in the broad categories of chromosomal genes targeted by CRP 
in K-12 and ETEC H10407, as shown in Figure 3.5D. The precise functioning of these sites 
might be a subject for further study. For example, in ETEC H10407, CRP has more binding 
targets associated with genes involved in amino acid metabolism and nucleotide metabolism 
compared to K-12. It is possible that this might reflect small changes in metabolic regulation 
in ETEC, which could confer an advantage in colonisation, when in competition with intestinal 
commensals. For example, Fabich et al. (2008) have shown that E. coli O157:H7 and MG1655 
utilise different sugars when colonising the mouse intestine. In addition, strain O157:H7 
switches to using gluconeogenic substrates in streptomycin-treated mice co-colonised with 
MG1655.  
Surprisingly, CRP binding was observed only on the H10407 chromosome, and no sites could 
be observed on any of the four virulence plasmids. CRP binding to these plasmids is of 
particular interest since they encode the pathogenicity factors. Despite a lack of CRP binding 
as determined by ChIP-seq we were able to identify a number of high affinity CRP targets 
bioinformatically. Two such targets were found upstream of genes encoding STa1 and STa2 
on p666 and p948 respectively. These sites were bound by H-NS, rather than CRP in vivo. Thus 
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it is likely that CRP binding is occluded by H-NS in these regions. H-NS occlusion of 
transcription factors has been previously described by Myers et al. (2013), who described a 
significant increase in FNR binding across the K-12 MG1655 chromosome in a Δhns/ΔstpA 
strain. Interestingly, like our study, Myers et al. found that transcription factor occupancy of a 
binding site correlated poorly with its resemblance to the consensus. Hence, the binding of 
conventional transcription factors is sensitive to other factors, including NAPs like H-NS. 
Transcriptional regulation of ETEC virulence gene expression by H-NS will require further 
study, although there are numerous reports of H-NS involvement in ETEC pathogenicity. For 
example, repression of the eltAB operon by H-NS has been reported by Yang et al. (2005). The 
heat-labile toxin is secreted through association with outer membrane vesicles (OMVs). 
Mutating the hns gene results in increased production of OMVs (Horstman and Kuehn, 2002). 
Jordi et al. (1994), have also reported H-NS-mediated repression of the cfaABCE operon. It 






































The analysis presented in Chapter 3 identified CRP sites upstream of the estA1 and estA2 genes 
that encode heat-stable enterotoxin derivatives. However, these targets were bound by H-NS 
rather than CRP in vivo under the conditions tested (Figure 4.1A and Figure 4.1B). Similarly, 
eltAB has been proposed to bind three CRP dimers, but the promoter region was bound by H-
NS not CRP in our ChIP-seq analysis (Figure 4.1C). A possible explanation for these 
observations is occlusion of CRP binding sites by H-NS. Binding of H-NS to promoters usually 
involves co-operative interactions between H-NS monomers bound at multiple adjacent sites. 
If promoters are removed from their genomic context this co-operativity is often lost and H-
NS binding is negated (Singh et al., 2014). Thus, in this chapter, we have examined the effect 
of removing H-NS bound CRP targets from their position within H-NS filaments. 
4.2 Characterisation of PestA2  
4.2.1 Identification of PestA2 transcription start site 
To characterise PestA2, a 93 bp DNA fragment was generated that included the predicted CRP 
site and translation start codon of estA2. Importantly, this fragment included a potential 
regulatory region (shown in Figure 4.2A) and lacked the H-NS bound estA2 coding sequence. 
The fragment was cloned into pRW50 to create a promoter::lacZ fusion, and used to transform 
E. coli K-12 strain M182. As a first step towards understanding PestA2 regulation we isolated 
RNA from the transformants and determined the PestA2 transcription start site by primer 
extension using an oligonucleotide primer that bound to the 5’ end of the lacZ mRNA of 
pRW50.  The result of the primer extension assay is shown in Figure 4.2B. A 109 nucleotide 
primer extension product was observed that maps to the transcription start site labelled ‘+1’ in 
Figure 4.2A. From the mapped transcription start site, we were able to identify a -35 hexamer 





Figure 4.1 Distribution of CRP and H-NS across ETEC H10407 enterotoxin gene loci as 
determined by ChIP-seq 
Genes are shown as grey and blue blocks, CRP binding is shown in orange, and H-NS binding is shown 
in green. Above the panel, the sequences of the predicted CRP sites (A and B), or previously 
characterised CRP sites (C) are shown. CRP half-sites are shown in orange, deviations from the 
consensus are underlined. Where appropriate, the predicted score assigned by PREDetector is shown in 
red. 
A) CRP and H-NS binding across the estA2 locus on p948. Maximum number of H-NS reads: 606. 
B) CRP and H-NS binding across the estA1 locus p666. Maximum number of H-NS reads: 892. 
C) CRP and H-NS binding across the eltAB locus on p666. CRP sites shown above the panel are 












































Figure 4.2 Mapping of the transcriptional start site of PestA2 
A) Sequence of the PestA2 regulatory region. The transcription start site (determined by primer 
extension) is labelled as ‘+1’, and is underlined in red. The -35 and -10 hexamers are shown 
in purple, the UP element is shown in blue, and the CRP half sites are shown in orange. 
B) Primer extension analysis of PestA2. Lane 5 shows the primer extension product, which 
labelled in purple. Lanes 1-4 are M13 T7 sequencing reactions (‘A’, ‘C’, ‘G’, and ‘T’) used to 
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CRP binding site was centred 59.5 bp upstream of the transcription start site.  
4.2.2 Binding of CRP to the predicted PestA2 CRP binding site 
DNAse I footprinting was used to confirm CRP binding to the predicted site. To this end, the 
PestA2 fragment was cloned into plasmid pSR and a 171 bp DNA fragment, containing the 93 
bp PestA2 sequence, was generated by digestion with AatII and HindIII. The fragment was 
end-labelled and used in DNAse I footprinting assays. Figure 4.3 shows the footprint. The gel 
was calibrated with a Maxim/Gilbert G+A ladder, and numbered according to the PestA2 
transcription start site (+1). Lane 1 shows the pattern of DNase I cleavage in the absence of 
CRP. Addition of CRP results in changes in the cleavage pattern between promoter 
positions -54 and -70 (Figure 4.3, lanes 2-8).  
4.2.3 CRP activates transcription from PestA2 in vitro and in vivo 
The configuration of PestA2 suggested that it was likely a class I CRP activated promoter (Zhou 
et al., 1993, Busby and Ebright, 1999). To test this prediction the pRW50 construct, containing 
PestA2, was used to transform M182 and the Δcrp derivative. LacZ activity levels were then 
determined in the transformants (Figure 4.4A). A four-fold increase in LacZ activity was 
observed in wildtype cells compared to cells lacking CRP. To confirm that the effect of CRP 
was direct, the pSR construct containing PestA2 was used as a template for in vitro transcription 
with purified RNA polymerase, and CRP. Transcription from PestA2 generates a 112 
nucleotide RNA separable from the RNAI control (which is not dependent on CRP) using high 










Figure 4.3 Confirmation of the position of the CRP site at PestA2 using DNAse I 
footprinting 
G + A is a Maxim/Gilbert G + A ladder, which shows the position of pyrimidine bases in the sequence. 
Numbering refers to distance from the transcription start site, as determined by primer extension. Each 
band represents a site at which DNA has been cleaved. Lane 1 shows the cleavage pattern of PestA2 
when exposed to DNAse I, in the absence of CRP. Lanes 2 to 8 show cleavage patterns of PestA2 when 
exposed to increasing concentrations of CRP. Final CRP concentrations used in lanes 2-8 respectively 
are; 0.35 μM, 0.7 μM, 1.05 μM, 1.4 μM, 1.75 μM, 2.1 μM and 2.45 μM. All reactions contain 0.2 mM 
cAMP. All reactions contained 12.5 μg/ml Herring Sperm DNA as a non-specific competitor. 0.2 units 
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Figure 4.4 PestA2 is activated by CRP in vivo and in vitro 
A) β-galactosidase activity of PestA2 cloned into pRW50, in M182 wildtype and M182 Δcrp 
background. Cells were grown to mid-log phase (OD650=0.3-0.6). Standard deviation is shown 
for three biological replicates. Activity shown is in Miller units. 
B) In vitro transcription products of PestA2 cloned upstream of a  λoop terminator in pSR. RNAP 
containing σ70 was used at a concentration of 400 nM, CRP was used at a concentration of 
350 nM. Reactions were run for 10 minutes at 37 oC before being stopped. Transcription 
products were run on a 6 % (w/v) denaturing gel. The PestA2 transcript and 108 nt RNAI control 
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4.3 Characterisation of PestA1 
4.3.1 Identification of the PestA1 transcription start site 
Having established that PestA2 is a class I dependent CRP activated promoter we next 
characterised regulation of estA1. Examination of the sequence upstream of estA1 revealed 
DNA elements similar to those at PestA2. Hence, a predicted CRP site and promoter-like 
sequences were present (Figure 4.5A). To determine if PestA2 and PestA1 share an equivalent 
transcription start site a 92 bp fragment was generated, equivalent to the PestA2 DNA fragment 
described above (Figure 4.5A). This DNA fragment was cloned into pRW50, and the resulting 
construct was used to transform M182 and the Δcrp derivative. RNA was extracted, and primer 
extension was used to determine the transcription start site of PestA1. Figure 4.5B shows the 
primer extension product, alongside calibrating sequencing reactions. Just as for PestA2, a 109 
nucleotide product is observed that maps to the equivalent transcription start site. However, the 
amount of primer extension product increased in cells lacking CRP. This was unexpected, since 
PestA1 superficially resembles PestA2.  
4.3.2 PestA1 is repressed by CRP 
To confirm that PestA1 was repressed by CRP, we measured LacZ activity in M182 and 
corresponding Δcrp cells transformed with the pRW50 construct containing PestA1 fused to 
lacZ. The data show that PestA1 is repressed by CRP and that, compared to PestA2, PestA1 is 
poorly active (compare Figure 4.4A and Figure 4.5C).  To check that the CRP effect was direct, 
the 92 bp PestA1 fragment was cloned into pSR and used as a template for in vitro transcription 
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PestA2 TGATA TC C A T AAAAAGTTTGCGCAATC T C GAT G T TAAATATTCGTGG
PestA1 CATG TG ACTC C A T AAAA TTGCAAAA CCGT T A TAATC- CAAATATCCGTGA
PestA2.1 CATG TG ACTC C A T AAAAAGTTTGCGCAATC T C GAT G T TAAATATTCGTGG
PestA2.2 TGATA TC C A T AAAAATTGCGCAATC T C GAT G T TAAATATTCGTGG
PestA2.3 TGATA TC C A T AAAAAGTTTGCAAAATC T C GAT G T TAAATATTCGTGG
PestA2.4 TGATA TC C A T AAAAAGTTTGCG AA CCGT T A TAATC- TAAATATTCGTGG
PestA2.5 TGATA TC C A T AAAAAGTTTGCAAAA CCGT T A TAATC- TAAATATTCGTGG
PestA2.6 TGATA TC C A T AAAAAGTTTGCGCAATC T C GAT TG T CAAATATTCGTGG
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Figure 4.5 PestA1 is a CRP-repressed promoter 
A) Alignment of PestA2 and PestA1 promoters. Numbering refers to PestA2 transcriptional start 
site. CRP half-sites are shown in orange, UP elements are shown in blue, -35 and -10 hexamers 
are shown in purple.  
B) Primer extension assay to map the transcriptional start site of PestA1. Lanes 1-4 are M13 T7 
sequencing reactions (‘A’, ‘C’, ‘G’, and ‘T’) used to calibrate the gel. RNA was extracted from 
M182 cells and M182 Δcrp cells harbouring a pRW50 plasmid containing the PestA1 promoter 
fragment. Lanes 5 and 6 show primer extension products generated from RNA from M182 
wildtype and Δcrp cells respectively which are labelled in purple. The mapped transcription 
start site is shown in Figure 4.5A. 
C) β-galactosidase activity of PestA1 cloned into pRW50, in M182 wildtype and M182 Δcrp 
background. Cells were grown to mid-log phase (OD650=0.3-0.6). Standard deviation is 
shown for three biological replicates. Activity shown is in Miller units. 
D) In vitro transcription products of PestA1 cloned upstream of a  λoop terminator in pSR. RNA 
polymerase was used at a concentration of 400 nM, CRP was used at a concentration of 350 
nM. Reactions were run for 10 minutes at 37 oC before being stopped. Transcription products 
were run on a 6 % (w/v) denaturing gel. The PestA1 transcript and 108 nt RNAI control 















4.4 Construction of hybrid PestA2:PestA1 promoters 
To understand why PestA1 and PestA2 behaved differently, a series of hybrid promoters was 
generated. The various hybrids are each based on PestA2 but contain a discrete promoter 
element from PestA1. The constructs are shown in Figure 4.6A, where underlining represents 
replacement of PestA2 sequence with the equivalent PestA1 element. The hybrid constructs 
were cloned into pRW50 and used to transform M182 and M182Δcrp. LacZ activities 
determined for the transformants are shown in Figure 4.6B. The table beneath the graph also 
describes the composition of each promoter construct. 
Each change has an effect on promoter activity. Introducing the PestA1 CRP site (PestA2.1), 
or PestA1 spacer region (PestA2.4) renders the hybrid promoter insensitive to CRP. Introducing 
the PestA1 UP element (PestA2.2) or -10 element (PestA2.6) reduces promoter activity, but not 
CRP-dependent activation. Crucially, replacement of the PestA1 -35 element of PestA2 with 
that of Pest1 (PestA2.3 and PestA2.5) results in repression by CRP. Only the discriminator 
sequence of PestA1 had no effect on promoter activity or regulation. We conclude that the -35 
element is responsible for CRP-dependent repression and that the other changes in the PestA1 
sequence (relative to PestA2) result in the overall lower activity of PestA1.  
4.5 CRP-dependent regulation at PeltAB 
Having established that CRP activates PestA2 and represses PestA1 we turned our attention to 
regulation of the eltAB operon encoding the heat-labile toxin gene. Recall that, PeltAB was 
previously suggested to bind CRP at three sites upstream of the transcription start site (Bodero 
and Munson, 2009). Binding of CRP to these sites is proposed to repress expression of eltAB. 
However, our bioinformatic screen (Chapter 3) did not predict any CRP sites at PeltAB. 
Moreover, the CRP sites predicted by Bodero and Munson are all a poor match to the consensus 





















CRP     UP element  -35       spacer -10 discriminator
PestA2 T GATACA TC C A T AAAGTTTGCGCAA CG TC GA TT GATTTA A AT C TGG
PestA1 C ATG AACTC C A T AAATTGC AAATCCGTTTA C AA -TCA ATATCCGTGA
PestA2.1 C ATG AACTC C A T AAAGTTTGCGCAA CG TC GA TT GATTTA A AT C TGG
PestA2.2 T GATACA TC C A T AAATTGCGCAA CG TC GA TT GATTTA A AT C TGG
PestA2.3 T GATACA TC C A T AAAGTTTGC AAA CG TC GA TT GATTTA A AT C TGG
PestA2.4 T GATACA TC C A T AAAGTTTGCGCAATCCGTTTA C AA C-TTA A AT C TGG
PestA2.5 T GATACA TC C A T AAAGTTTGC AAATCCGTTTA C AA C-TTA A AT C TGG
PestA2.6 T GATACA TC C A T AAAGTTTGCGCAA CG TC GA TT GATTCA A AT C TGG






























CRP site N/A PestA2 PestA1 PestA2 PestA2 PestA2 PestA2 PestA2 PestA2 PestA1
UP element N/A PestA2 PestA2 PestA1 PestA2 PestA2 PestA2 PestA2 PestA2 PestA1
-35 element N/A PestA2 PestA2 PestA2 PestA1 PestA2 PestA1 PestA2 PestA2 PestA1
spacer N/A PestA2 PestA2 PestA2 PestA2 PestA1 PestA1 PestA2 PestA2 PestA1
-10 element N/A PestA2 PestA2 PestA2 PestA2 PestA2 PestA2 PestA1 PestA2 PestA1
descriminator N/A PestA2 PestA2 PestA2 PestA2 PestA2 PestA2 PestA2 PestA1 PestA1
wt
Dcrp
2.1       2.2       2.3        2.4       2.5       2.6       2.7
different PestA hybrid promoters
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Figure 4.6 PestA2:PestA1 hybrid promoters 
A) Hybrid promoters generated for PestA2:PestA1 trajectory mutagenesis. All sequences are based 
on PestA2, but contain one or more promoter elements from PestA1, these are underlined. CRP 
half-sites are shown in orange, the UP element in shown in blue, -35 and -10 hexamers are 
shown in purple.  
B) β-galactosidase activity of PestA2/PestA1 hybrid promoters cloned into pRW50, in M182 
wildtype and M182 Δcrp backgrounds. Cells were grown to mid-log phase (OD650=0.3-0.6). 
Standard deviation is shown for three biological replicates. Activity shown is in Miller units. 
The schematic below the graph indicates the composition of the promoter. Grey boxes indicate 
elements from PestA2, yellow boxes indicate elements from PestA1. Empty pRW50 vector 



























4.5.1 CRP does not bind the PeltAB region in vitro 
As a starting point a 359 bp EcoRI- HindIII fragment containing PeltAB was generated. This 
is a precise match to the PeltAB fragment used in the study of Bodero and Munson (Figure 
4.7A) (2009). The DNA fragment was radiolabelled and used for in vitro EMSA experiments 
to test CRP binding. We also ran and EMSA experiments with PestA2 as a positive control. 
The data are shown in Figure 4.7B. The PestA2 fragment bound CRP tightly and formed a 
discrete complex with CRP (lanes 3-6). Further increases in CRP concentration led to non-
specific binding of CRP to PestA2, which manifested itself as a smear in lane 7 of Figure 4.7B. 
Conversely, no specific binding of CRP to PeltAB was observed (lanes 8-13) but, at high CRP 
concentrations, non-specific binding was apparent (lane 14).  
4.5.2 Repression of PeltAB by CRP is indirect 
Our EMSA data suggest that CRP does not bind specifically to PeltAB. Consequently, we 
reasoned that the repressive effect of CRP on PeltAB reported by Bodero and Munson must be 
indirect. To test this prediction, a series of PeltAB derivatives was generated where the CRP 
sites were sequentially removed (Figure 4.8A). PeltAB 1.1 is the 359 bp PeltAB fragment, 
identical to that used by Bodero and Munson (2009). PeltAB 1.2 is a shorter 118 bp fragment, 
which contains only the promoter proximal CRP site. PeltAB 1.3 is a derivative of PeltAB 1.2 
in which the remaining CRP site has two point mutations in each half site. The various PeltAB 
fragments were cloned into pRW50 and used to transform M182 cells or the Δcrp derivative. 
Results of β-galactosidase assays are shown in Figure 4.8B. Removal of the two upstream CRP 
sites and mutation of the remaining downstream CRP site did not change the response of the 
promoter to CRP; in all PeltAB derivatives promoter activity increased 2.5 fold in Δcrp cells. 
Taken together, the lack of CRP binding to PeltAB, and the insensitivity of the promoter to 








Figure 4.7 CRP does not bind to the PeltAB promoter in in vitro EMSAs 
A) Sequence of the PeltAB region. CRP half-sites defined by Bodero and Munson (2009) are 
shown in orange and are underlined. The -35 and -10 hexamers are shown in purple. Annotation 
is relative to the transcription start site (indicated by ‘+1’).  
B) In vitro EMSA of the PeltAB (lanes 8-14) and PestA2 promoter (lanes 1-7). End- labelled 
EcoRI-HindIII flanked fragments were incubated with various concentrations of CRP at 37 oC 
for 20 minutes before being loaded onto a 7.5 % (w/v) polyacrylamide gel. CRP concentrations 
for each panel are as follows; 0 μM, 0.175 μM, 0.35 μM, 0.7 μM, 1.4 μM, 2.8 μM, and 7 μM. 
All reactions contain 12.5 μg/ml Herring Sperm DNA as a non-specific competitor, and 0.2 mM 
cAMP. 
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Figure 4.8 Truncation/mutation of the CRP sites at PeltAB does not alter CRP-
dependent regulation 
A) Variants of the PeltAB promoter cloned into pRW50 and subsequently used for 
truncation/mutation analysis. PeltAB 1.1 is the full length 359 bp PeltAB promoter 
containing all three CRP sites defined by Bodero and Munson (2009). PeltAB 1.2 is a 118 
bp truncated variant, containing only the downstream CRP site. PeltAB 1.3 is a derivative 
of PeltAB 1.2 with a mutated CRP site.  
B) β-galactosidase activity of PeltAB variants cloned into pRW50, in M182 wildtype and 
M182 Δcrp backgrounds. Cells were grown to mid-log phase (OD650=0.3-0.6). Standard 






































4.6 Discussion:  
4.6.1 Regulation of ST expression in ETEC H10407 
Here we demonstrate that the two heat-stable toxin promoters of H10407 are directly regulated 
by CRP. The PestA2 promoter of plasmid p948 is activated by CRP from a class I position. 
The architecture of the PestA1 promoter on plasmid p666 appears to be similar to PestA2, 
however, there are differences that result in PestA1 being repressed by CRP and having an 
overall lower activity than PestA2. The trajectory mutagenesis showed the difference in PestA1 
activity results from a combination of differences but the PestA1 -35 element is key for 
repression by CRP.  
Repression mediated by a single CRP bound at position -58.5 relative to the transcription start 
site has not previously been reported. However, repression by transcription factors bound with 
incorrect helical phasing (as defined by Gaston et al., (1990)) has been reported. At the Bacillus 
subtilis φ29 phage early A2c promoter, the phage-encoded regulator p4 normally binds 39 
bases upstream of the transcription start site. Binding of RNA polymerase re-positions p4 to a 
site centred 71 bases upstream of the transcription start site, which represses transcription 
activation (Monsalve et al., 1998). The α-CTD-p4 interaction is critical for repression, so 
presumably p4 prevents RNAP from escaping the promoter. At class I promoters, where the 
CRP site is positioned at -59.5, an α-CTD protomer sits between CRP and σ4 bound at the 
promoter -35 element (Ross et al., 2003). Thus, one possible explanation might be that 
replacing the -35 element of PestA2, with that from PestA1, results in subtle changes in the 
positioning of the RNAP holoenzyme. This could constrain the positioning of α-CTD so that 
i) CRP binding to its site displaces α-CTD and prevents RNAP recruitment or ii) unproductive 




4.6.2 CRP indirectly regulates the heat-labile toxin 
Bodero and Munson (2009) proposed three CRP sites upstream of PeltAB, which negatively 
regulate eltAB expression. However, the authors did not link occupation of these sites to PeltAB 
repression by CRP. Moreover, it is unlikely that i) CRP centred at position -261 interacts with 
transcriptional machinery, and ii) that such poor CRP sites would be able to prevent RNAP 
binding to the promoter.  
4.6.3 A model for enterotoxin production in ETEC H10407 
Figure 4.9 is a simple model for CRP-dependent regulation of ETEC enterotoxins. CRP directly 
activates estA2 and directly represses estA1. CRP binding alone at the promoters of these genes 
is sufficient for the observed regulation. Repression of eltAB expression must be indirect since 
CRP does not bind PeltAB in vitro, and the CRP sites are not required for repression in vivo. 
From a wider perspective, one might speculate that initial intoxication of epithelial cells by LT 
early in the infection process would lead to increasing levels of cAMP in the gut lumen. This 
would stimulate a switch from LT production to ST production mediated by CRP. Co-opting 
global transcriptional regulators, such as CRP and H-NS, is an effective strategy to control 
toxin expression, without major re-wiring of regulatory networks. For example, it is already 
known that CRP upregulates many genes important for mouse intestinal colonisation (Chang 
et al., 2004). Futher more, use of CRP as a regulator of toxin expression has also been observed 
before. For example, the pet promoter of EAEC 042, is dependent on CRP for activation 
(Rossiter et al., 2011). Additionally, exotoxin A production in Pseudomonas aeruginosa is 








Figure 4.9 Proposed models for CRP-dependent enterotoxin regulation in ETEC 
H10407 
A model for CRP-dependent regulation of enterotoxin production in ETEC H10407. Arrows indicate 
positive regulation. Blunt-ended lines indicate repression. Heat-stable toxin genes are shown in blue, 







































Our bioinformatic screen of plasmids p948 and p666 also a predicted CRP binding site at the 
aatPABC locus (Figure 5.1 and Figure 5.2). The aatPABCD operon has been previously 
characterised in enteroaggregative E. coli (EAEC) and encodes the Aat type I secretion system 
(Nishi et al., 2003). The Aat system is responsible for the secretion of dispersin, a small 
10.2 kDa hydrophilic protein that associates with AAF/I and AAF/II fimbriae to maintain their 
correct positioning (Figure 5.2). In ETEC, the 12.4 kDa CexE protein is a secreted dispersin-
protein encoded by the cexE gene which is genomically associated with the aatPABC locus 
(Crossman et al., 2010, Pilonieta et al., 2007). Unusually, the CRP site (target ‘2’, from our 
bioinformatics screen) was located at the 3’ end of the aat operon, centred 19 bp downstream 
of aatC, and bound CRP with high-affinity in vitro. Given the central role of CRP in controlling 
the expression of ST and LT we were intrigued by the possibility that CRP may also influence 
expression of the Aat system. The unusual position of the CRP at this locus suggests that i) 
CRP acts via an unusual mechanism or ii) this CRP site does not have a regulatory function. In 
this chapter, we have investigated these possibilities.  
Our starting point was to search the 3’ end of the aatPABC operon for an unidentified promoter 
that may exist in the vicinity of the CRP site. Hence, we searched 100 bp either side of the CRP 
site for sequences that resembled -10 or -35 hexamers. A potential -10 element with the 







Figure 5.1 Genetic organisation of the aat locus, and the position and sequence of target 
‘2’ on plasmid p948 of ETEC H10407 
Black lines represent DNA, coloured arrows show genes, the CRP site is shown in orange. The sequence 
of the CRP site is shown in orange below. The potential -10 element is shown in red. The predicted 


































Figure 5.2 Predicted function of the ETEC Aat system based on Aat system of EAEC 
Subunits are colour coded with genes in Figure 5.1., CexE is shown as a blue rectangle. Red arrows 
show the pathway for CexE secretion. The black box on CexE represents a signal peptide. Yellow 




















5.2 CRP target ‘2’ lies upstream of a promoter driving transcription anti-sense to the 
aat operon 
Our next aim was to characterise the promoter lying adjacent to the CRP site. Thus, the 134 bp 
fragment shown in Figure 5.1 (that includes the predicted promoter and CRP site) was cloned 
into pRW50. M182 cells and the Δcrp derivative were transformed with the resulting plasmid 
construct. RNA was extracted from log-phase cultures and used as a template for primer 
extension assays to i) determine the promoter transcription start site and ii) to determine if the 
promoter was CRP dependent. A 166 nucleotide primer extension product was observed (lane 
5 in Figure 5.3A) which could be mapped to a thymine residue 39.5 bases downstream of the 
CRP site (marked as “+1” in Figure 5.3B). However, note that this transcription start site is 5 
bp, rather than 7 bp, downstream of the -10 element. Hence, the CRP site is in a perfect class 
II position with respect to the proposed -10 and -35 elements. Consistent with this, almost no 
primer extension product was observed in experiments using RNA from Δcrp cells, (lane 6 in 
Figure 5.3A), suggesting that CRP activates transcription. Intriguingly, we were also able to 
identify an open reading frame downstream of this possible promoter using NCBI ORF finder, 
which was located within the coding sequence of aatC (Figure 5.1). For convenience, we 















Figure 5.3 Characterisation of the promoter adjacent to target ‘2’ on p948 
A) Primer extension analysis of promoter adjacent to target ‘2’. Lane 5 shows the primer extension 
product generated from RNA isolated from wildtype cells, lane 6 shows the primer extension 
product generated from RNA isolated from Δcrp cells which labelled in purple. Lanes 1-4 are 
M13 T7 sequencing reactions (‘A’, ‘C’, ‘G’, and ‘T’) used to calibrate the gel.  
B) Mapping of the transcription start site of the promoter adjacent to target ‘2’. The transcription 
start site is labelled as ‘+1’, the proposed -35 and -10 elements are highlighted in purple boxes. 
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5.2.1 CRP binds to a site centred at position -39.5 relative to the PaatS transcription 
start site to activate transcription 
Next, we used DNAse I footprinting to confirm CRP bound to the predicted site upstream of 
PaatS. The 134 bp PaatS DNA fragment was cloned into pSR and a 212 bp AatII-HindIII 
fragment was excised from the plasmid for use in DNAse I footprinting experiments. The 
footprint is shown in Figure 5.4. Lane 1 shows DNAse I cleavage patterns produced at PaatS 
in the absence of CRP. Alterations to this pattern are evident in lanes 2-6 as increasing CRP 
concentrations are added. CRP induced the appearance of three hypersensitive bands (starred) 
and protection of two regions of DNA (underlined) (Figure 5.4). We tested for direct CRP-
dependent activation using the construct carrying PaatS as a template for in vitro transcription. 
We expected the transcript generated from PaatS to be 169 nucleotides long. A band of this 
size was observed in the products of the in vitro transcription experiment. Production of this 
transcript was dependent on CRP (Figure 5.5A). Similar results were obtained in β-
galactosidase assays using M182, and the Δcrp derivative, transformed with pRW50 containing 


















Figure 5.4 DNAse I footprinting analysis of PaatS 
G + A is a Maxim/Gilbert G + A ladder, which shows the position of pyrimidine bases in the sequence. 
Numbering refers to distance from the transcription start site, as determined by primer extension. Each 
band represents a site at which DNA has been cleaved. Lane 1 shows the cleavage pattern of PaatS 
when exposed to DNAse I, in the absence of CRP. Lanes 2 to 5 show cleavage patterns of PaatS when 
exposed to increasing concentrations of CRP. Final CRP concentrations used in lanes 2-5 respectively 
are; 0.35 μM, 0.7 μM, 1.05 μM and 1.4 μM. All reactions contain 0.2 mM cAMP. Additionally, all 
reactions contained 12.5 μg/ml Herring Sperm DNA as a non-specific competitor. Zero point two units 
of DNAse I were used per reaction. Reactions were run on a 6 % (w/v) denaturing gel. Red stars 
highlight hypersensitive bands which form in the presence of CRP, red dashes highlight protection of 

























Figure 5.5 CRP activates transcription from PaatS in vivo and in vitro 
A) The panel shows in vitro transcription products of PaatS cloned upstream of a  λoop terminator 
in pSR. RNA polymerase was used at a concentration of 400 nM, CRP was used at a 
concentration of 219 nM if 438 nM. Reactions were run for 10 minutes at 37 oC before being 
stopped. Transcription products were run on a 6 % (w/v) denaturing gel. The 169 nt PaatS 
transcript and 108 nt RNAI control transcript are labelled. Corresponding relative intensities 
(PaatS/RNAI) are displayed below the panel. 
B) β-galactosidase activity of PaatS cloned into pRW50, in M182 wildtype and M182 Δcrp 
background. Cells were grown to mid-log phase (OD650=0.3-0.6). Standard deviation is less 
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5.3 PaatS lies upstream of a predicted 62 amino acid open reading frame 
As previously mentioned, we identified a small open reading frame downstream of PaatS, 
within the coding region of aatC. This small ORF, potentially encoding a 62 amino acid 
protein, is located 82 bp downstream of PaatS transcription start site, within the coding region 
of aatC. Interestingly, this open reading frame encodes a conserved domain of unknown 
function (DUF1602) found in 37 hypothetical genes in the NCBI database. Strikingly, of these 
37 genes, many were genetically associated with operons implicated in transport functions. 
Furthermore, the 37 genes frequently overlap adjacent genes. Remarkably, possible AatS 
homologues are found in multiple phylogenetic groups. In addition to finding homologues in 
Gram positive and Gram negative bacteria (including α, β, δ and γ proteobacteria), we also 
identified homologs in eukaryotes such as the fungal pathogens Sclerotinia sclerotiorum and 
Trichophyton rubrum. Figure 5.6A is an alignment of the predicted AatS sequences. Figure 
5.6B shows the genomic position of the hypothetical genes. The predicted aatS homologue 
frequently overlaps a gene encoding the ATP-subunit of a transporter. Note that aatS was not 
found in all sequenced ETEC isolates. For example, in strains E42377A and 1392/75, the start 
codon of aatS is absent (Figure 5.6C). In strain B7A, we found an open reading frame encoding 
a 90 amino acid protein 85.5 % similar to AatS from H10407 (Figure 5.6D). Note that, like 
aatS from H10407, aatS from B7A also lies completely within the aatC coding region (Figure 
5.6E). The high-affinity CRP site upstream of the aatS open reading frame (shown in orange 
















AatS        (ETEC H10407)                         -------------------------MIFFLLLLSKLAVGSSASSILGFFIKALASATRCFSP 37                                                                             
Adeh_1080 [Anaeromyxobacter dehalogenans 2CP-C]   -----MCVTTTAVIPIRTFRSASKAWIPSAVCGSRLPVGSSASSSFGWRHSARARATRCCSP 57 
BURPS1710b_2717 [Burkholderia pseudomallei 1710b] -----------------------------------MPVGSSASTQAGLVTSARAIATRWRSP 27 
RD1_1447  [Roseobacter denitrificans OCh 114]     ------------MVMPSSASSIMVSSTSLIISGSSAEVGSSNNMIRGFMQSERAMATRCCCP 50 
Spaf_0664 [Streptococcus parasanguinis FW213]     -------MIPNSSLILFN-----NSIIFCSLSASKLPVGSSAINISGLLIRALAKATLCFSP 50 
XNC1_2169 [Xenorhabdus nematophila ATCC 19061]    --------MTIVVPLLFNSLS--DDKILSPFTLSKLPVGSSANKIAGLDIIALAIATRYC-- 52 

































Synechococcus sp. PCC 7002 (NC_010475.1) 47% identity over a 49 AA region





















E24377A      AAAGACCTGAACTTTCAGAACATCATTTTATTGT-TCGCATTAGTA--ATATATAGATAT 
1392/75      AAAGACCTGAACTTTCAGAACATCATTTTATTGT-TCGCATTAGTA--ATATATAGATAT 
H10407       AGTTGCCGTAGTTATTC----GTGAGGGAAAAATCCAATCATACTTTTTGTATGGTCGCT 
B7A          GATCACCCAATCACTACCACCCTAGAAGGTGATTTAGGAATAACAATGTTATATTGTTCT 
                  **  *    *       *          *        *                * 
 
E24377A      CTAACCACTGAGAATTACCCATATTAAAACGATAAATTTAAAGCGTTATTACTTTCATAT 
1392/75      CTAACCACTGAGAATTACCCATATTAAAACGATAAATTTAAAGCGTTATTACTTTCATAT 
H10407       GGCGAAATAAAGTGATAAAAATCACATAAAATTTTTATTAAAAGGATATAACCTTCATAT 
B7A          GGCGGAATAAAGTGATAAATAATCTATAGAGAAATTATCAAAAGGAAATGACTCTCATCT 
                   *   **   **   *    * *         * ***  *  ** **  **** * 
 
E24377A      CTGTTGTGATTATATTTGTATCATGCGTTATCATAACAACTGTTCCACCGCGCTTATAAT 
1392/75      CTGTTGTGATTATATTTGTATCATGCGTTATCATAACAACTGTTCCACCGCGCTTATAAT 
H10407       CACTTGTAATTAAATTTGTGTCATGGGTTACCATAACAACTGTTCCACCTTGTTTATAAT 
B7A          CATTAGTAATTAAATTTGTGTCATGAGTAACCATAACAACAGTTCCGCCTTGTTTATAAT 
             *  * ** **** ****** ***** ** * ********* ***** **  * ******* 
 
E24377A      AATTAAGTATTACATTCATAACTTTCTCTTTATTATCATTATCCAAACTCGCTGTTGGTT 
1392/75      AATTAAGTATTACATTCATAACTTTCTCTTTATTATCATTATCCAAACTCGCTGTTGGTT 
H10407       ACTTAAGAAGTATATCCATGATTTTTTTTTTGTTATTATTATCTAAGCTTGCCGTTGGTT 
B7A          ACTCAAGAAGTATATCCATGATTTTTTCTTTGTTATTTTTATCTAAACTTGCTGTTGGTT 




















Anaeromyxobacter dehalogenans 2CP-C NC_007760.1 66% identity over a 32 AA region
AatS (H10407)    MIFFLLLLSKLAVGSSASSILGFFIKALASATRCFSPPDSKAADASGDMPCNPTFSSSFKTT---------------------------- 
AatS (B7A)       MIFSLLFLSKLAVGSSASNILGFFIKALASATRCFSPPDNRAADTSGDMPCNPTFSSAFKIILLHSFCFFNSIIDSKFLRIVCFSFISES 






Figure 5.6 Conservation (A) and genomic location (B) of AatS homologues found in 
other bacteria, and occurrence of aatS and PaatS-like sequences amongst ETEC strains 
(C-E) 
A. Alignment of predicted protein sequence of AatS with homologues proteins containing 
DUF1602 determined by NCBI BLAST. Only regions of homology are shown. Alignments 
were done using Clustal Omega. 
B. Genomic context of some aatS homologues. In each case, the species, NCBI genome accession 
number, and the degree of amino acid identity between the protein sequence and AatS is shown. 
Coloured arrows depict genes, arrows shaded orange represent aatS homologues. Protein 
functions are given above each arrow if known.  
C. Alignment of PaatS-like sequences in different ETEC strains. The figure shows an alignment 
of the 3’ ends of aatC (in the reverse, complemented orientation) from different ETEC isolates. 
The stop codon of aatC is highlighted blue, the predicted start codon of aatS is shown in a red 
box. CRP half-sites are shown in orange, mismatches from the consensus are underlined within 
these sites. The transcription start site of PaatS in H10407 is shown in red and is underlined. 
D. Alignment of predicted protein sequence of AatS from strain H10407 with that from ETEC 
strain B7A. Alignments were done using Clustal Omega. 
E. Genomic context of aatS from strain B7A. The degree of amino acid identity between the B7A 
protein sequence and AatS is shown. Coloured arrows depict genes, arrows shaded orange 



















5.3.1 The aatS leader contains translation initiation signals 
The 5’ end of the putative aatS mRNA contains the sequence 5’-UAAGAAGU-3’, (Figure 
5.7A) which bears similarity to the consensus Shine-Dalgarno sequence (consensus 
UAAGGAGGU) (Shine & Dalgarno, 1974), and is concordant with the sequence logo 
compiled by Shultzaberger et al. (2001) from 4122 translation initiation sites. In addition, the 
predicted aatS ribosome binding site is located 5 bp upstream of the aatS start codon, a position 
optimal for translation initiation (Chen et al., 1994).  
To investigate whether the Shine-Dalgarno sequence was functional, we created translational 
aatS::lacZ fusions and explored the effects of mutating the ribosome site on aatS expression. 
Fortuitously, the 134 bp PaatS DNA fragment used for characterisation of PaatS included the 
Shine-Dalgarno sequence, and start codon of aatS (Figure 5.7A). Additionally, we generated a 
derivative of this fragment where the entire Shine-Dalgarno sequence was inverted (Figure 
5.7B). We cloned both fragments into pRW225 (Islam et al., 2012), to translationally fuse aatS 
to lacZ. This vector contains a functional lac operon downstream of the multiple cloning site, 
but unlike pRW50, does not contain a Shine-Dalgarno sequence upstream of the lacZ gene. 
Hence, supplied Shine-Dalgarno sequences included on cloned fragments can be tested for 
functionality. Plasmid constructs were transformed into M182 and the Δcrp derivative, and 
LacZ activities were determined in the transformants (Figure 5.7C). We found LacZ activity 
was significantly reduced in lysates of cells transformed with pRW225 derivatives where the 













































Figure 5.7 Predicting expression of aatS using translational fusions 
A. Sequence of PaatS cloned into pRW225 containing the native Shine-Dalgarno sequence, shown 
in blue. CRP half-sites are shown in orange, the transcription start site. 
B. Sequence of PaatSΔSD cloned into pRW225, containing an inverted Shine-Dalgarno sequence, 
shown in blue. CRP half-sites are shown in orange, the transcription start site. 
C. β-galactosidase activity of PaatS cloned into pRW225, in M182 wildtype and M182 Δcrp 
background. Cells were grown to mid-log phase in M9 minimal media supplemented with 1 % 
(w/v) fructose (OD650= 0.3-0.6). Standard deviation is shown for three biological replicates. 
Activity shown is in Miller units. Note that in M182 wildtype cells, CRP was supplied in trans, 
by transforming cells with plasmid pDCRP, which contains the crp gene under the control of 



















5.3.2 Attempts to identify interactions of AatS with subunits of the Aat system  
Since aatS is preceded by a functional Shine-Dalgarno sequence, our attention turned to 
possible roles for AatS. First, we sought to determine if AatS might interact with subunits of 
the Aat system. To explore this possibility, we used the bacterial two-hybrid system 
(BACTH). We cloned each Aat subunit separately, in-frame, into pKT25, pUT18 and 
pUT18C. Figure 5.8 is a schematic showing the different fusion proteins produced from these 
plasmid contructs. Furthermore, we used Spoctopus software (Viklund et al., 2008) to look 
for any possible signal peptides. The N-terminal region of AatS was predicted to contain a 
signal peptide. Thus, we generated a shortened version of aatS, named ‘aatS short’, which 
was also used in the BACTH assays. We first looked for interactions between AatC and 
AatS, due to their genomic association with each other. However, we were unable to detect 
LacZ activity significantly above background, and thus no measureable interaction (Figure 
5.9A). Consequently, we expanded our study to explore interactions between AatC and other 
subunits in the Aat system. Again, no interaction signals were detected (Figure 5.9B).  
Furthermore, we could not detect interactions between any of the well-characterised Aat 








Figure 5.8 BACTH fusions constructed and used for investigating inter-subunit 
interactions of the Aat system 
Gene fusions were constructed in pKT25 (i), pUT18 (ii), or pUT18C (iii). In experiments, a pKT25 











































































Figure 5.9 BACTH assays measuring interactions between AatC and AatS (A), and 
AatC and other Aat system components (B) 
β-galactosidase activity measured in BACTH assays in BTH101 cells. Cells were grown to mid-log 
phase (OD650= 0.3-0.6). Standard deviation is shown for three biological replicates. Activity shown is 
in Miller units. Note that aatC was cloned into pKT25, and aatS, or other Aat subunits were cloned into 








































































Figure 5.10 BACTH assays measuring interactions between all Aat subunits 
β-galactosidase activity measured in BACTH assays in BTH101 cells. Cells were grown to mid-log phase (OD650= 0.3-0.6). Standard deviation is shown for 
three biological replicates. Activity shown is in Miller units. In each panel, a positive and negative control is included. (A-D) are assays were aatP, aatA, aatB, 





































































































































5.3.3 Attempts to determine the effect of AatS expression on CexE secretion  
Since BACTH assays were unsuccessful in yielding clues as to the function of AatS, we 
decided to investigate the effect of AatS expression on CexE secretion into culture 
supernatants. We reasoned that this approach would be valid since CexE is presumed to be the 
substrate of the Aat system in ETEC H10407 (Crossman et al., 2010). In our system plasmid 
pJ204::aatS (AmpR) encodes aatS under the control of the constitutive lacUV5 promoter. 
Plasmids pJRH1-4 contain the full aatPABCD operon and Shine-Dalgarno sequence. In 
plasmids pJRH3 and pJRH4, the start codon of the predicted aatS open reading frame has been 
removed. Plasmids pJRH2 & 4 also encodes CexE (the putative substrate for the Aat system). 
The composition and structure of each plasmid is shown in Figure 5.11A and 5.11B 
respectively. Note that, in all four constructs, expression of genes in the aatPABCD operon is 
driven by PlacUV5.  
Constructs were used to transform E. coli K-12 JCB387 cells and transformants were grown to 
stationary phase in M9 minimal media supplemented with 1 % (w/v) fructose. Cells were then 
harvested, and proteins in the culture supernatant precipitated using 10 % (w/v) trichloroacetic 
acid (TCA). Precipitated proteins were run on polyacrylamide gels. Additionally, to detect any 
CexE protein which had not been secreted, cell lysates were also run. Note that, although the 
lacUV5 promoter is subject to LacI binding and repression, the lacI locus of JCB387 has been 
replaced with an X174 phage, and therefore LacI is not expressed. The results of the experiment 
are shown in Figure 5.12A. We were unable to discern any difference between samples from 
different constructs. Our ChIP-seq analysis showed that the aat operon is bound by H-NS in 
vivo, and hence is likely to be repressed. Hence, we performed a final set of experiments using 
M182Δhns cells. For these experiments we were able to run purified CexE protein (generously 
donated by Dr. Tim Wells) alongside our samples. Unfortunately, we were unable to detect 





Plasmid pJRH1 pJRH2 pJRH3 pJRH4 
lacUV5 + + + + 
cexE - + - + 
aat operon + + + + 






Figure 5.11 Composition (A) and structure (B) of plasmids pJRH1-4 
The schematic in (A) shows the composition of each of pJRH derivative. Note that all plasmids contain 
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Figure 5.12 TCA precipitation of CexE from culture supernatants and cell extracts 
The gels show TCA precipitated protein and cell extract samples extracted from JCB387 cells grown 
in M9 minimal media supplemented with 1 % (w/v) fructose to stationary phase. All gels are calibrated 
with PageRuler Plus prestained protein ladder (Thermo Scientific) (“M”).  
A. TCA precipitations and cell extracts from JCB387 cells transformed with a pJRH derivative, 
genes present in the construct are indicated above in each case. 
B. TCA precipitations from JCB387 cells transformed with a pJRH1-4, or transformed with a 
pJRH derivative and pJ204::aatS as indicated above the gel. Additionally, control TCA 
precipitations are shown to the right of the marker. These include control precipitations from 
supernatants of JCB387 cells not containing any plasmids, cells containing pJ204::cbpAB, or 
pJ204::aatS, without any pJRH derivative.     
C. TCA precipitations and cell extracts from M182Δhns cells transformed with pJRH1-4. Ten μl 
































We have identified a gene (aatS) within the coding sequence of aatC. Expression of aatS is 
activated by CRP via a class II mechanism. Our efforts to elucidate a role for AatS have, as 
yet, not provided insight into AatS function. In any case, the CRP-dependent regulation of 
PaatS/aatS appears to be specific to H10407. Thus, although strain B7A also contains an AatS 
homologue, there is no CRP site upstream of aatS. We speculate that ETEC H10407 represents 
a snap-shot of evolution in the aat gene cluster. Thus different combinations of PaatS, the 
associated CRP site, and aatS are found in different ETEC isolates.  
Regardless of AatS functionality, the transcription from the PaatS promoter, which drives 
RNAP into the 3’ end of the aatC gene, is likely to interfere with transcription of the aatPABC 
operon. Elongating RNAP transcribing the aatPABC operon could collide with RNAP from 
PaatS, with transcriptional termination driven by the build up of supercoiling between the two 
RNAP enzymes. This transcriptional interference phenomenon is well documented in the 
ubiGmccBA operon of Clostridium acetobutylicum (André et al., 2008). The products 
ubiGmccBA operon convert methionine to cysteine. In the presence of cysteine, an S-box-
dependent promoter (which senses S-adenosyl-methionine, a co-enzyme in sulphur 
metabolism) is activated, and drives transcription into the 3’ end of the ubiGmccBA operon, 
reducing the abundance of full length ubiGmccBA mRNA trancripts. 
Currently, it is difficult to speculate on a role for AatS, since the domain of unknown function 
(DUF1602) has not been studied in detail. Small proteins can be encoded on anti-sense RNAs. 
An example of this is SgrT, which is encoded by the small 227 nucleotide non-coding RNA 
SgrS, from Salmonella typhimurium (Wadler and Vanderpool, 2007). The 3’ region of SgrS 
binds to the translation initiation region of the ptsG mRNA and silences translation. The 5’ 
region of SgrS encodes a 43 amino acid protein called SgrT, which inhibits existing EIIBCGlc, 
through an unknown mechanism. SgrT expression does not affect ptsG mRNA expression or 
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EIIBCGlc protein abundance, so it has been suggested that SgrT acts as a ‘plug’ to block glucose 
import. Hence, the combined action of SgrS and SgrT is thought to reduce the toxic effects of 
glucose-6-phosphate accumulation in the cell when glycolysis is blocked.  
In the case of the aatPABC operon, it is possible that the anti-sense PaatS promoter and the 
AatS protein have redundant effects on the expression of the Aat system in ETEC H10407. The 
fact that the PaatS CRP site is not present in all strains might suggest that control of the PaatS 
promoter is in the process of being recruited to (or lost from) the CRP regulon in ETEC. The 
substrate of the Aat system, CexE, is thought to promote dispersal of ETEC cells through the 
mucus layer surrounding the gut lumen. Given that E. coli strains utilise mucus, and not luminal 
contents, as a nutrient source, it is possible that penetration of ETEC cells into the mucus lining 
will modulate PaatS activity through metabolic cues sensed by CRP (Le Bouguénec and 
Schouler, 2011). Downregulation of the Aat system (through PaatS transcriptional interference 
or AatS expression) may be beneficial to ETEC pathogenesis. Perhaps preventing CexE 




































The aim of this study was to define the regulons of CRP, H-NS and σ70 in Enterotoxigenic 
Escherichia coli strain H10407. Here, we show that all three factors are central to virulence 
regulation. Thus both estA2 and estA1 are directly regulated by CRP. We show that repression 
of eltAB by CRP occurs through an indirect mechanism. Intriguingly, all three toxin genes are 
occupied by H-NS not CRP in vivo, which suggests that H-NS may occlude CRP from its 
binding sites. This was also the case for other characterised binding sites that bound CRP with 
high-affinity in vitro. 
Our observations have implications for the treatment of ETEC-mediated disease. Briefly, the 
treatment for ETEC-mediated diarrhoea is oral rehydration with a 1 % (w/v) solution of glucose 
and 60 mM NaCl (Nalin et al., 1968). Ingestion of these solutions results in rehydration of the 
patient (Guerrant et al., 2003). Importantly, CRP is a sensor of glucose concentration and H-NS 
is a sensor of osmotic flux. Hence, it is likely that toxin production can be influenced by sugar 
and salt concentrations in solutions used to rehydrate patients. This is an area which will require 
further direct study.  
We speculate that cAMP extrusion from epithelial cells mediated by LT is likely to activate 
CRP, and stimulate ST production. Future experiments might involve exchanging the 
regulatory regions of the estA2 gene and eltAB operon, and studying an effects on 
pathogenicity. ETEC strain H10407 is unusual in expressing LT, STp, STh and many of the 
additional minor virulence factors; including EtpA, CexE, Tia, TibA, LeoA and EatA. The 
presence of these additional virulence factors is thought to contribute to the unique severity of 
the strain (Crossman et al., 2010, Porter et al., 2011, Turner et al., 2006). It is interesting to 
speculate that the differential regulation of the expression of the two estA genes might enable 
ETEC H10407 to produce ST irregardless of intracellular cAMP levels. Our study highlights 
the fact that TFs that apparently bind at activatory positions at promoters (for example, PestA1) 
may not behave in the expected way, and are sensitive to subtle changes in promoter 
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architecture. Hence, TF binding sites identified in genome-wide screens must be directly 
studied in detail, before inferences can be drawn about their possible function.  
Finally, a central paradigm of gene regulation is that TF binding sites, and promoters, are 
located at the 5’ end of genes. The use of genome-wide approaches often leads to identification 
of anomalies that do not fit these expectations. It is often unclear what function these anomalies 
might have. For example, our bioinformatic screen identified a high-affinity CRP-binding site, 
located at the 3’ end of the aatPABC operon, which controlled the activity of a nearby promoter. 
However, the CRP site, promoter, and downstream gene were only partially conserved in other 
ETEC genomes. Given that any genome can only be considered as being at a “mid-point” in 
evolution it is perhaps not surprising that such anomalies are common place. ETEC H10407 is 
the only strain in which we were able to identify both an aatS open reading frame, in 
combination with a CRP binding site which resembled the consensus. It is possible that the 
presence of these elements may contribute to strain H10407 disease severity in some way.  
Future work in this area will focus on the interplay between CRP and H-NS in the regulation 
of ETEC toxin genes, and the response of the promoter regions controlling them to different 
sugar and salt concentrations. Since CRP represses eltAB expression indirectly, further studies 
should be directed at finding the mechanism of regulation. For example, in Vibrio cholerae, 
CRP negatively regulates the ctxAB operon, which encodes Cholera toxin. This regulation 
occurs through three sets of regulators; TcpP and TcpH (membrane-bound), ToxR and ToxS 
(membrane-bound), and ToxT, which directly activates PctxAB (Kovacikova and Skorupski, 
2001). Beyond these experiments, changes in the ETEC transcriptome will be need to be 
measured in vivo using a suitable model organism.   
Finally, the environmental conditions found in the mucus lining of the intestine are not well 
studied. Hence, it is difficult to predict the transcriptional responses of bacteria to this 
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Enterotoxigenic Escherichia coli (ETEC) cause severe diarrhoea in humans and neonatal farm animals. Annually, 380,000
human deaths, and multi-million dollar losses in the farming industry, can be attributed to ETEC infections. Illness results
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Introduction
ETEC are Gram negative bacteria that cause severe diarrhoea,
known as non-vibrio cholera, in humans [1,2]. First isolated in
1971, ETEC are responsible for 210 million infections annually,
mostly in developing countries, leading to 380,000 deaths [3].
Disease results primarily from the action of two enterotoxins. The
heat-labile toxin (LT) is similar in structure and function to cholera
toxin [4,5]. The heat-stable toxin (ST) mimics the human
hormone guanylin [6]. Both toxins are secreted by ETEC during
infection. Made up of two subunits, encoded by the eltAB operon,
LT has the configuration AB5 [5,7]. In the gut, LT binds to host
cell GM1 gangliosides and is endocytosed [8,9]. This triggers
constitutive cAMP production in the affected cell [8]. The ST
toxin, encoded by the estA gene, also interferes with cell signalling
[6]. Hence, ST binds to the guanylate cyclase C receptor and
stimulates overproduction of cGMP. The combined actions of LT
and ST cause loss of H2O, and electrolytes, from epithelial cells
into the gut lumen [4]. Oral Rehydration Therapy (ORT) is used
to redress the resulting electrolyte imbalance and rehydrate the
patient [10]. In its most simple form, ORT requires only an
aqueous solution of glucose and salt. Hence, the availability of
metabolites and cations are a central theme of ETEC mediated
disease. The effect of ORT on human physiology is well
understood: glucose and Na2
+ are transported across the epithelial
membrane, along with water, to promote rehydration [11].
Surprisingly, despite the existence of molecular mechanisms that
allow bacteria to respond to these signals, the consequences for
ETEC are unknown.
In E. coli, the transcriptional response to glucose is controlled by
cAMP receptor protein (CRP) [12]. In the absence of glucose,
intracellular cAMP levels increase and CRP binds DNA targets
with the consensus sequence 59-TGTGA-n6-TCACA-39 [13].
Subsequently, gene expression is reprogrammed to make use of
alternative carbon sources [14]. Note that the gene regulatory
network managed by CRP includes many indirect pathways
[14,15]. Hence, CRP is also a pleiotropic regulator of transcrip-
tion. Whilst indirect regulatory effects are difficult to characterise,
genes that are directly controlled by CRP can be divided into
distinct classes [12]. At Class II targets, CRP binds to a site
overlapping the promoter -35 element and interacts directly with
both the N-terminal and C-terminal domains of the RNA
polymerase a subunit (aNTD and aCTD). At Class I targets,
CRP binds further upstream and interacts only with aCTD. This
interaction can be further stabilised by UP-elements, AT-rich
DNA sequences, adjacent to the CRP site, that facilitate aCTD-
DNA interactions [12]. At both classes of promoter, the various
contacts enhance gene expression by stabilising the transcription
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initiation complex. Unsurprisingly, most genes regulated by CRP
encode proteins involved in metabolism. However, in some
bacteria, CRP has been co-opted as a virulence regulator [16].
The Histone-like Nucleoid Structuring (H-NS) factor is a
component of bacterial nucleoprotein. Consequently, H-NS also
influences gene expression on a global scale [17]. Briefly, H-NS
targets sections of the genome with a low GC content [17].
Depending on H-NS conformation, the resulting nucleoprotein
complexes can be filamentous or bridged in organisation [18].
Filamentous complexes favour gene regulation by excluding RNA
polymerase, and transcriptional regulators, from their targets
[19,20]. Bridged complexes favour RNA polymerase trapping
[21]. In all scenarios, it is thought that H-NS acts primarily to
silence transcription [22]. The conformation of H-NS, and hence
the way in which it modulates DNA topology, can be controlled by
divalent cations. Consequently, H-NS mediated repression can be
relieved by increased osmolarity [23]. Like CRP, H-NS has been
incorporated into the virulence gene regulatory networks of many
bacteria [17].
In this work we define the molecular trigger that controls toxin
expression in ETEC. We show that CRP and H-NS are key
regulatory factors. Strikingly, this allows ETEC to integrate
extracellular signals of osmolarity and metabolism to control toxin
production. Hence, we propose that ETEC toxicity responds
directly to osmo-metabolic flux. Interestingly, the precise regula-
tory settings are different for each toxin encoding gene. The
differences result from i) varying promoter configurations and ii)
competition between CRP and H-NS for overlapping DNA
targets. This is significant since fluctuations in osmolarity, and
changes in the availability of metabolites, are central to ETEC
infection and its treatment.
Results
Binding of CRP and H-NS across the ETEC H10407
genome
The prototypical ETEC strain H10407 reproducibly elicits
diarrhoea in human volunteers and has a well-defined genome
that shares 3,766 genes with E. coli K-12 [1]. Pathogenicity arises
from 599 ancillary genes encoded by 25 discrete chromosomal loci
and 4 plasmids. The plasmids, named p948, p666, p58 and p52,
encode the enterotoxins. Derivatives of the estA gene are found on
plasmids p666 (estA1) and p948 (estA2). A single copy of the eltAB
operon is encoded by plasmid p666. We used Chromatin
Immunoprecipitation (ChIP) coupled with next-generation DNA
sequencing (ChIP-seq) to map CRP and H-NS targets across the
ETEC H10407 genome. The binding profiles are shown in
Fig. 1A. In each plot genes are illustrated by blue lines (tracks 1
and 2), DNA G/C content by a cyan and pink graph (track 3), H-
NS binding is in green (track 4) and CRP binding is shown in
orange (track 5). As expected, H-NS binding is inversely correlated
with DNA G/C content (compare tracks 3 and 4). Similarly, CRP
binding occurs in expected locations; 96% of the CRP binding
sites are associated with the DNA logo shown in Fig. 1B (i.e. the
known CRP consensus sequence (13–15)). We identified a total of
111 high-confidence CRP targets (Table 1). Of these targets 93%
were present in the genome sequences of both ETEC H10407 and
E. coli K-12. The most common location for CRP sites was in
intergenic regions (66% of targets) whilst a smaller number of
targets were found within genes (34%). Consistent with expecta-
tions, CRP sites were most frequently located ,40.5 bp, or
,92.5 bp, upstream of experimentally determined transcription
start sites (TSSs). Surprisingly, CRP binding was restricted to the
ETEC chromosome (Fig. 1Ai). Conversely, H-NS bound to
chromosomal and plasmid loci (Fig. 1Ai), including all toxin
encoding genes (Fig. 1Aii).
Unoccupied high-affinity CRP binding targets on p948
and p666 are bound by H-NS
To better understand the lack of CRP binding to p948 and
p666 we took a bioinformatic approach. CRP targets were aligned
to generate a position weight matrix (PWM). The PWM was then
used to search p948 and p666 for CRP sites. A continuum of over
100 potential CRP targets was identified. However, we recognise
that the vast majority of these are likely to be false positives.
Hence, we next sought to differentiate between genuine CRP sites
and spurious predictions. To do this, predicted sites were scored,
grouped, and ranked on the basis of their match to the PWM
(Fig. 2A, S1 Table). Electrophoretic mobility shift assays (EMSA)
were then used to measure binding of CRP to a target from each
group so that a meaningful cut-off could be established. The result
is illustrated graphically in Fig. 2B. The raw data are shown in
S1A Fig. We found that predicted sites with a score,10 did not
bind CRP. To assess the affinity of CRP for all predicted targets
scoring .10 a second set of EMSA experiments was done (S1B
Fig.). Hence, we identified a total of 5 potential CRP targets on
p666 and p948. Interestingly, the estA1 and estA2 genes, which
both encode ST, were amongst the 5 targets (Fig. 2C). Remark-
ably, all 5 of the plasmid borne CRP targets identified in silico,
and bound tightly by CRP in vitro, were occupied by H-NS in
vivo (Fig. 2C).
The estA2 gene is transcribed from a Class I CRP
dependent promoter
To understand if CRP could regulate ST production we focused
first on estA2. This derivative of the toxin is more commonly
associated with human disease and ETEC H10407 is somewhat
unusual in also encoding estA1 [24]. The sequence of the estA2
regulatory region is shown in Fig. 3A. A 93 bp DNA fragment,
containing the regulatory region, was cloned into the lacZ reporter
plasmid pRW50 to generate a lacZ fusion (S2A Fig.). The estA2
TSS was then determined using mRNA primer extension analysis.
We detected a single extension product, of 109 nucleotides (nt) in
length (Fig. 3B). The position of the TSS is labelled ‘‘+1’’ in
Fig. 3A. Promoter -10 (59-TTAAAT-39) and -35 (59-TTGCGC-
39) elements were observed at the expected positions upstream of
the TSS. Throughout this work we refer to this promoter,
highlighted purple in Fig. 3A, as PestA2. To confirm CRP binding
Author Summary
Diarrheagenic illness remains a major disease burden in
the developing world. Enterotoxigenic Escherichia coli
(ETEC) are the leading bacterial cause of such disease;
hundreds of millions of cases occur every year. The severe
watery diarrhoea associated with ETEC infections results
from the action of enterotoxins. The toxins target human
gut epithelial cells and trigger the loss of water and
electrolytes into the gut lumen. Oral rehydration therapy
can counteract this process. Hence, glucose and salt
solutions promote rehydration of the patient. In this work
we show that the gene regulatory mechanisms controlling
toxin expression respond directly to sugar and salt.
Furthermore, we describe a molecular mechanism to
explain these effects. Hence, we provide a starting point
for the optimisation of oral rehydration solutions to reduce
toxin expression over the course of an ETEC infection.
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at the predicted site we used DNase I footprinting (Fig. 3C). As
expected, CRP protected the predicted target from digestion.
Additionally, CRP induced DNase I hypersensitivity in the centre
of the site. Note that the CRP site is centred 59.5 bp upstream of
the TSS and adjacent to an AT-rich sequence that may be an UP
element (Fig. 3A). Thus, we hypothesised that PestA2 is a class I
CRP activated promoter. To test our hypothesis we first
determined whether CRP could indeed activate PestA2. To
do this, we compared LacZ expression in M182Dlac and
M182DlacDcrp cells carrying the PestA2::lacZ fusion. The data
show that loss of CRP results in a 3-fold decrease in LacZ
expression from PestA2 (Fig. 3D). We next tested the ability of
CRP to activate PestA2 in vitro. The 93 bp DNA fragment was
cloned upstream of the loop terminator in plasmid pSR. In the
context of this construct a 112 nt transcript is generated by RNA
polymerase from PestA2 in vitro. The amount of transcript can
then be quantified by electrophoresis. The result of the analysis,
with and without CRP, is shown in Fig. 3E. As expected, an
intense band corresponding to the 112 nt transcript was observed.
Production of the transcript was stimulated by CRP. Note that
CRP had no effect on production of the 108 nt control RNAI
transcript from the plasmid replication origin. Finally, we
examined the AT-rich DNA sequence (highlighted blue in
Fig. 3A) located between the CRP site and the promoter -35
element. We found that increasing the GC content of the putative
UP-element altered migration of the 93 bp DNA fragment on an
agarose gel, consistent with a change in DNA topology (S3A Fig.).
Moreover, these changes to the UP-element rendered PestA2
insensitive to CRP in vivo and in vitro (S3B Fig.).
H-NS excludes CRP from the estA2 promoter and
represses estA2 transcription
Promoters can be liberated from H-NS repression if separated
from flanking, H-NS bound, DNA [25]. We reasoned that this
Fig. 1. Distribution of CRP and H-NS across the ETEC H10407 genome. A) The panel shows maps of the ETEC H10407 chromosome (i) and
associated plasmids (ii). In each plot, tracks 1 and 2 (blue lines) show the position of genes, track 3 (purple and cyan graph) is a plot of DNA GC
content, track 4 (green) is the H-NS binding profile and track 5 (orange) is the CRP binding profile. B) A DNA sequence motif generated by aligning
regions of the ETEC H10407 chromosome bound by CRP.
doi:10.1371/journal.ppat.1004605.g001
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Table 1. High-confidence CRP binding sites on the ETEC H10407 chromosome identified by ChIP-seq.
Peak Centrea Binding Site(s)b Gene(s)c K-12 Homologuesd
45284 TGTGATTGGTATCACA ETEC_0040 caiT
92014 AGTGATGGATGTCACG (ETEC_0078) (cra)
176905 AGCGTTCCACGTCACA (ETEC_0150) (hemL)
408885 TGTGATCTCTCTCGCA ETEC_0385/ETEC_0386 yahN/yahO
461874 TGTGCGCAAGATCACA ETEC_0434 ddlA
463095 TTTGCGCGAGGTCACA (ETEC_0436) (phoA)
468009 AGGGATCTGCGTCACA ETEC_0443 aroM
492973 ATCGATTGCGTTCACG ETEC_0464 tsx
540805 TGTGATCTTTATCACA ETEC_0511 maa
574230 GATGACGACGATCACA (ETEC_0538) (ybaT)
683187 AGTGATCGAGTTAACA ETEC_0628 cstA
697540 AGTGATTTGCGTCACA ETEC_0639 rnk
739223 CGTTACCCTTGTCGCA ETEC_0680 rihA
941002 TGTGATGAGTATCACG ETEC_0869 ybiJ
958866 TGTGTACGAAATCACA ETEC_0886/ETEC_0887 ybiS/ybiT
1128472 n.d. (ETEC_1030) (yccS)
1205350 AGTGATGTAGATCACA ETEC_1101 ycgZ
TGAGATCGAGCACACA
1263558 TTTGACGGCTATCACG ETEC_1166 ptsG
1274886 TGTGATCTGGATCACA ETEC_1176/ETEC_1177 ycfQ/bhsA
1301786 GATGATCCGCATCACA (ETEC_1206)/ETEC_1207 ETEC-specific/ETEC-specific
1348166 ATTGAACAGGATCACA (ETEC_1259)/ETEC_1260 (rluE)/icd
1376374 GGTGAGCTGGCTCACA ETEC_1292/ETEC_1293 ycgB/dadA
1388620 AGTGAGCCAGTTAACA (ETEC_1303) (dhal)
1541732 CGTGAACCGGGTCACA ETEC_1443/ETEC_1444 ycjZ/mppA
1567885 GTTAAGTAAAATCACA ETEC_1462/ETEC_1463 paaZ/paaA
1701402 TGTGATGGATGTCACT ETEC_1568 ydeN
1767726 TGTGATTAACAGCACA ETEC_1628 mlc
1777143 TGTGATCTAGCGCCAA ETEC_1637 pntA
1811426 CGTGATCAAGATCACG (ETEC_1668A) (ETEC specific)
1859265 ATTGAGCGGGATCACA (ETEC_1713) (sufS)
1887513 AGTGATGCGCATCACG ETEC_1737 aroH
TGCGAGGTGTGTCACA
2126754 TGTGGCGTGCATCACA n.a. n.a.
2201816 GGTGACGCGCGTCACA ETEC_2057 yedP
2210222 CGTGATCTCGCGCACA ETEC_2065/ETEC_2066 yedR/ETEC-specific
2458348 TGTGATCTGAATCTCA ETEC_2278 cdd
TGCGATGCGTCGCGCA
2492757 ATTGATCGCCCTCACA ETEC_2309 yeiQ
2555083 CGTGACCAAAGTCTCA (ETEC_2360) (yfaQ)
2729713 TTTGAAGCTTGTCACA ETEC_2510/ETEC_2511 mntH/nupC
2735124 AGTTATTCATGTCACG ETEC_2514 yfeC
2795423 TGTGAGCCATGACACA (ETEC_2572)/ETEC_2573 (aegA)/narQ
2810983 CGTGATCAAGATCACA ETEC_2586 hyfA
2887131 TTTGATCTCGCTCACA (ETEC_2666)/ETEC_2665 (xseA)/guaB
3012645 TGTGATCCCCACAACA (ETEC_2793) (ung)
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Table 1. Cont.
Peak Centrea Binding Site(s)b Gene(s)c K-12 Homologuesd
3048307 TTTGACGAGCATCACC (ETEC_2822) (emrB)
3132920 GGTGACCGGTTTCACA ETEC_2905/ETEC_2906 ascG/ascF
3161660 TGTGACCGTGGTCGCA (ETEC_2933) (nlpD)
3184337 CGTGATGCGTGTAACA (ETEC_2956)/ETEC_2955 (cysI)/cysH
3196088 TGTGATTACGATCACA ETEC_2966/ETEC_2967 ygcW/yqcE
3223792 AGTGATCTTGATCTCA ETEC_2986 sdaC
AGTTATGTATCTATCA
3234980 TGCGATCGTTATCACA (ETEC_2994)/ETEC_2995 (fucU)/fucR
3265047 TGTGACCTGGGTCACG ETEC_3017 rppH
3324543 TGTGGGCTACGTAACA (ETEC_3075) (ydhD)
3361162 n.d. ETEC_3105 serA
3368992 TTTGATGCACCGCACA (ETEC_3113) (ygfI)
3382158 TGTGATCTACAACACG ETEC_3126 cmtB
3390811 TGTGATTTGCTTCACA ETEC_3133 galP
3408173 TGTGATGTGGATAACA ETEC_3154 nupG
3442697 TGTGATGATTGTCGCA ETEC_3186 ETEC-specific
3558573 AGTGATTTGGCTCACA ETEC_3291 ygiS
3580767 AGTGACTTGCATCACA (ETEC_3318) (yqiH)
3635301 ATTGATCTAACTCACG ETEC_3362 uxaC
3642302 CTTGAAGTGGGTCACA (ETEC_3372) (yqjG)
3665634 TGTGATCAATGTCAAT ETEC_3393/ETEC_3394 garP/garD
TGTGCTTTAGCGCGCA
3721308 GGTGATTGATGTCACC (ETEC_3446) (greA)
3785700 CGTGGGTCGCATCACA (ETEC_3510) (mreC)
3878729 GGTGATTTTGATCACG ETEC_3614/ETEC_3615 ppiA/tsgA
3908574 GGTGATCGCGCTCACA (ETEC_3645) (hofM)
3918861 TGTGAGTGGAATCGCA ETEC_3652/ETEC_3653 yhgE/pck
3986400 CGTGATTTTATCCACA ETEC_3707 rpoH
4105040 AGTAAGGCAAGTCCCT n.a. n.a.
4111116 TGTGACGGGGCTAACA (ETEC_3806) (wecH)
4153055 TGTGATCTGAATCACA ETEC_3840 yibI
TGTGATCTACAGCATG
4153191 TGTGATTGATATCACA ETEC_3841 mtlA
TGTGATGAACGTCACG
4158433 n.d. ETEC_3846 lldP
4196869 TGCAATCGATATCACA ETEC_3886 dinD
4251326 CTTACTCCTGCTCACA ETEC_3938 ETEC specific
4266125 GGTGATGGCATCCGCG (ETEC_3956) (nepI)
4290730 GGTGAGCAAAACCACG (ETEC_3979) (yidR)
4322430 ATTGACCTGAGTCACA (ETEC_4010) (yieL)
4340544 CTTGACCACGGTCAGA (ETEC_4025)/ETEC_4024 (atpA)/atpG
4344649 TGTGATCTGAAGCACG ETEC_4030 atpI
4373517 TGTAATGCTGGTAACA (ETEC_4051) (ilvG)
4402013 CGTGCTGCATATCACG (ETEC_4077) (rffM)
4412999 CGTGATCAATTTAACA ETEC_4085/ETEC_4085 hemC/cyaA
4438352 GGTGATGAGTATCACG ETEC_4107/ETEC_4108 ysgA/udp
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might be why, when isolated on the 93 bp fragment, PestA2 was
active and dependent on CRP. To test this logic we generated a
further two PestA2::lacZ fusions using the pRW50 plasmid system.
The additional PestA2 DNA fragments were both 460 bp in length
and include the full estA2 gene that was entirely bound by H-NS
in our ChIP-seq assay (Fig. 2C). The CRP site was ablated in one
of the additional fragments by introducing point mutations that
are predicted to disrupt CRP binding. The sequence of the DNA
fragments is shown in S2A Fig. The lacZ fusions are illustrated
graphically in Fig. 4A. Our expectation was that the longer
460 bp fragment would bind H-NS whilst the starting 93 bp
fragment would not. To test this prediction we used ChIP. Thus,
we compared H-NS binding to the different PestA2 containing
fragments in vivo. Fig. 4B shows results of a PCR analysis to
measure enrichment of the PestA2 locus. As expected, PestA2 was
only enriched in anti-H-NS immunoprecipitates when in the
context of the 460 bp fragment. Crucially, enrichment is specific
because, in a set of control PCR reactions, there was no
enrichment of the yabN locus in any immunoprecipitate.
Our ChIP analysis suggests that the 460 bp fragment containing
PestA2 is subject to regulation by H-NS. To confirm that this was
the case, the various pRW50 derivatives were used to transform
M182Dlac and M182DlacDhns cells. We then measured LacZ
activity, driven by PestA2, in the transformants. Consistent with
our expectations the data show that PestA2 is repressed 5-fold by
H-NS only in the context of the 460 bp DNA fragment (Fig. 4C).
Importantly, mutations in the CRP binding site abolish PestA2
activity in the absence of H-NS. Hence, the measured LacZ
expression must be driven by PestA2 rather than any spurious
promoters located within the estA2 gene. Taken together our
ChIP-seq and LacZ activity data show that H-NS prevents CRP
from activating PestA2.
The estA2 and estA1 promoters are differently regulated
by CRP but similarly regulated by H-NS
The estA1 regulatory region, located on plasmid p666, contains
a sequence similar to PestA2 (Fig. 5A). We expected that this
sequence would be the estA1 promoter (PestA1). To test this
expectation we created a 92 bp PestA1::lacZ fusion, equivalent to
the 93 bp PestA2::lacZ fusion described above, and mapped the 59
end of the resulting mRNA. As expected, the primer extension
product was 109 nt in length (Fig. 5B). Hence, PestA1 and PestA2
use equivalent TSSs. However, we were surprised that the
intensity of the PestA1 primer extension product increased in cells
lacking CRP (Fig. 5B). Closer examination of the alignment in
Fig. 5A shows that, whilst PestA1 and PestA2 are similar, there are
differences in the sequence and position of key promoter elements.
To try and understand which changes result in the aberrant
behaviour of PestA1 we made a set of hybrid promoters. The
hybrid constructs are derived from the CRP-activated estA2
promoter. In each hybrid, named PestA2.1 through PestA2.7, a
region of PestA2 was replaced with the equivalent region from
Table 1. Cont.
Peak Centrea Binding Site(s)b Gene(s)c K-12 Homologuesd
TGTGATTTGAATCACT
4508745 TGTGATATTTGTCACA (ETEC_4165)/ETEC_4164 (fdhD)/fdoG
4517442 CGTGATCGCTGTCCCA (ETEC_4173) (rhaA)
4564670 TGCGATCCGCCTCATA ETEC_4216/ETEC_4217 ptsA/frwC
4668870 TGTAACAGAGATCACA ETEC_4289/ETEC_4290 malE/malK
4725047 TGTGCGGATGATCACA n.a. n.a.
4731402 TGTGATCTTGCGCATA (ETEC_4365) (aphA)
4761367 CGTGATGGCTGTCACG ETEC_4389 fdhF
4846352 n.d. ETEC_4464 ETEC-specific
4848117 CGTGAGTTCTGTCACA n.a. n.a.
4863253 TTTGATCAACATCGCA (ETEC_4478) (ETEC-specific)
4873926 GGTGATCTATTTCACA ETEC_4486/ETEC_4487 aspA/fxsA
4930149 TGTGATGAACTTCAAA ETEC_4545/ETEC_4546 yjfY/rpsF
4940903 TGTGATCACTATCGCA ETEC_4557/ETEC_4558 ETEC-specific/ytfA
4993073 TGTGACTGGTATCTCG (ETEC_4604) (valS)
5002854 TGTAACCTTTGTCACA ETEC_4610/tRNA-Leu yjgB/tRNA-Leu
5030724 TGCGATGAATGTCACA ETEC_4633/ETEC_4634 gntP/uxuA
5129400 CGTACCGTCGGTCACA (ETEC_4736) (yjjI)
5129944 TGTGATGTATATCGAA ETEC_4736/ETEC_4737 yjjI/deoC
aChomosome coordinate of the ChIP-seq peak in H10407. Underlined text indicates that the ChIP-seq peak maps to sequence that is not conserved in E. coli K-12.
bCRP binding site sequence predicted by MEME. ‘‘n.d.’’ indicates that MEME did not detect a putative binding site.
cGenes in parentheses indicate that the ChIP-seq peak is located within that gene. Downstream genes are only listed if the annotated gene start is #300 bp
downstream of the CRP ChIP-seq peak. ‘‘n.a.’’ indicates that no genes starts are #300 bp from the CRP ChIP-seq peak.
dE. coli K-12 homologues are listed for the ETEC genes in the previous column. Genes in parentheses indicate that the ChIP-seq peak is located within that gene. ‘‘n.a.’’
indicates that no genes starts are #300 bp from the CRP ChIP-seq peak. ‘‘ETEC-specific’’ indicates that there is no K-12 homologue. Underlined genes have been
identified as CRP targets in a previous ChIP-chip study [15]. Bold genes are listed as CRP targets in the Ecocyc database.
doi:10.1371/journal.ppat.1004605.t001
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PestA1 (see underlined sequences in Fig. 5C). The ability of the
different hybrid promoters to drive lacZ expression, with and
without CRP, was then tested. The results are shown in Fig. 5D.
Note that, in Fig. 5D, the composition of each hybrid promoter is
indicated in the grid below the graph. For example, PestA2.1 is
derived from PestA2 but contains the PestA1 CRP site. As
expected, both PestA1 and PestA2 were able to drive lacZ
expression but CRP had opposite effects. Moreover, maximal
expression from PestA1 was 3-fold lower than from PestA2. Only
PestA2.3 and PestA2.5, which both carried the same changes in
the promoter -35 element, exhibited a reversed dependence on
CRP. Hence, the PestA1 -35 element must be responsible for the
altered CRP dependence. All other hybrid promoters exhibited an
overall reduction in activity compared to the parent PestA2
construct. We conclude that this combination of changes results in
the lower activity of PestA1. Note that both PestA1 and PestA2
were bound by H-NS in our ChIP-seq analysis (Fig. 2C). We
reasoned that cloning PestA1, with flanking DNA, would reveal H-
NS mediated repression. We generated a derivative of the
PestA1::lacZ fusion where the downstream boundary was extend-
ed to include the entire estA1 gene (S2B Fig., Fig. 5Ei). As
expected, transcription from PestA1 was repressed by H-NS in the
presence of downstream DNA (Fig. 5Eii).
The eltAB operon is indirectly repressed by CRP and
directly repressed by H-NS
We next turned our attention to the LT toxin promoter (PeltAB)
[26,27]. Previously, Bodero and Munson [27] showed that
transcription from this promoter was repressed by CRP. A
mechanism for repression was proposed whereby CRP acted
directly by binding three DNA targets overlapping PeltAB [27].
Even so, no CRP binding at PeltAB was identified by our ChIP-
seq analysis (Fig. 6A). It is possible that this is because H-NS also
excludes CRP from this locus (Fig. 6A). However, we also failed to
identify CRP targets at PeltAB in our bioinformatic screen, even
below the stringent cut-off (Fig. 2, S1 Table). In retrospect, this
appears to be because all of three PeltAB CRP binding sites
contain at least 4 mismatches to the consensus for CRP binding
(Fig. 6A). Hence, we measured the affinity of CRP for PeltAB
using EMSA assays. In parallel, we tested CRP binding to PestA2
as a control. As expected, CRP bound tightly to PestA2 at low
concentrations (Fig. 6B, lanes 1–6). At high CRP concentrations
further non-specific binding was observed (evidenced by a
conspicuous ‘‘smear’’ in DNA migration in lane 7). In the
equivalent experiment, with PeltAB, no specific binding of CRP
was observed (lanes 8–13). However, non-specific CRP binding
was again detectable at high protein concentrations (lane 14).
Hence, CRP does not bind specifically to PeltAB. We hypothesised
that previously observed changes in PeltAB activity, in cells lacking
CRP, may occur indirectly. To test this, we cloned a 359 bp DNA
fragment, containing PeltAB, into our pRW50 lacZ expression
system. We also made a truncated 118 bp derivative of this
construct where two of the three putative CRP targets were
removed. A derivative of the truncated 118 bp construct, where
the remaining CRP site was completely ablated by point
mutations, was also made. The DNA sequences of the different
constructs are shown in S2C Fig. They are illustrated graphically
in Fig. 6Ci. Consistent with previous measurements, we found that
transcription from PeltAB increased 2.5 fold in the absence of
CRP. However, the response of PeltAB was identical when the
CRP binding sites were removed (Fig. 6Cii). Hence, although
CRP represses transcription from PeltAB, this must occur
indirectly.
Given the configuration of H-NS binding at the eltAB locus
(Fig. 6A) we reasoned that PeltAB would be repressed by H-NS in
the presence of sufficient flanking DNA. As we had done
previously for PestA1 and PestA2, we compared the binding of
H-NS to PeltAB in the presence and absence of the downstream
flanking sequence. The different DNA constructs are illustrated in
Fig. 7A and results of ChIP experiments to measure H-NS binding
are shown in Fig. 7B. As predicted, enrichment of PeltAB, in
immunoprecipitations with anti-H-NS, was only observed in the
presence of downstream DNA. Importantly, this enrichment was
specific to PeltAB and not observed for the control locus yabN.
Corresponding LacZ activities, for the different DNA constructs,
measured in M182 or the Dhns derivative, are shown in Fig. 7C.
Incorporation of flanking DNA downstream of PeltAB resulted in
a 15-fold reduction in LacZ activity that was largely relieved in the
absence of H-NS.
CRP and H-NS allow the estA1, estA2 and eltAB promoters
to respond to glucose and salt
Given the established regulatory connections between CRP and
glucose, and between H-NS and salt, we next measured changes in
the activity of PestA1, PestA2 and PeltAB in response to glucose
and salt. A complete description of assay conditions is provided in
the Materials and Methods section. Briefly, to establish the range
Fig. 2. Unoccupied CRP sites on p666 and p948 align with H-NS
bound regions. A) A histogram showing the number of putative CRP
binding sites in each of 7 discrete bins. Each bin is delineated by the
‘‘score’’ of the putative CRP site. A high score indicates a better match
to the Position Weight Matrix that represents the consensus for CRP
binding. B) The graph illustrates binding of CRP to a target from each of
the bins shown in Panel A. CRP was used at concentrations of 0, 175,
350 or 700 nM. C) ChIP-seq data for CRP and H-NS binding at five
regions of plasmids p666 and p948 that contain unoccupied CRP
targets bound by CRP in vitro. The CRP and H-NS binding profiles are
plots of sequence read counts at each position of the genome on both
the top (above the central line) and bottom (below the central line)
strand of the DNA. The y-axis scale is the same in each panel. The scale
for H-NS binding is 1,785 reads on each strand and for CRP binding is
14,000 reads on each strand.
doi:10.1371/journal.ppat.1004605.g002
The Molecular Basis for Control of ETEC Enterotoxin Expression
PLOS Pathogens | www.plospathogens.org 7 January 2015 | Volume 11 | Issue 1 | e1004605
of conditions across which the promoters were able to respond, we
examined the effect of titrating glucose or salt into the growth
medium individually. In all experiments, we used the promoter::
lacZ fusions that included downstream flanking DNA. This was to
ensure that signals sensed by both CRP and H-NS could
be integrated. As expected, the activity of PestA1 was low.
Consequently, the effects of glucose and salt were negligible (S4A
Fig.). Conversely, the activity of PestA2 was sensitive to both
glucose and salt (S4B Fig.). Thus, lacZ expression driven by PestA2
was repressed by glucose (orange line) and enhanced by salt (green
line). As expected, PeltAB activity increased in the presence of
both salt and glucose, but induction by salt was more prominent
(S4C Fig.). We hypothesised that, for PestA2, the inhibitory effect
of glucose should override the stimulatory effect of salt. Our
reasoning was that, although H-NS can repress PestA2, the
promoter is ultimately dependent on CRP for activity. Hence, we
examined the effect of adding salt and glucose, to cells carrying the
PestA2::lacZ fusion, separately and in combination (Fig. 8A). As
predicted, the inhibitory effect of glucose was dominant (Fig. 8Ai)
and was still observed in the absence of H-NS (Fig. 8Aii).
Conversely, the stimulatory effect of salt required H-NS (compare
green bars in Fig. 8). Importantly, in a separate experiment, we
also showed that the effect of glucose on PestA2 activity requires
that the CRP site is intact (S4D Fig.). The combined effect of salt
and glucose on PeltAB was more difficult to predict because CRP
acts via an undefined, and indirect, mechanism. The result of the
analysis (Fig. 8B) shows that the stimulatory effects of salt and
glucose on transcription from PeltAB are not additive. Moreover,
the stimulatory effect of glucose requires H-NS.
The response of PeltAB and PestA2 to CRP and H-NS is
conserved in other ETEC isolates and during host cell
attachment
Examination of all sequenced ETEC genomes reveals slight
variations in the sequence of the eltAB and estA2 promoter
sequences (recall that ETEC H10407 is somewhat anomalous in
also encoding estA1). Thus, we next sought to understand if our
model for regulation of LT and ST expression was broadly
applicable. We focused our efforts on ETEC E24377A since i) the
genome has been sequenced and ii) a vast array of independently
generated transcriptomic data are available for this organism
Fig. 3. The estA2 promoter is activated by a Class I CRP dependent mechanism. A) Sequence of the estA2 gene regulatory region. The CRP
binding site is shown in orange, the UP element is blue and the promoter -10 and -35 elements are shown in purple. The different promoter positions
are numbered relative to the transcription start site (+1). B) Location of the PestA2 transcription start site. The gel shows the product of an mRNA
primer extension analysis to determine the estA2 transcription start site (Lane 5). The gel was calibrated using arbitrary size standards (A, C, G and T in
Lanes 1–4). C) Binding of CRP to PestA2. The panel shows the result of a DNAse I footprint to monitor binding of CRP to the 93 bp PestA2 DNA
fragment. The gel is calibrated with a Maxim-Gilbert DNA sequencing reaction. CRP was added at concentrations of 0.35–2.1 mM. D) CRP is required
for transcription from PestA2 in vivo. The panel shows a cartoon representation of the 93 bp PestA2::lacZ fusion and a bar chart illustrates LacZ activity
in lysates of cells carrying this fusion. Assays were done in LB medium. E) i) Stimulation of PestA2 by CRP in vitro. The figure shows the results of an in
vitro transcription reaction. The 112 nt transcript initiates from PestA2 and the 108 nt RNAI transcript is an internal control. CRP was added at a
concentration of 350 nM and RNA polymerase was added at a concentration of 400 nM. ii) quantification of band intensities from the in vitro
transcription analysis.
doi:10.1371/journal.ppat.1004605.g003
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[28,29]. Using ETEC E24377A DNA as a template, we generated
a 460 bp PestA2, and 1126 bp PeltAB DNA fragment. The
sequences are shown in S2D Fig. The DNA fragments were cloned
into pRW50 and the ability of the promoters to drive lacZ
expression in response to CRP and H-NS was measured. As
expected, transcription from PestA2 was repressed by H-NS and
activated by CRP whilst PeltAB was repressed by H-NS (Fig. 9A).
We observed no effect of CRP on transcription from PeltAB in the
context of the 1126 bp ETEC E24377A fragment. This is not
unexpected because CRP acts indirectly and these indirect CRP
effects have only previously been observed in the context of short
DNA fragments containing PeltAB that are not subject to direct
repression by H-NS. We note that Sahl and Rasko previously
examined the global transcriptome response of E24377A to
glucose levels and bile salts [28]. In exact agreement with our
model for toxin regulation, and the data in Fig. 9A, this study
confirmed that i) salt induced expression of both toxins and ii)
glucose inhibited expression of estA2 [28]. Fortuitously, changes in
the ETEC E24377A transcriptome, prompted by ETEC attach-
ment to human gut epithelial cells, have also been quantified
comprehensively [29]. Briefly, in these experiments, ETEC were
added to sets of Caco-2 intestinal epithelial cell tissue cultures.
Over a time course, ETEC that had adhered to host cells were
separated from non-adhered ETEC. The transcriptomes of
adhered and non-adhered ETEC were then compared. By mining
these data, we next sought to determine if our model was
consistent with observed changes in the transcription of crp, hns,
eltA and estA during host cell attachment. Briefly, our data predict
that changes in estA expression should be directly correlated to
changes in the level of CRP and inversely correlated with changes
in levels of H-NS. Conversely, levels of eltA expression should be
inversely correlated with levels of H-NS. The result of the analysis
is illustrated in Fig. 9B. The data show that the relative levels of
crp transcription in attached and unattached cells are similar
(orange line). However, levels of hns transcription change
dramatically (green line) 60 minutes after host cell attachment.
As predicted by our model, levels of estA2 and eltA transcription
(dashed lines) inversely track changes hns transcript levels. When
undertaking this analysis we noticed that, although there was little
change in the relative level of crp mRNA between attached and
unattached ETEC cells, the absolute level of crp mRNA did
fluctuate across the time course of the experiment and between
biological replicates. Strikingly, when these absolute mRNA levels
are compared there is a clear linear relationship between crp and
estA2 expression (Fig. 9C). Note that in Fig. 9C the absolute level
of hns mRNA has been added in parenthesis for each data point.
Remarkably, the only two outlying data points in this plot
correspond to the two samples with increased hns expression. We
conclude that regulation of estA2 and eltA by CRP and H-NS is
important during the attachment of ETEC to human intestinal
epithelial cells, and that the regulatory control of ETEC toxins is
conserved across different strains.
Disrupting the regulatory switch attenuates ETEC
virulence
Taken together, our data suggest that CRP and H-NS form a
regulatory switch that controls ETEC toxicity. We next sought to
examine the effect of disabling the switch on virulence. This is not
straightforward because no animal model faithfully mimics the
disease caused by ETEC in humans. However, intranasal mouse
models have been used as a proxy for measuring E. coli
pathogenicity [30]. Importantly, pathogenic E. coli cause more
severe disease in this model than non-pathogenic strains [30].
Furthermore, ETEC strains lacking genes encoding toxins and
known colonisation factors are less virulent in this model [31]. We
opted to disrupt the regulatory switch by removing the crp rather
than the hns gene. This was a deliberate decision since E. coli
strains lacking hns are severely attenuated for growth in laboratory
conditions. Conversely, the crp null derivative of ETEC H10407
was only mildly compromised for growth in liquid culture. Hence,
we compared pathogenicity of ETEC H10407, and the crp
derivative, using the intranasal mouse model [30]. Note that the
outcome of this experiment is difficult to predict since the effects of
CRP on pathogenicity likely go far beyond the control of toxin
expression. However, it is reasonable to assume that ETEC
virulence should differ in cells lacking crp. The median survival of
mice challenged with wild type ETEC was 53 hours and the
Fig. 4. The estA2 promoter is repressed by H-NS. A) The panel shows different PestA2::lacZ fusions. The lacZ gene is shown as a red arrow and
the estA2 gene is shown as a blue arrow. PestA2 is illustrated using a bent arrow and the CRP binding site is shown as an orange box. B) H-NS binds to
PestA2 only in the presence of flanking DNA. ChIP-PCR was used to measure binding of H-NS to the different PestA2 derivatives cloned in pRW50. PCR
products were generated using primers that could detect PestA2 in the context of both the 93 bp fragment and the longer 460 bp fragment. C) The
values are b-galactsidase activity values for lysates of M182, or M182Dhns, carrying the different PestA2 derivatives. Assays were done in LB medium.
doi:10.1371/journal.ppat.1004605.g004
The Molecular Basis for Control of ETEC Enterotoxin Expression
PLOS Pathogens | www.plospathogens.org 9 January 2015 | Volume 11 | Issue 1 | e1004605
mortality rate was 100%. Conversely, the median survival of mice
challenged with Dcrp ETEC was 72 h and 20% of the mice
survived (Fig. 9D). Thus, whilst the full extent to which CRP co-
ordinates the ETEC virulence programme remains to be
determined, CRP is clearly central to the pathogenic response.
Discussion
A complex hierarchy of salt and glucose-dependent
regulation controls toxin expression
We propose that toxin expression in ETEC can be controlled by
osmo-metabolic flux. This is relevant to conditions in the small
intestine (osmolarity equivalent to 300 mM NaCl) disease symp-
toms (the extrusion of cations and cAMP into the gut lumen) and
treatment (the ingestion of solutions containing glucose and salt)
[7–11,32]. A molecular model, describing how the different signals
are integrated, is illustrated in Fig. 10. Two gene regulatory
proteins, CRP and H-NS, are central to our model. Hence, H-NS
directly represses the expression of eltAB, estA1 and estA2
(pathways ‘‘a’’ and ‘‘b’’ in Fig. 10). For estA2 and eltAB this
repression can be relieved, in an H-NS dependent manner, by
increased osmolarity. At PestA2 CRP directly activates transcrip-
tion by a Class I mechanism (pathway ‘‘c’’). H-NS can interfere
with this process by competing with CRP for binding at PestA2
(pathway ‘‘d’’). Finally, CRP can indirectly repress expression of
eltAB via an unknown pathway that is influenced by H-NS (‘‘e’’).
Both pathways ‘‘c’’ and ‘‘e’’ are sensitive to glucose availability
because of their dependence on CRP. We speculate that pathway
Fig. 5. Comparison of PestA1 and PestA2 reveals differential activity and regulation by CRP. A) Comparison of PestA1 and PestA2. The
panel shows the DNA sequences of PestA1 and PestA2. Bases that are identical are highlighted by a solid vertical line. The CRP sites are shown in
orange, the UP element in blue and the core promoter elements in purple. The sequences are numbered with respect to the transcription start site (+
1). B) Location of the PestA1 transcription start site. The gel shows products from an mRNA primer extension analysis (Lanes 5 and 6). The gel was
calibrated using arbitrary size standards (A, C, G and T in Lanes 1–4). C) Sequences of hybrid estA promoters. The sequences labelled estA2.1 through
estA2.7 are derivatives of the 93 bp PestA2 DNA fragment where different sequence elements have been replaced with the equivalent sequence from
PestA1. D) The bar chart shows b-galactosidase activity measurements for lysates obtained from cultures of M182, or the Dcrp derivative, containing
the indicated hybrid promoter fragment was fused to lacZ. E) The panel shows different PestA1::lacZ fusions. The lacZ gene is shown as a red arrow
and the estA1 gene is shown as a blue arrow. PestA1 is illustrated using a bent arrow and the CRP binding site is shown as an orange box. Assays were
done in LB medium.
doi:10.1371/journal.ppat.1004605.g005
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‘‘e’’ may include H-NS since the effects of salt and sugar on eltAB
expression were epistatic (Fig. 8). Our model for H-NS repression
of eltAB is consistent with previous work [26]. However, our
conclusion that eltAB is indirectly repressed by CRP disagrees with
a previous study [27]. Even so, we were able to faithfully
reproduce most of the observations previously described by
Bodero and Munson [27]. We note that Bodero and Munson
previously suggested that CRP may bind targets at PeltAB with a
7, rather than 6, base pair spacer between the two CRP half sites.
Such CRP targets have never been described amongst hundreds of
known CRP regulated promoters. Furthermore, we found no such
CRP sites in our ChIP-seq analysis. Given that these DNA
sequences can be deleted, without negating the effect of CRP on
PeltAB activity, the regulatory effect of CRP must be indirect.
Oral Rehydration Therapy is likely to impact on toxin
expression
Our model for regulation of ST and LT expression is pertinent
to both ETEC mediated disease and its treatment. ST and LT
trigger the extrusion of H2O, cations, and cAMP (the cofactor for
CRP) from the small intestine into the gut lumen [4–9].
Furthermore, solutions of salt and glucose are consumed by
patients to reverse this process [10,11]. We speculate that, during
infection, extrusion of electrolytes and cAMP into the gut lumen
could create a positive feedback loop to drive toxin expression.
Importantly, our model also suggests that ORT may provide
benefits beyond stimulating rehydration of the patient. The
concentration of glucose used in ORT is ,10-fold higher than
is required to repress estA2 expression. Hence, even if 90% of
glucose present in ORT solutions is absorbed before reaching the
site of infection, sufficient glucose should be present to down
regulate toxin expression. Furthermore, even though salt is able to
induce expression of estA2 and eltAB, the effect is only observed at
concentrations far higher than those found in ORT solutions.
Differential regulation of estA1 and estA2 by CRP
Our observation that estA1 and estA2 are oppositely regulated
by CRP is intriguing given the similarities between the promoter
sequences of these genes. Differential regulation is dependent on
the promoter -35 element (Fig. 5). At Class I CRP regulated
promoters an aCTD protomer sits between CRP and domain 4 of
the RNA polymerase s subunit, which is bound to the promoter -
35 element [12]. Thus, one possible explanation is that changes in
the -35 element result in subtle repositioning of s. This could
result in unproductive interactions between aCTD and s when
CRP is present.
Fig. 6. The eltAB promoter is indirectly repressed by CRP. A) The Panel shows ChIP-seq data for CRP and H-NS binding at the eltAB locus. The
sequence of 3 putative CRP binding sites proposed by Bodero and Munson (2009) are shown. The CRP and H-NS binding profiles are plots of
sequence read counts at each position of the genome on both the top (above the central line) and bottom (below the central line) strand of the DNA.
The y-axis scale for H-NS binding is 1,785 reads on each strand and for CRP binding is 14,000 reads on each strand. B) Results of an Electorphoretic
Mobility Shift Assay to measure binding of CRP to the 93 bp PestA2 fragment (Lanes 1–7) or the 359 bp PeltAB fragment (Lanes 8–14). Specific and
non-specific binding of CRP is indicated to the left and right of the gel. CRP was added at a concentration of 0.2–7.0 mM. C) Panel (i) shows different
PeltAB::lacZ fusions. The lacZ gene is shown as a red arrow and the eltAB operon is shown in purple. PeltAB is illustrated using a bent arrow and the
putative CRP binding sites are shown as open orange boxes. In panel (ii) the values are b-galactsidase activity measurements taken in M182 or the
Dcrp derivative. Assays were done in LB medium.
doi:10.1371/journal.ppat.1004605.g006
Fig. 7. The eltAB promoter is directly repressed by H-NS. A) The panel shows two PeltAB::lacZ fusions. B) The results of a ChIP-PCR analysis
used to measure binding of H-NS to the two different PeltAB derivatives shown in Panel A. C) The values are b-galactsidase activity measurements for
lysates of M182, or the Dhns derivative, carrying the different PestA2::lacZ fusions. Assays were done in LB medium.
doi:10.1371/journal.ppat.1004605.g007
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H-NS prevents CRP regulation of select target genes
Our data indicate that several strong CRP binding sites in the
H10407 genome are occluded by H-NS. This strongly suggests
that the CRP regulon has evolved to incorporate additional
environmental signals through the action of H-NS. The repressive
effect of H-NS on transcription has been widely described [23]. H-
NS represses transcription predominantly by occluding the
binding of RNAP or by trapping RNAP at promoters [20].
Recently, it was shown that H-NS occludes many binding sites for
the CRP homologue, FNR, in E. coli [21]. Thus, occlusion of
transcription factor binding sites appears to be a major function of
H-NS, especially for CRP family proteins. Note that, in order to
exclude CRP from target promoters, sites of H-NS nucleation and
CRP binding need not overlap precisely. For example, at both
estA1 and estA2, maximal H-NS binding is observed within the
coding sequence of the gene (Fig. 2C). Despite this, H-NS
oligomerisation across adjacent DNA is sufficient to prevent
CRP binding.
Conclusions
In summary, our model provides a framework for better
understanding ETEC mediated disease and its treatment. More-
over, our catalogue of CRP and H-NS binding targets provide a
useful community resource for further studies of all E. coli strains.
In particular, our ChIP-seq data for CRP report .50 targets not
identified previously in E. coli K-12 and 8 ETEC-specific targets.
Finally, our data show how very small changes in the organisation
Fig. 8. H-NS and CRP integrate signals of osmolarity and
metabolism to control expression of LT and ST. The figure shows
b-galactosidase activity measurements for lysates obtained from
cultures of M182 (i) or the Dhns derivative (ii) containing A) PestA2 or
B) PeltAB fused to lacZ in plasmid pRW50. Cultures were grown in the
presence and absence of 2% glucose and/or salt (60 mM NaCl and
20 mM KCl). Assays were done in M9 minimal medium so that the
glucose and salt concentrations could be more accurately controlled.
doi:10.1371/journal.ppat.1004605.g008
Fig. 9. Modulation of estA2 and eltA transcription during attachment of ETEC E24377A to gut epithelial cells. A) The figure shows b-
galactosidase activity measurements for lysates obtained from cultures of M182 or the Dhns and Dcrp derivatives containing PestA2 (460 bp
fragment) or PeltAB (1126 bp fragment) from ETEC 24377A fused to lacZ in plasmid pRW50. B) The panel shows log2 fold changes in the transcription
of crp, hns, eltA and estA in ETEC E24377A cells over a two hour incubation with a Caco-2 intestinal epithelial cell culture (29). The log2 values
represent the fold change in transcription between ETEC cells attached and unattached to Caco-2 cells at each time point. C) The panel shows a
scatter plot of absolute crp and estA2 mRNA levels in ETEC E24377A attached to Caco-2 intestinal epithelial cells. Each data point represents a
different biological replicate. For each data point the absolute level of hns mRNA is shown in parenthesis. D) The panel shows the survival rate of
BALB/C mice (n = 30) after intranasal inoculation with wild type ETEC H10407 or the Dcrp derivative.
doi:10.1371/journal.ppat.1004605.g009
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of gene regulatory regions can have major effects on gene
expression, such that transcription responds differently to the same
environmental cues.
Materials and Methods
Strains, plasmids and oligonucleotides
ETEC strain H10407 is described by Crossman et al. [1]. The
C-terminal crp-36FLAG tag was introduced into the H10407
chromosome using the recombineering method of Stringer et al.
[33]. Wild type E. coli K-12 strains JCB387 and M182 have been
described previously [34,35]. The Dhns M182 derivative was
generated by P1 transduction of hns::kan from E. coli K12
derivative YN3144 (a gift from Ding Jin). Plasmids pRW50 and
pSR are described by Lodge et al. [36] and Kolb et al. [37]. More
detailed descriptions of strains and plasmids, along with the
sequences of oligonucleotides, are provided in S2 Table.
ChIP-seq
Cultures were grown to mid-log phase in M9 minimal medium
with 1% (w/v) fructose at 37uC. Targeted ChIP experiments
(Fig. 4 and 6) were done exactly as described by Singh and
Grainger [38] using PestA2 or PeltAB fragments cloned in pRW50
carried in strain M182. The ChIP-seq was done as described
extensively by Singh et al. [25] using strain H10407. Briefly, H-NS
and CRP-36FLAG were immunoprecipitated using protein A
sepharose (GE Healthcare) in combination with 2 mL of anti-H-
NS or 2 ml of anti-FLAG respectively. After immunoprecipitation
and washing, beads were resupended in 100 mL 16 Quick
Blunting Buffer (NEB) with dNTPs (as specified by the manufac-
turer) and 2 mL Quick Blunting Enzyme Mix, and incubated for
30 minutes at 24uC with gentle mixing. After being collected by
centrifugation, the beads were again washed and the associated
DNA was A-tailed by resuspension of beads in 100 mL 16 NEB
buffer #2 supplemented with 2 mM dATP and 10 units of
Klenow Fragment (39R59 exo-; NEB). Following incubation for
30 minutes at 37uC, with gentle mixing, the beads were again
collected and washed. Illumina adapters (1 ml NEXTflex ChIP-seq
barcoded adapters; BioO Scientific) were added to beads
resuspended in 100 mL 16 Quick Ligation reaction buffer and
4 mL Quick T4 DNA Ligase (NEB), and incubated for 15 minutes
at 24uC with gentle mixing. After washing the beads, the DNA was
the eluted into a fresh tube by addition of 100 mL ChIP elution
buffer (50 mM Tris–HCl, pH 7.5, 10 mM EDTA, 1% SDS) and
incubation at 65uC for 10 minutes. The eluate was collected by
centrifugation for one minute at 4000 rpm. Crosslinks were
reversed by incubation for 10 minutes at 100uC. Samples were
purified by phenol extraction and precipitated with ethanol, 40 mg
glycogen and 8.3 mM sodium acetate. DNA was pelleted for
15 minutes at 4uC at top speed in a microcentrifuge, washed with
70% ethanol, dried and resuspended in 11 mL H2O. After
quantification by PCR each library was amplified, purified and
resuspended in 20 mL H2O. Libraries were the sequenced using a
HiSeq 2000 sequencer (Illumina; University at Buffalo Next
Generation Sequencing Core Facility). Sequence reads were
aligned to non-repetitive sequences in the E. coli H10407 genome
using CLC Genomics Workbench and overall coverage was
determined using custom Python scripts. Sequence reads have
been submitted to the EBI ArrayExpress database and can be
accessed using accession number E-MTAB-2917.
Bioinformatics
ChIP-seq peaks were identified as described previously [25].
We refer to these peaks as ‘‘high stringency’’ peaks. A second
round of peak calling was performed in which the sequence read
threshold values (i.e. the minimum number of sequence reads at a
given genomic position that is required for a peak to be called)
was reduced by 20%. We refer to these peaks as ‘‘low stringency’’
peaks. MEME [39] was used to identify enriched sequence motifs
in the sequences from 50 bp upstream to 50 bp downstream of
the high stringency peak centres. Thus, we identified a motif
closely resembling the known CRP consensus site in many of the
regions surrounding high stringency ChIP-seq peaks. These CRP
site sequences are included in Table 1. Those high stringency
peaks for which MEME did not identify a motif were used for a
second round of analysis using MEME. This also identified a
motif closely resembling the known CRP consensus site. These
CRP site sequences are also included in Table 1. We used
MEME to identify enriched sequence motifs in the low stringency
peak list. This also identified a motif closely resembling the
known CRP consensus site. These CRP site sequences are also
included in Table 1. ‘‘High-confidence’’ ChIP-seq peaks listed in
Table 1 include all the high stringency peaks but only those low
stringency peaks for which we identified a motif using MEME. A
complete list of all peaks, including low stringency peaks for
which a motif was not identified by MEME, is provided in S3
Table. In order to assess the location of CRP sites with respect to
TSSs we used the targets listed in Table 1. For each target the
predicted sequence from MEME was used in a BLAST search
against the E. coli K-12 MG1655 genome. All but 11 CRP sites
in ETEC had a single perfect match in the E. coli K-12
chromosome. For each perfect match the distance from the
centre of the CRP site to all transcription start sites was
calculated. Transcription start site coordinates are from Kim et
al. [40] and Cho et al. [41]. Distances between 2200 and +100
were selected and all other distances were discarded. Distances
were then grouped in bins of 5 bp each and the most common
distance bins were identified. Note that, because the position of
the CRP site was transposed onto the E. coli K-12 genome, the
distance between CRP sites and TSSs
The PWM describing CRP binding sites was generated using
the PREDetector software package and our previous list of 68
CRP binding sites in the E. coli K-12 genome [15,42]. Subsequent
bioinformatic screens of plasmids p666 and p948 were done by
importing the relevant genbank files into PREDetector and
running a binding site search with a cut-off of 7 using settings
that did not exclude CRP sites within genes. The ‘‘score’’ for each
site predicted by PREDetector increases if a closer match to the
PWM is found. To generate the chromosome and plasmid maps
shown in Fig. 1 we used DNA plotter software [43].
Data shown in Fig. 9B–C were extracted from the publically
available datasets of Kansal et al. [29] that measure changes in the
Fig. 10. An osmo-metabolic gene regulatory circuit comprised
of CRP and H-NS controls expression of LT and ST. The diagram
illustrates the regulatory effects of salt, cAMP and glucose on
transcription from the various ST and LT promoter regions.
doi:10.1371/journal.ppat.1004605.g010
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ETEC E24377A transcriptome upon contact with Caco-2
intestinal epithelial cells. The data are hosted under the GEO
accession code GSE40427. For each assay condition (planktonic
and attached ETEC cells) we extracted the signal intensity for
microarray probe sets A1527 (crp), UTI189_C1433 (hns), D4754
(eltA) and D4048 (estA). The average signal intensity was
calculated and the fold change in transcription in attached
compared to planctonic ETEC cells was determined for each time
point. The data in Fig. 9C show a comparison of absolute signal
intensities for probe sets A1527 (crp) and D4048 (estA) compared
for each of the two replicates obtained at 30, 60 or 120 minutes
after attachment to host cells. Signal intensities obtained after
30 minutes growth in LB medium (three replicates) are also
included in this analysis.
Proteins
The CRP and s70 purification was done exactly as described
previously [44,45]. RNA polymerase core enzyme was purchased
from Epicenter. RNA polymerase holoenzyme was generated by
incubating the core enzyme with an equimolar concentration of
s70 at room temperature for 20 minutes prior to use. H-NS was
overexpressed in T7 express cells from plasmid pJ414hns. After
overexpressing H-NS, cells were collected from the culture by
centrifugation and resuspended in buffer A (20 mM Tris-HCl
pH 7.2, 1 mM EDTA and 10% (v/v) glycerol) containing
100 mg/ml PMSF. Cells were lysed by sonication and the sample
was cleared by centrifugation. The supernatent was loaded directly
onto a Heparin column (Amersham) pre-equilibrated with buffer
A. A linear NaCl gradient was applied and H-NS was found to
elute at approximately 500 mM NaCl. The peak fractions were
pooled and diluted 3-fold with buffer A. The sample was then
loaded onto an S-FF column (Amersham) pre-equilibrated with
Buffer A. A NaCl gradient was applied and H-NS eluted at
approximately 550 mM NaCl. The H-NS containing fractions
were then dialysed against a buffer containing 20 mM Tris HCl
(pH 7.2), 300 mM KCl and 10% Glycerol (v/v)for storage at 2
80uC.
DNAse I footprinting and Electrophoretic Mobility Shift
Assays
DNA fragments for DNAse I footprinting or EMSA assays were
excised from pSR by sequential digestion with HindIII and then
AatII. After digestion, fragments were labelled at the HindIII end
using [c-32P]-ATP and T4 polynucleotide kinase. DNAse I
footprints and EMSA experiments were then done as described
by Grainger et al. [45] except that cAMP was added to reactions
at a concentration of 0.2 mM. Radio-labelled DNA fragments
were used at a final concentration of ,10 nM. Note that all in
vitro DNA binding reactions contained a vast excess
(12.5 mg ml21) of Herring sperm DNA as a non-specific compet-
itor. Footprints were analysed on a 6% DNA sequencing gel
(molecular dynamics). The results of all footprints and EMSA
experiments were visualized using a Fuji phosphor screen and Bio-
Rad Molecular Imager FX.
Primer extension assays
Transcript start sites were mapped by primer extension, as
described in Lloyd et al. [46] using RNA purified from strains
carrying the 92 bp PestA1 or 93 bp PestA2 fragment cloned in
pRW50. The 59 end-labelled primer D49724, which anneals
downstream of the HindIII site in pRW50, was used in all
experiments. Primer extension products were analysed on
denaturing 6% polyacrylamide gels, calibrated with size standards,
and visualized using a Fuji phosphor screen and Bio-Rad
Molecular Imager FX.
In vitro transcription assays
The in vitro transcription experiments were performed as
described previously Savery et al. [35] using the system of Kolb
et al. [38]. A Qiagen maxiprep kit was used to purify supercoiled
pSR plasmid carrying the different promoter inserts. This template
(,16 mg ml21) was pre-incubated with purified CRP in buffer
containing 0.2 mM cAMP, 20 mM Tris pH 7.9, 5 mM MgCl2,
500 mM DTT, 50 mM KCl, 100 mg ml21 BSA, 200 mM ATP,
200 mM GTP, 200 mM CTP, 10 mM UTP with 5 mCi [a-32P]-
UTP. The reaction was started by adding purified E. coli
RNA polymerase. Labelled RNA products were analysed on a
denaturing polyacrylamide gel.
b-galactosidase assays and addition of glucose and salt
to growth medium
b-Galactosidase assays were done using the protocol of Miller
[47]. All assay values are the mean of three independent
experiments with a standard deviation ,10% of the mean. Cells
were grown aerobically at 37uC to mid-log phase in LB medium
unless stated otherwise. For all experiments investigating the
effects of glucose and salt M9 minimal medium was used so that
the glucose and salt concentrations could be controlled more
accurately. The amount of glucose is shown as percentage w/v.
The addition of ‘‘salt’’ refers to a 3:1 molar ration of NaCl to KCl.
We have arbitrarily described 30 mM NaCl and 10 mM KCl as
being a ‘‘1%’’ salt solution.
Intranasal mouse infection model assays
Strains of ETEC were grown in Luria Broth (LB) to an OD600
of 1.0. Groups of 10 mice (8–10 week old BALB/c) were infected
intranasally with approximately 16109 colony forming units of
bacteria in 100 ml of inoculums according to Byrd et al. [30]. Mice
were monitored daily for 6 days post-infection for weight and
morbidity.
Ethics statement
The protocol 12-02-015IBT ‘‘Oral Immunization of Mice with
Enterotoxigenic: E coli (ETEC)’’ has been approved by the Noble
Life Sciences IACUC committee. All animal care and use
procedures adhere to the guidelines set by the Public Health
Service Policy, U.S. Dept. of Agriculture (USDA) and the Guide
for the Care and Use of Laboratory Animals of the National
Institutes of Health.
Supporting Information
S1 Fig Binding of CRP to predicted targets in vitro. A)
The data show binding of CRP to a target from each of the bins
shown in Fig. 2. B) CRP binding to remaining targets scoring
.10. CRP was used at concentrations of 0, 175, 350 or 700 nM.
The ‘‘score’’ describes how well the predicted target matches the
PWM.
(PDF)
S2 Fig Promoter DNA fragments used in this work. A)
ETEC H10407 PestA2 containing DNA fragments. B) ETEC
H10407 derived DNA fragments containing PestA1. C) ETEC
H10407 PeltAB containing sequences. D) DNA fragments
containing sequences upstream of the estA2 and eltAB genes of
ETEC E24377A.
(PDF)
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S3 Fig A) Mutations in PestA2 UP-element alter the
migration of the promoter DNA on an agarose gel. The
DNA sequences used are shown in part (i) and the mobility of the
fragments, on an agarose gel, are shown in part (ii). Note that each
sample has been loaded in duplicate. B) Mutating the UP-element
renders PestA2 uninducible by CRP. Part (i) shows LacZ activity
data for the different promoter fragments cloned in pRW50. The
pRW50 derivatives were used to transform M182 or the Dcrp
derivative. Part (ii) shows the result of in vitro transcription assays
using the different promoter fragments, cloned in pSR, as a
template.
(PDF)
S4 Fig Activity of different promoter::lacZ fusions in
the presence of increasing glucose and salt concentra-
tions. The figure shows b-galactosidase activity measurements for
lysates obtained from cultures of M182 carrying the A) estA1 B)
estA2 or C) eltAB promoters cloned in pRW50. Panel D) shows b-
galactosidase activity values for lysates of M182 and M182Dhns
cells, carrying the estA2 promoter, or a derivative lacking the CRP
site, cloned in pRW50. Cells were grown in the presence or
absence of 2% glucose. Assays were done in M9 minimal medium
so that the glucose and salt concentrations could be more
accurately controlled.
(PDF)
S1 Table Putative CRP binding targets on ETEC
plasmids p948 and p666 identified by PREDetector.
(DOCX)
S2 Table Strains, plasmids and oligonucleotides.
(DOCX)
S3 Table All CRP binding sites on the ETEC H10407
chromosome identified by ChIP-seq.
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